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ABSTRACT 
Following the molecular cloning of the PVM genome, the opportunity to 
study the individual genes and proteins of PVM has arisen. This study investigated 
the nucleocapsid (N) gene and the phosphoprotein (P) gene of PVM and attempted to 
characterise the polypeptide products expressed from the N and P genes both in vitro 
and in PVM-infected cells. The ability of the PVM N and P proteins to interact with 
each other was also investigated. 
The nucleotide sequence of the PVM P gene was determined to be 903 
nucleotides in length and shown to comprise a long open reading frame capable of 
encoding the 295 amino acid long P protein and also a smaller second ORF with the 
potential to express a polypeptide 137 amino acids in length. The PVM P protein 
shows overall amino acid homology of 35.3%, 35.6% and 28.3% to the P proteins of 
pneumovirus members HRSV, BRSV and TRTV respectively. The PVM P gene 
contrasts with the P genes of other pneumovirus genus members which do not possess 
any extensive alternative ORFs. 
Both the N and P genes of PVM were shown to be capable of directing the 
synthesis of more than one polypeptide product both in vitro and in PVM-infected 
BSC1 cells. mRNA transcribed from the PVM P gene long ORF directed the in vitro 
expression of the 39 kDa P protein and four additional polypeptides. By constructing 
transcription plasmids that contained 5' terminally truncated P gene cDNA insets, 
these polypeptides were determined to be expressed by translational initiation on 
internal P gene initiation codons. Western blot analysis determined that in addition to 
the PVM P protein, two of these in vitro expressed P protein species, with molecular 
weights of 26 kDa and 23 kDa, were expressed in PVM-infected BSC 1 cells and this 
observation was supported by the results of anti-P protein monoclonal antibody 
epitope mapping studies. The ability of the PVM P gene to direct the expression of P 
protein related polypeptides from internal initiation codons is a feature not yet 
described for any other pneumovirus member. 
By immunising rats with a synthetic peptide, antiserum specific for the second 
ORF polypeptide product (P2) was generated. Western blot analysis using this anti-P2 
antiserum identified a species thought to represent P2 in PVM-infected BSC 1 cell 
material. The ability of the PVM P gene to express a polypeptide from an alternative 
ORF is a feature common to the P genes of most other morbilliviruses and 
paramyxoviruses. 
mRNA transcribed from PVM N gene cDNA was able to direct the in vitro 
translation of the 43 kDa N protein and also a highly abundant polypeptide with a 
molecular weight of 24 kDa which was shown to be expressed by way of internal 
initiation on the fifth N gene AUG codon of the N gene sequence. The 24 kDa N 
protein related polypeptide was expressed in E. coli, purified, and used to immunise a 
rabbit for the production of anti-24 kDa polypeptide antiserum. Western blot analysis 
using this antiserum with PVM-infected BSC1 cells detected the 43 kDa N protein, a 
highly abundant 30 kDa N protein related species, but not the 24 kDa polypeptide. 
The precise identity of the 30 kDa polypeptide was not determined. Possible 
mechanisms which could account for the expression of the protein products of the N 
and P genes are discussed. 
By using a protein blotting technique the interaction that occurs between the N 
and P proteins of PVM was investigated. The P protein binding affinities of in vitro 
expressed truncated N proteins suggested that many regions of the N protein are co- 
operatively involved in the binding process, although some regions contributed more 
than others. The N protein of Sendai virus is believed to bind to the Sendai virus P 
protein in a similar way. It was also determined that both the amino and the carboxyl- 
terminal regions of the PVM P protein were found to be essential for binding to N 
protein. This contrasts with the situation determined for Sendai virus in which 344 P 
protein amino-terminal amino acids were found to be dispensable for binding N 
protein. 
CHAPTER I 
INTRODUCTION. 
Introduction 
1.1: TAXONOMIC STATUS OF THE FAMILY PARAMYXOVIRII)AE. 
1.1.1: Initial classification. 
In 1975, the International Committee on Taxonomy of Viruses (ICTV) 
suggested that the family Paraniyxoviridae should subsume three genera, namely 
paramyxovirus, morbillivirus and pneumovirus. The viruses that are currently classified 
in these three genera are shown in table 1. 
The division of the family into three genera at this time was based upon a 
consideration of physical details of both nucleocapsid structures and envelope surface 
projections determined by electron microscope investigations, and also on antigenic 
and biochemical aspects of the large glycoprotein moiety present in the virion 
envelope. Members of the morbillivirus and paramyxovirus genera possess 
nucleocapsids with a diameter of 18 nm and a helical pitch of 5-6 nm whereas the 
pneumovirus nucleocapsid has been determined to have a diameter of 13.5 nm and a 
helical pitch of 6.5 nm. The pneumovirus members possess surface projections with a 
length of 12 nrn in contrast to the paramyxovirus and morbillivirus surface projections 
which have a length of 8 nm. The members of the paramyxovirus genera all possess 
antigenically cross-reacting glycoprotein epitopes which distinguish them from the 
pneumovirus and morbillivirus genus members. The paramyxovirus genus members are 
also distinguishable by the ability of their major glycoprotein to exhibit both 
haemagglutin and neuraminidase activity whereas the major glycoprotein of neither the 
morbillivirus nor the pneumovirus genera members displays neuraminidase activity. 
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paramyxovirus morbillivirus pneumovirus 
Human parainfluenza viruses 
1,2,3, and 4 
Mumps virus 
Newcastle disease virus 
Simian virus 5 
Simian virus 41 
Bovine parainfluenza viruses 
Sendai virus (murine PIV-1) 
La-Piedad-Michoacan- 
Mexico virus 
Avian parainfluenza viruses 
Measles virus 
Canine distemper virus 
Phocine distemper virus 
Rinderpest virus 
Peste des petits ruminants 
virus 
Human respiratory 
syncytial virus 
Bovine respiratory syncytial 
virus 
Pneumonia virus of mice 
Turkey rhinotracheitis virus 
Table 1: Members of the Purunryxnviriclue family. Adapted from Galinski and 
Wechsler (1991). 
3 
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1.1.2: Current classification. 
(a) Introduction 
Since the initial classification of these genera, techniques have emerged which 
have allowed analysis of the genome and individual genes of these viruses at the 
molecular level. The gene order of the three Paramyxoviridae family genera are shown 
in figure 1. The organisation and the nucleotide sequence of the genome of 
Paramyxoviridae family members are more meaningful criteria on which to deduce 
evolutionary relatedness than the macromolecular observations that were used in the 
initial classification, described above. Genetic analysis of Paramyxoviridae family 
members has suggested that the family can be separated into four groups, namely the 
pneumoviruses, the morbilliviruses and two subgroups of the paramyxovirus genus. 
Analysis of these viruses at the molecular level has emphasised the uniqueness of the 
pneumoviruses and also confirmed the relatedness that exists between the morbillivirus 
and paramyxovirus genera. 
(b) Pneurnovirus characteristics. 
The pneumovirus genus presently comprises four viruses namely pneumonia 
virus of mice (PVM), human respiratory syncytial virus (HRSV), bovine respiratory 
syncytial virus (BRSV) and turkey rhinotracheitis virus (TRTV). These 
pneumoviruses possess a markedly different genomic structure to the other members 
of the Pararrryxoviridae family, for example their genomes have ten genes compared 
with six or seven for the paramyxovirus or morbillivirus genomes (figure 1). In 
addition, the polypeptides which are encoded by the pneumovirus genome are 
generally smaller than their homologues in other paramyxoviruses and morbilliviruses 
and the polypeptides display virtually no amino acid similarity to those of other 
viruses outside the genus 
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Genus Morbillivirus 
3' NP P/CN MF 
Measles virus 
H 
-4 
Genus Paramyxovirus 
3' NP P/CN MF HN 
L 
Parainfluenza virus III 
L 
5' 
5' 
Genus Paramyxovirus Mumps virus 
3' NP PN MF SH HN L 5' 
Genus Pneumovirus 
3' IC 1B NPM SH GF 22K 
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Figure 1. Gene order of representatives of members of the different genera of the 
family Paramyxoviridae 
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(Spriggs and Collins, 1986; Barr et a/., 1991; Yu et al., 1992a, 1992c; Chambers et 
a!., 1992), with the exception of the L protein (Stec et at., 1991) and the F protein 
(Spriggs and Collins, 1986) which both show a low but significant level of similarity. In 
addition, except for TRTV, the most recent pneumovirus member, the order of the 
glycoprotein genes on the pneumovirus genome is the reverse of that found in the 
other viruses. These disparate characteristics indicate that the pneumoviruses are 
relatively distinct evolutionarily from the other members of the Paramyxoviridae 
family. This was recognised in 1978 when the study group on the Paramyxoviridae 
family stated that future transfer of the pneumovirus genus to another taxon would not 
be surprising (Kingsbury, 1978). More recently, in 1993, the ICTV suggested that the 
pneumovirus genus should be associated with the Paramyxoviridae family but should 
be given separate taxonomic status as the sub-family Pneurnoviridae (Francki, 1991). 
Isolates of HRSV can be categorised into different subgroups on the basis of 
the reactivity of the virus encoded G, F, M and N polypeptides towards a panel of 
monoclonal antibodies (Mufson el al., 1985; Anderson el al., 1985). Between these 
subgroups, designated A or B, HRSV isolates also display variation in the molecular 
weights of the F, and F2 polypeptides (Norrby ei al., 1986) and the P protein (Cash el 
al., 1977; Norrby el cil., 1986). 
Analysis of the subgroup A and B isolates at the molecular level has allowed 
the genetic basis of the subgroup variations to be studied and these studies have 
revealed the extent of the inter-subgroup variation. Within subgroups, the G protein 
amino acid identity is high with 94% identity between subgroup A isolates A2 and 
Long (Johnson ei al., 1987) and 98% identity between subgroup B isolates 18537 and 
8/60 (Sullender el al., 1990). This contrasts sharply with the level of amino acid 
identity identified between strains A2 and 18537 which was only 53% (Johnson et al., 
1987). Although other HRSV proteins do show difference between subtype isolates, 
the variation is less than that displayed by the G protein. The SH proteins from 
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different subgroups show an overall amino acid identity of 76% (Collins et al., 1990) 
and for the F protein the inter-subgroup identity between two isolates (A2 and 18537) 
was found to be 91% (Johnson and Collins, 1988). The inter-subgroup amino acid 
identity (for strains A2 and 18537) of the internal virion components is consistently 
high (N [96%], IB [92%], 22K [92%], P [90%], IC [87%], Reviewed by Collins, 
1991). The intra-group amino acid conservation is considerably higher than inter-group 
conservation for all proteins which suggests that the two subgroups have been 
evolving for some time. 
(c) Division of the paramyxovirus genus. 
From comparisons of the amino acid sequence of many of the proteins 
expressed by members of the paramyxovirus genus it has been concluded that the 
genus can be divided into two distinct groups, namely the homogeneous PIV-I group 
containing HPIV-l, SEN, HPIV-3, and BPIV-3 and the more diverse PIV-2 group 
which is composed of HPIV-2, SVS, SV4I, MuV, HPIV-4A, HPIV-4B and NDV. 
(Rima, 1989, Miyahara e/ a/., 1992). This grouping is supported by several other 
observations, such as immunological cross-reactivity and electrophoretic mobility of 
the member virus P proteins. The strategy used to express the P gene also divides the 
paramyxoviruses into these two groups. The P protein of the PIV-I group is encoded 
by a faithfully copied rnRNA and the V protein is translated from a mRNA in which a 
non-templated G residue has been inserted (section 1.4.3.1). In contrast the P protein 
of the PIV-2 group is translated from an mRNA in which two non-templated G 
residues are inserted and the mRNA faithfully copied from the P gene encodes the V 
protein. Additional reinforcement of this division is seen in the gene start sequences 
and the intergenic sequences of the paramyxovirus members. In the viruses of PIV-1 
group these sequences show a fair degree of conservation, whereas in the PIV-2 
group, these sequences are variable. 
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(d) Paramyxovirus and morbillivirus relationships. 
The morbillivirus genus members are almost identical to the members of the 
PIV-I group of paramyxoviruses in regard to genetic map, arrangement and sizes of 
ORFs and sequences of intergenic regions (Collins, 1991). In addition the morbillivirus 
N, M, F, and L proteins share sequence relatedness to their paramyxovirus 
counterparts. The degree of relatedness shown by the morbilliviruses to each of these 
two groups depends on which of the viral proteins are being compared. For example, 
on the strength of amino acid sequence similarities of the N proteins, the morbillivirus 
members are more related to the PIV-1 group, whereas if the M protein amino acid 
sequences are compared, the morbillivirus members are more related to the PIV-2 
group. Recent phylogenetic analyses based on the nucleotide sequence of the L protein 
gene and the P and V protein gene of many paramyxovirus and morbillivirus members 
have suggested that measles virus (MV) is more closely related to the PIV-1 group of 
paramyxoviruses than the PIV-1 group is towards NDV, a PIV-2 group member (Stec 
et al., 1991). 
1.2: THE INCIDENCE OF PVM. 
1.2.1: Original isolation. 
The isolation of a novel virus capable of inducing a fatal pneumonia in mice 
was reported in 1939 (Horsfall and Hahn, 1939). These workers were attempting to 
isolate a virus from the pharyngeal washings of patients with various non-influenzal 
diseases. The washings were inoculated into mice via the nasal route and lung 
suspensions of inoculated mice were serially passed to other mice. To act as a control, 
lung homogenates of apparently healthy mice were also serially passed to other mice. 
In both series, passage of lung material resulted in the appearance of pulmonary 
consolidation in subsequent lung biopsies. In a later study, a total of 31 separate series 
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were carried out. From 65% of these series an agent responsible for producing 
transmissible pneumonia was isolated. Death resulted on average after the fifth passage 
but occurred as early as the third passage and the cultivation of a disease causing agent 
was believed to be due to the presence of a latent virus in the original animals (Horsfall 
and Hahn, 1940). 
1.2.2: Incidence in mammals. 
Early studies found evidence for infection in several other species of animal 
following intranasal inoculation with PVM. This observation led to the conclusion that 
PVM was only pathogenic towards mice (Horsfall and Hahn, 1940). Evidence for the 
occurrence of a virus related to PVM in hamsters (Pearson and Eaton, 1940) and in 
both cotton rats and rabbits (Eaton and Van Herick, 1944) was reported soon after. 
Horsfall and Curnen (1946), later demonstrated the presence of PVM neutralising 
antibody in rabbits, cotton rats, monkeys (Macaca mtnlalla), humans, chimpanzees, 
hamsters and guinea pigs, but not in chickens or mongooses. Since the presence of 
such antibodies suggested a previous encounter with PVM, it was postulated that 
PVM or a related virus was widely distributed amongst mammalian species. More 
recent studies have identified PVM as being prevalent in laboratory animal colonies of 
both hamsters and guinea pigs (Carthew cat (r/., 1978), although Gannon and Carthew 
(1980) were unable to detect the presence of PVM in two guinea pig colonies which 
were tested. Several studies have found that PVM replication is restricted to the lungs 
(Carthew and Sparrow, 1980; Weir e1 al., 1988, Horsfall and Hahn, 1940; Horsfall and 
Ginsberg, 1951). However a more recent study by Smith ei al., (1984) determined that 
replication can also occur in the upper respiratory tract. PVM may therefore not be 
strictly pneumotropic. 
1.2.3: Incidence in humans. 
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In initial studies, the presence of PVM neutralising antibody in the serum taken 
from laboratory workers in contact with mice was reported. Humans who had no such 
contact with mice also possessed neutralising antibodies (Horsfall and Hahn, 1940). An 
additional study by Horsfall and Curnen (1946) demonstrated the presence of 
neutralising antibody in 27% of a large group of humans. Horsfall ei al., (1943) also 
reported the recovery of a virus believed to be PVM from patients with primary 
atypical pneumonia. Unfortunately these virus isolates are no longer available for 
clarification of this potentially important finding. 
A more recent study performed by Pringle and Eglin (1986) determined that in 
a random sample of adult sera, 75% possessed PVM neutralising antibody. A study of 
108 paired serum samples was undertaken and in 4 instances apparent seroconversion 
occurred, indicating that PVM, or an antigenically related virus, may contribute to the 
load of human respiratory disease, although the clinical significance is unclear. 
1.3: THE STRUCTURE OF THE PNEUMOVIRUS VIRION. 
With the use of halogenated deoxyuridines and acridine orange, PVM was 
demonstrated to possess a single-stranded RNA genome (Harter and Chopin, 1967). 
Electron microscopic examination of PVM morphology identified the presence of an 
outer membrane surrounding both circular and filamentous PVM particles. This 
membrane was determined to be host cell derived due to the observation that the 
budding virion was continuous with the cell membrane. The presence of an internal 
thread-like structure within the filamentous particles was identified, and the diameter of 
this internal component of the filaments was found to be between 12 and 15 nm. The 
circular particles were extremely abundant and because of this were thought not to 
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represent cross-sectioned filaments (Compans et a/., 1967). In a comparative study of 
the morphology of I-IRSV and PVM, Berthiaume ei a/., (1974) described the PVM 
virion in more detail. The internal, thread-like, nucleocapsid component of the 
filamentous PVM virions was measured with increased resolution and determined to 
have a diameter of 13.5 nm and a helical pitch of 6.5 nm. The thread-like nucleocapsid 
structures were absent from the circular virion forms but due to the appearance of dots 
in their centres, these circular forms were believed to represent filament cross sections. 
A diagrammatical representation of the PVM virion is shown in figure 2. The 
internal nucleocapsid component of the virion is composed of the RNA genome 
associated with the nucleocapsid protein (N), the phosphoprotein (P) and the large 
protein (L). Surrounding the internal nucleocapsid is the virion envelope which is the 
location for the attachment glycoprotein (G), the fusion glycoprotein (F) and possibly 
the small hydrophobic protein (SH). The matrix protein (M) and the 22K (or M2) 
protein are believed to be located on the inner face of the outer membrane. The 
remaining two PVM polypeptides, IB and I C, are believed to be non-structural by 
analogy with HRSV. 
1.4: THE POLYPEPTIDES OF PVM. 
1.4.1: Introduction 
In the instances where little is known about a PVM polypeptide, the 
corresponding polypeptide of HRSV is discussed in detail. Due to the close 
relatedness of these viruses, their protein components are expected to be very similar 
in structure and function. The polypeptides are described in turn beginning with the 
II 
Figure 2. Diagramatic representation of the PVM virion 
showing the major protein components. 
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internal nucleocapsid associated components (N, P and L), followed by the matrix (M) 
and 22K proteins, then the non-structural IC and IB proteins and finally the membrane 
proteins F, G and SH. 
1.4.2: The nucleocapsid protein. 
The PVM N gene, which is the third gene on the PVM genome, is 1215 
nucleotides in length and has the capacity to encode the 393 amino acid long PVM N 
protein (Barr el al., 1991). The molecular weight of the N protein predicted from the 
amino acid sequence (43,141 Da), matches the molecular weight calculated for this 
protein by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE; 
43 kDa). Comparison of the amino acid sequence of the N proteins of PVM and 
HRSV reveals that they are extremely similar with an overall identity of 60%. 
Especially high identity between these two proteins is seen for the region containing 
amino acids 245 to 3 15 for which 68 out of 71 amino acids are identical. The high 
degree of conservation that is seen between these proteins is consistent with the 
observation that the N proteins of PVM and HRSV are serologically related (Gimenez 
el al., 1984). The PVM N protein also shows a good level of identity with the BRSV 
N protein (Samal el al., 1991) and the TRTV N protein (45%, A. Easton, pers. 
comm. ) and thus it seems that the pneumovirus N proteins are well conserved. The 
pneumovirus nucleocapsid proteins are very much shorter than the N proteins of other 
Paramyxoviridae family members, and this feature complicates the search for amino 
acid and structural homologies that may exist between these proteins. However, 
limited regions of apparent identity have been identified between the PVM N protein 
and the N proteins of various other non-segmented, negative sense, single stranded 
RNA viruses such as the rhabdovirus, vesicular stomatitis virus, and the filovirus, 
Ebola virus (Barr el al., 1991). Furthermore, the hydropathy profiles of N proteins 
from PVM and from members of each of the distinct groups of non-segmented, 
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negative sense, single stranded RNA viruses resemble each other in the same region 
that displays greatest sequence similarity between the N proteins of the paramyxovirus 
and morbillivirus genera (Galinski el al., 1986). In accordance with the assumption that 
the pneumovirus N protein shares functional properties with N proteins of other 
Paramyxoviridae family members, the PVM N protein would be expected to represent 
the major structural protein of the viral nucleocapsid which is responsible for 
encapsidation of the RNA genome, a function which requires the ability for the N 
protein to not only interact with the negative stranded genome molecule (vRNA) but 
also to other N protein molecules. In addition, the functional N protein must allow the 
RNA dependant RNA polymerase to access the vRNA and this function supposes that 
the N protein must be capable of interacting with the polyrnerase components, namely 
the L and P proteins. In accordance with this scheme, recent work has shown that the 
BRSV N protein is capable of interacting with the BRSV P protein (Samal el al., 
1993), and work presented in this thesis shows that the PVM N protein is able to 
interact with the PVM P protein (chapter 10). The N and P proteins of HRSV have 
also been shown to form an association when co-expressed from cDNA clones using a 
vaccinia transient expression system (Garcia el at., 1993). 
1.4.3: The phosphoprotein. 
Determination of the PVM P gene nucleotide sequence is reported in this thesis 
and for this reason the results of the sequence analysis are not extensively reported in 
this section, but are fully described in Chapter 3. 
The PVM P gene is 903 nucleotides in length, and directs the synthesis of the 
295 amino acid PVM P protein from a open reading frame that stretches from an AUG 
codon at nucleotide position 10, to an UAG codon at nucleotide position 895. The P 
gene also contains a second open reading frame which begins at an AUG codon at 
nucleotide position 131 and which ends at an UAG codon located at nucleotide 
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position 542. This smaller ORF has the capacity to encode a polypeptide 137 amino 
acids in length. The P protein genes of HRSV and TRTV do not possess a second 
open reading frame (Satake et (d., 1984, Lambden, 1985; A. Easton, pers. comm. ). The 
presence of the second ORF in the P gene of PVM means that possession of aP gene 
with multiple ORFs is not an exclusive property of the P genes of members of the 
paramyxovirus and morbillivirus genera. The predicted molecular weight of the PVM P 
protein is 32,916 Da. This figure is not in close agreement with the observed molecular 
weight of the P protein as estimated by SDS-PAGE analysis, which is 39 kDa (Cash et 
al., 1979, Ling and Pringle, 1989a). Aberrant migration in SDS-PAGE seems to be a 
common feature of the P proteins of Paramyxoviridae family members and this 
phenomenon is believed to stem from the inability of SDS to maximally bind to the P 
proteins on account of their characteristically negative charge (Caravokyri and Pringle, 
1992). In vivo labelling studies determined that the PVM P protein is phosphorylated 
(Ling and Pringle, 1989a). The HRSV P protein is also phosphorylated and a study by 
Navarro el al., (1991) mapped the sites of the phosphorylated residues to the central 
region of the molecule. By analogy with the P proteins of other Paramyxoviridae 
family members, the PVM P protein is believed to represent a component of the RNA 
dependent RNA polymerase. In these viruses, phosphorylation of the P protein is 
involved in the regulation of transcriptional activity of the viral polymerase complex, 
and thus phosphorylation of the HRSV and PVM P proteins may perform a similarly 
crucial function. 
In the light of finding that the PVM P gene has a second extensive ORF, it is 
informative to understand the strategies used in the expression of the multiple ORFs of 
the P genes of other Paramyxovir/dae family members. 
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1.4.3.1: THE P PROTEIN OF PARAMYXOVIRII)AE FAMILY MEMBERS. 
All paramyxovirus and morbillivirus P genes analysed to date are capable of 
directing the expression of several polypeptide products. In order to do this the P 
genes are able to utilise reading frames other than that which encodes the major P 
protein, or are able to switch between ORFs by RNA editing. The mechanism of RNA 
editing has been demonstrated in a number of viruses including SV5 (Thomas ei al., 
1988), MV (Catteneo el al., 1989), SEN (Vidal el al., 1990a), MuV (Paterson and 
Lamb, 1990, Takeuchi ei al., 1990), HPIV-2 (Ohigmoto el al., 1990, Southern et al., 
1990) HPIV-4A and 4B (Kondo el a/., 1990), BPIV-3 (Pelet el al., 1991), HPIV-3 
(Galinski el al., 1992), phocid distemper virus (Blixenkrone-Moller el al., 1992) and 
porcine LPMV (Berg ei al., 1992). RNA editing activity results in the insertion of non- 
templated G nucleotides at specific sites during transcription of the P gene which 
causes a frame-shift, thus allowing access to alternative reading frames. These above 
viruses fall into two groups based on the way in which they express their P proteins. 
For MV, SEN, BPIV-3, HPIV-3 and phocid distemper virus, the unedited mRNA is 
translated to give the P protein whereas the edited mRNA accesses the V ORF. 
However, with MuV, SV5, HPIV-2 and 4, and LPMV, the P protein is expressed from 
an edited mRNA and the V protein is expressed from the unedited message. 
Interestingly the V protein is the most highly conserved of all the paramyxovirus and 
morbillivirus P gene products, particularly in a 55 amino acid domain which contains 
six conserved cysteine residues (Thomas cal al., 1988). The similarity of these V 
proteins to transcriptional cofactors such as zinc-finger proteins (Klug and Rhodes, 
1987) and the HIV tat protein (Frankel el a/., 1988) has led to speculation that the V 
protein may be involved in RNA synthesis and available evidence supports this (Curran 
el al., 1991 a, 1991 b). 
In addition to the mechanism of RNA editing, many of these viruses contain 
alternative cistrons which are accessed by independent ribosomal initiation. The P 
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gene of SEN has been particularly well studied and has been found to give rise to 8 
polypeptides by using both expression strategies (Curran et al., 1991a, b). The SEN P 
gene has three ORFs, the P ORF, the C ORF and the V ORF (figure 3). The C ORF is 
expressed by independent ribosomal initiation at four separate initiation codons, one 
of which is a non-AUG codon (ACG), to give rise to the C, C', Y1 and Y2 
polypeptides. The V ORF is expressed from an mRNA which contains a single G 
nucleotide insertion at a specific site and causes a switch from the P ORF to the V 
ORF at this position. The insertion of G residues at the insertion site is not always 
precise and the addition of two G residues rather than one leads to the transcription of 
an mRNA capable of expressing the W protein which represents a truncated form of P 
with two codons of the C ORF at its carboxyl-terminal end. The final polypeptide 
expressed from the SEN P gene is the X protein which is thought to be expressed 
from the P protein ORF by ribosomal initiation on either of two AUG codons located 
at least 1500 nucleotides from the 3' end of the P gene coding region. Which of the P, 
C, V or W mRNAs are responsible for expression of the X polypeptide and also the 
way in which scanning ribosomes are able to initiate at this codon when it is 
positioned so far from the 5' mRNA cap structure is unclear (Curran et al., 1988b). 
The insertion of non-templated G residues is believed to occur by controlled 
polymerase stuttering in which the polymerase pauses on the P gene and the 3' end of 
the newly formed mRNA slips upstream of the template re-exposing an already 
copied region of the template which can then be re-transcribed into the nascent mRNA 
(Vidal ei al., 1990b). For each group of viruses, the precise number of Gs which 
correctly change the P and V ORFs are inserted with high frequency and the slippage 
model is able to explain this feature due to the stability of the miss-aligned intermediate 
which in the case of SEN occurs after a one base slippage and in the case of BPIV-3, 
occurs after a two base slippage. The expression of the P gene is further complicated in 
HPIV-3 and BPIV-3 in that a 
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Figure 3. Protein coding regions of the SEN P/C and SEN V/C mRNAs (adapted 
from Kolakofsky et al., 1991). The P, C, and V ORFs are shown as clear, shaded and 
black rectangles respectively. The nucleotide positions of several start codons and also 
the polypeptides they encode are indicted. The insertion site at which a single 
nucleotide is added in the synthesis of the V/C mRNA and which leads to a fusion of 
the P and V ORFs is also indicated. The X protein is thought to be expressed by 
initiation on AUG 1523. Addition of two G residues at the insertion site gives rise to an 
mRNA that encodes the W protein which represents a fusion of the P and the C ORFs. 
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fourth ORF, called the D ORF, exists which is in the same phase as the C ORF and 
which is accessed by insertion of 2G residues at the insertion site (Pelet et al., 1991). 
Although two slippage sites have been identified on the BPIV-3 P gene only the first 
one appears to be functional and access to all the P ORFs is achieved by removing the 
constraints which control the number of slippage rounds that can take place at this 
position. The C proteins expressed from the P gene of SEN and several of these other 
viruses seem to be present at very low abundances as structural components of purified 
virions (Yamada el al., 1990), and since they can clearly associate with nucleocapsid 
components, much attention has been focused on assessing whether these polypeptides 
play a role in the regulation of the function of the viral polymerase. 
1.4.4: The Large protein. 
A cDNA clone representing the PVM L protein gene has not yet been obtained 
and this reflects the scarcity of L gene mRNA due to its location on the genome 
furthest from the postulated 3' polymerase binding site (figure 1). The PVM L protein 
migrates in SDS-PAGE with an observed molecular weight of 191 kDa (Cash et al., 
1979; Ling and Pringle, 1989a) which is similar to the observed molecular weight of 
the HRSV L protein which Cash el a!., (1977) determined to be approximately 200 
kDa and Ling (1989) determined to be 190 kDa. 
The nucleotide sequence of the HRSV L protein was recently determined (Stec 
et al., 1991). The deduced amino acid sequence of the 1-[RSV L protein is 2165 amino 
acids in length and has a calculated molecular weight of 250,226 Da which is in close 
agreement with the observed molecular weight values given above, given the inherent 
inaccuracies of the gel system used. The 22K gene of HRSV contains the gene start 
signal for the L gene (Collins et at, 1987). The two genes overlap by 68 nucleotides 
and whilst the L gene overlap contains the beginning of the L ORF, the sequence of the 
22K gene in the overlap region is non-coding. A consequence of this overlap is that L 
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gene start is followed 68 nucleotides later by the 22K gene stop signal, and thus in 
order for the L gene to be expressed, this stop sequence must be ignored. The presence 
of the gene end sequence within the L gene leads to drastic attenuation of L gene 
transcription. The PVM 22K and L genes do not appear to overlap in this way (P. 
Chambers, unpublished data). 
By analogy with other similar viruses, the pneumovirus L protein is believed to 
represent the major component of the viral RNA dependent RNA polymerase which is 
responsible for the synthesis of viral rnRNAs, full-length replicative positive sense 
genomes and progeny vRNA genomes. Also by analogy, the pneumovirus L protein 
would be expected to possess enzymatic activities of mRNA capping, methylation and 
polyadenylation and the ability to act as a protein kinase (Hamaguchi el al., 1983; Hunt 
et al., 1984; Sanchez el al., 1985). Since the HRSV L protein sequence was reported, 
several observations have been made which support the validity of these functional 
assignments for the pneumovirus L protein. The HRSV L protein is very similar in 
length to the L proteins of other non-segmented and segmented negative stranded 
viruses, which are remarkably constant in length being between 2109 and 2238 amino 
acids long (Stec et al., 1991). Poch el al., (1989) identified 4 regions within a variety 
of RNA dependent RNA and DNA polymerases that were proposed to be involved in 
polymerase function. These 4 domains are present in the HRSV L protein which 
suggests distant relatedness and common function. Statistically important sequence 
similarity was detected between the HRSV L protein and several other non-segmented 
negative stranded RNA viruses. In descending order, the most similar were the L 
proteins from PIV-3, MV, SEN, NDV and rabies virus. The L protein is only the third 
pneumovirus protein, after the 1- RSV F protein (Spriggs and Collins, 1986) and the 
PVM N protein (Barr et al., 1991) to share some degree of amino acid relatedness 
with other members of the family Parannyxoviridae, although the homology 
demonstrated by the L protein is by far the most significant. 
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1.4.5: The Matrix protein. 
The Matrix protein gene of PVM is 927 nucleotides in length and has the 
capacity to encode a polypeptide 257 amino acids in length (P. Chambers, pers. 
comm. ). The predicted molecular weight of this polypeptide is 28,312 Da, which 
closely agrees with the observed molecular weight of the putative PVM M protein in 
SDS-PAGE (27.3 kDa; Ling and Pringle, 1989a). The PVM M protein shows a good 
degree of amino acid identity with the M protein of HRSV (41.3%; Satake and 
Venkatesan, 1984), however no identity has been detected between the PVM M 
protein and the M proteins of any other Paramyxoviridae family members. The PVM 
M protein is both extremely basic and extremely hydrophobic. It has been suggested 
that a hydrophobic domain located in the carboxyl-terminal region of the HRSV M 
protein, which is also present in the PVM M protein, may be responsible for interaction 
with the cell membrane (Collins, 1991). Reports concerning pneumovirus M protein 
phosphorylation are conflicting; Gruber and Levine (1985) believed that the HRSV M 
protein was not phosphorylated whereas studies by Lambert (1988) suggested that it 
was. The M protein expressed in PVM-infected BSCI cells is not thought to be 
phosphorylated (Ling and Pringle, 1989a). 
The pneumovirus M protein has not been functionally characterised, and so 
functions are inferred from the more extensively characterised counterparts in the 
Paramyxoviridae and Rhahdovirideie families. The M proteins of many 
Paramyxoviridae family members are believed to be involved in functions relating to 
maturation and assembly of the virion, and it has also been suggested that the M 
protein may be able to regulate RNA synthesis by interacting with active nucleocapsid 
structures. The M protein is considered to form an essential bridge between the 
assembled nucleocapsid and the cytoplasmic tail of the viral glycoprotein, and this 
supposition is strengthened by studies that have indicated that the M protein of 
Paramyxoviridae family members is able to interact with the nucleocapsid structure, 
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the viral glycoproteins and also itself (Peeples, 1991). In addition, the M protein is able 
to interact with a variety of cellular components such as membrane lipids and 
cytoskeletal elements which may be involved in the assembly of virus particles, and 
also in virus budding. 
The association of the NDV M protein with plasma membranes was initially 
revealed by cell-fractionation experiments (Schwalbe and Hightower, 1982). Faaberg 
and Peeples (1988) demonstrated that the ability of NDV M protein molecules to 
associate with lipid membrane structures in the form of liposomes was not governed by 
forces of an electrostatic nature, but that the interaction probably arose through the 
presence of a hydrophobic domain on the M protein. Charge independent association 
of M protein and lipid membranes was previously shown to occur with the M protein 
of influenza virus (Bucher el al., 1980). In contrast to these results was the finding that 
the interaction between the VSV M protein and lipid membranes was dependent to 
some degree on electrostatic attraction since M protein only binds negatively charged 
liposomes (Zakowski et cal., 1981). The nature of the interaction between VSV M 
protein and the cell membrane still remains unclear. The VSV M protein is believed to 
associate with the membrane of Hela cells in the absence of all other virus encoded 
components and during the interaction with the membrane, part of the M protein is 
thought to be extended into the membrane interior (Chong et al., 1993). Experiments 
by Li et cil., (1993) using a baculovirus expression system, have indicated that the VSV 
M protein has the intrinsic property of promoting invagination of a circumscribed 
region of the host cell cytoplasmic membrane, leading to the liberation of liposome 
structures. This function was found to be solely directed by the M protein, a finding 
contradicted by Pattnaik and Wertz (1991) using a vaccinia virus T7 expression 
system, who did not observe budding when M protein was expressed alone. The ability 
of VSV M protein to independently bind to membranes differs from the situation in 
SEN where the M protein was found to be unable to associate with membranes when 
expressed on its own (Sanderson et al., 1993). 
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There is much evidence to suggest that the M protein is able to associate with 
viral glycoproteins. In VSV, the M protein has been shown to be physically attached to 
G protein in virions through chemical cross-linking experiments (Dubovi and Wagner, 
1977). The VSV M protein is believed to associate with G protein in a specific and 
reversible manner which is a necessary requirement to account for the proposed role of 
the M protein in virus assembly (Lyles el al., 1992). These workers also revealed that 
the binding of M protein to G was enhanced when the M protein was supplied in the 
form of N-M complexes, supporting the assembly model in which the M protein brings 
the nucleocapsid and glycoprotein laden membrane together in the process that leads 
to budding of the virus particle. In either paramyxovirus or morbillivirus systems, 
demonstration that a definitive physical relationship exists between M and G proteins 
has not yet been reported, although the observation that cellular location of membrane 
bound M protein appears to be determined by the location of the SEN glycoproteins 
suggests that these protein species do associate (Sanderson et al., 1993). 
Whereas the ability of the paramyxovirus M protein to bind to glycoproteins is 
somewhat unclear at present, chemical cross-linking experiments have unequivocally 
shown that it is capable of interacting with itself (Nagai el al., 1978). In addition, 
electron micrographs of preparations of purified M protein have revealed the ability of 
M protein to associate and form tube structures composed of a two-dimensional 
crystalline array of parallel strands wound into a helix, reminiscent of structures found 
on the cytoplasmic surface of infected cell plasma membranes. Interaction of the 
paramyxovirus M protein with the N protein is also well established. Homann ei al., 
(1991) demonstrated specific binding between the SEN M and N proteins using a 
protein blotting technique. These workers also demonstrated that the M protein was 
capable of association with an unidentified cellular component, a function also 
suggested by Sanderson et al., (1993). 
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The SEN M protein has been shown to inhibit, by 90%, the ability of purified 
nucleocapsids to transcribe RNA (Marx el al., 1974) and the inhibitory effect of M 
protein on transcription of VSV genomes is well documented (De ei al., 1982, Black 
et al., 1992; Black el al., 1993, Li el al., 1993). The M protein is able to condense the 
nucleocapsid into transcriptionally inactive forms, the inactivity presumably being due 
to structural hindrance of the polymerase as it attempts to pass along the template (De 
ei al., 1982). It has been suggested that the VSV M protein associates with the 
nucleocapsid by its amino-terminal end (Shipley el a!., 1988). 
It has been suggested that defects in the M protein may be responsible for establishing 
MV persistence. M proteins isolated from a patient with SSPE were found to be 
unable of associating with nucleocapsids (Hirano et at., 1992) and the M gene of a MV 
isolate taken from a patient afflicted with SSPE was found to contain an amber 
mutation which prevented expression of functional M protein (Catteneo et al., 1986). 
1.4.6: The 22K (M2) protein. 
The 22K gene of PVM is 868 nucleotides long and has the potential to encode 
a polypeptide 176 amino acids in length. Using two dimensional SDS-PAGE, Ling and 
Pringle (1989a) identified a basic polypeptide having a molecular weight of between 23 
kDa and 24 kDa which they suggested was the PVM 22K species. The PVM 22K 
protein shows considerable amino acid identity to the 22K proteins of HRSV, BRSV 
and TRTV, and these three polypeptides have similar hydropathy plots which indicates 
a degree of structural conservation over regions where amino acid identity is not 
strong (Yu el al., 1992b; Collins and Wertz ., 
1985; Zamora ei al., 1992). The 
pneumovirus 22K proteins have not been functionally characterised, and since the 22K 
proteins are unique to the pneumoviruses, no possible functions can be inferred from 
other related viruses. Fluorescent antibody studies have suggested that, in HRSV- 
infected cells, the HRSV 22K protein associates with the N and P proteins (Routledge 
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et al., 1987). In addition, the N and 22K proteins of BRSV have been shown to 
associate in vitro using a protein blotting technique (Samal et al., 1993). The 
interaction of 22K and N proteins both in HRSV-infected cells and also in cells 
transfected with vaccinia vectors was demonstrated by Garcia et al., (1993) using 
immunofluorescence and immunoprecipitation studies. In addition to the identification 
of internally located 22K protein, the 22K species has been shown to be present within 
the cell membrane of HRSV-infected cells by salt and detergent dissociation studies 
(Huang et al., 1985). Thus, like the M protein, the 22K protein seems to be found in 
association with both nucleocapsid structures and also the cell membrane, suggesting 
that, like M protein , 
it may be involved in virion assembly. It has been suggested that 
the functions fulfilled by the M protein of other non-segmented negative sense RNA 
viruses has been split between the pneurnovirus M and 22K proteins (Collins, 1991). 
1.4.7: The 1B and IC proteins. 
The genes which encode these two proteins are located closest to the 3' end of 
the PVM genome. Given a single entry site for transcription by the pneumovirus RNA 
dependant RNA polymerise at the 3' end of the genome, and attenuation of 
transcription at successive intergenic regions, this location would suggest high levels of 
transcription of mRNA species corresponding to these genes (figure 1 and section 
1.6.4). This suggestion is supported by the high proportion of lB and 1C mRNA 
species cloned as cDNA, reported during the molecular cloning of PVM (Chambers el 
al., 1990a), and also the high levels of the lB and IC proteins in PVM-infected BSC 1 
cells (Cash el al., 1979, Ling and Pringle, 1989a). 
The IB and IC genes are 410 and 571 nucleotides in length respectively. The 
IC gene polypeptide product is predicted to be 113 amino acids long and have a 
molecular weight of 12,906 Da. This is in close agreement with the observed molecular 
weight for this species in PVM-infected BSC I cells which is between 14 and 16 kDa, 
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depending on the SDS-PAGE system used (Cash el al., 1979; Chambers el al., 1990a, 
Ling and Pringle, 1989a), The IB gene polypeptide product is 156 amino acids in 
length and is predicted to have a molecular weight of 18,234 Da which is close to the 
molecular weight of this species determined by SDS-PAGE, which varies between 17 
kDa and 20 kDa depending on the conditions of electrophoresis (Cash et al., 1979; 
Ling and Pringle, 1989a; Chambers el al., 1990a). Interestingly the IC gene has an 
extensive second open reading frame which is accessed by the third AUG codon from 
the 5' end of the mRNA and is capable of encoding a polypeptide 69 amino acids in 
length. In addition, the first AUG codon of the IC gene is followed by a second AUG 
codon only nine nucleotides downstream. Neither of these AUGs are in good context 
for initiation (Kozak, 1986a, 1986b) but it is possible that they are both used since two 
closely migrating forms of the IC polypeptide are seen in PVM-infected BSCI cells 
(Ling and Pringle, 1989a). Perhaps the poor initiation context for these two in-frame 
AUG codons allows scanning ribosomes to access the second ORF. 
The IB and IC genes of PVM are not detectably homologous to the lB and 
1C genes of HRSV, or any other HRSV gene. A comparison of amino acid homologies 
between the lB and IC gene products and their HRSV counterparts was more 
successful in that a moderate level of homology (29% identity) was identified over a 35 
amino acid carboxyl-terminal segment of the PVM and HRSV 1B polypeptides 
(Chambers el cd., 1991). 
The lB and IC polypeptides of PVM or HRSV have not been functionally 
characterised although due to their absence in the virion they appear not to be 
structural, and this observation invites the suggestion that these polypeptides may be 
involved in replication and transcription of the genome. 
1.4.8: The fusion protein. 
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The F gene of PVM is 1657 nucleotides in length and encodes a polypeptide 
537 amino acids in length (Chambers et al., 1992). From the deduced amino acid 
sequence, the predicted molecular weight of the F protein is 59,374 Da. Hybrid 
arrested translation experiments identified the F gene protein product to have a 
molecular weight of only 49,000 Da (Chambers el al., 1990a). The PVM F protein 
shows approximately 40% overall amino acid identity with the HRSV and TRTV F 
proteins (Chambers et al., 1992). The amino acid sequence identity between the BRSV 
and HRSV F proteins is 80% and 81%, depending on HRSV subgroup, and this figure 
is slightly lower than for the identity between the F proteins of the two HRSV 
subgroups which is 90% (Walravens el a!., 1990). In common with other PVM 
proteins, comparisons between the PVM F protein and the F proteins of other 
paramyxovirus and morbillivirus members revealed only a low (10%) overall amino 
acid identity (Chambers et a!., 1992). A slightly higher degree of amino acid identity 
exists between the F proteins of HRSV and several other paramyxoviruses (Spriggs 
and Collins, 1986). Despite the lack of amino acid identity between the F proteins of 
viruses belonging to these groups, structural analyses has revealed the presence of 
various secondary structural elements that were well conserved between the F proteins 
of all morbillivirus and pararnyxovirus members (Chambers et al., 1992). This 
observation is pertinent as all the Paraniyxnº'iridae family members studied to date 
possess F proteins that share characteristics presumably relating to a common function. 
These common characteristics as well as the various structural motifs with which these 
characteristics are associated are described below. 
The F proteins of Paramyxoviridae family members are synthesised as a full- 
length inactive precursor (Fo) which is then cleaved by cellular proteases to yield a 
functional moiety composed of F, and F2 subunits which are linked by a disulphide 
bond. The cleavage site responsible for generating the two PVM F protein subunits has 
been suggested to lie between amino acids 101 and 102 by analogy with the known 
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cleavage site in the F protein of HRSV (Chambers el al., 1992; Elango et al., 1985). 
The cleavage releases a 101 amino acid long F2 subunit and a 436 amino acid long F, 
subunit. The F, subunit of PVM contains two potential acceptor sites for N-linked 
glycosylation whereas the F2 subunit contains none. The distribution of potential 
glycosylation sites in HRSV is somewhat different with all but one of the sites (a total 
of 5 or 6, depending on the strain) being located in the F2 subunit. 
In common with F proteins of other Paramyxaviridae family members, the 
PVM F protein has three highly hydrophobic regions which have been assigned 
separate functions. Firstly, located at the extreme amino-terminal of the F2 subunit is a 
hydrophobic signal peptide that is responsible for the cotranslational translocation of 
the F protein through the rough endoplasmic reticulum and which is cleaved off during 
or after translocation. The second region is the fusion related domain which is located 
at the amino-terminus of the F, subunit generated following cleavage. This region is 
thought to mediate fusion between both virus particle and cell membrane and also 
between adjacent infected and uninfected cells by localised disruption of the lipid 
membrane. The third region which is the most hydrophobic of all is the putative 
transmembrane region which is located at the carboxyl-terminus of F,. These three F 
protein regions are diagrammatically represented in figure 4. 
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Figure 4. Schematic representation displaying structural and functional features that are 
common to the F1 and F2 subunits of the F proteins of Paramyxoviridae family members. 
Introduction 
In addition to these conserved regions of hydrophobicity, several other 
secondary structural features shared by the F proteins of Paramyxoviridae family 
members have been identified (Chambers et al., 1992). The amino-terminal region of 
F2 is thought to be composed of p-sheet and turn or coil structures. The carboxyl- 
terminus of F2 is thought to form an amphipathic a-helical structure. These two 
regions of F2 are separated by a region that contains the only cysteine of F2, the 
presence of which is essential in order for cross-linking to F,. Not surprisingly, this 
cysteine is conserved in all paramyxovirus F proteins. The amino-terminus of F1 
contains the previously mentioned hydrophobic fusion domain. Located on the 
carboxyl-terminal side of this is a region of secondary structure known as a heptad 
repeat. The heptad repeats are sequences of amino acids arranged with a seven residue 
periodicity in which positions I and 4 are predominantly occupied by small 
hydrophobic or neutral residues. These heptad repeat regions suggest the presence of 
extended a-helical conformations. On the carboxyl-terminal side of the heptad repeat is 
one region which may form helical structures, and another which displays relative 
variability between the F proteins of the Pcrranryxoviridae family members. On the 
carboxyl-terminal side of the variable region is a cysteine rich domain where the 
location of seven or eight cysteines are conserved between all paramyxovirus and 
pneumovirus genus members (Shioda et al., 1986). Between this region and the 
aforementioned hydrophobic transmembrane region, located at the carboxyl-terminal 
end of the Fu subunit, is another region of heptad repeat which has been likened to the 
leucine zipper motif described by Buckland and Wild (1989). By specific alteration of 
residues in the hydrophobic amino-terminal domain of paramyxovirus F proteins it has 
been shown that amino acid changes that increase the helical content of the 
transmembrane region increase the cell-fusion activity of mutant F proteins (Horvath 
and Lamb, 1992). 
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The SEN F protein has been isolated as a tetramer and due to the known 
similarities that exist between the paramyxovirus and pneumovirus F proteins it is 
possible that the PVM or HRSV F proteins may exist in a similar form. The PVM F 
protein may form multi-subunit assemblies constructed around the region where the 
heptad repeat and cc-helical coils are located, and additionally, the highly hydrophobic 
nature of the F protein may aid hydrophobic contact between individual subunits 
(Chambers et al., 1990c). 
Investigations into the mechanism responsible for cleavage of the F protein into 
the two subunits determined that amino acid changes in the F, subunit were responsible 
for the loss of F cleavage, thus alteration of one region of the F protein can influence 
changes in another that is spatially separate (Anderson et cil., 1992). 
1.4.9: The attachment protein 
The PVM G gene is 1330 nucleotides long and encodes a polypeptide 363 
amino acids in length. The 3' end of the PVM strain 15 G gene contains a small ORF 
beginning at an AUG at nucleotide position 83. This ORF overlaps with the large 
second ORF which is initiated from an AUG codon at nucleotide position 183 and is 
believed to express the G protein. In PVM strain 3666, the first and second ORFs have 
been merged and expression of the G protein is believed to be initiated from the AUG 
codon at nucleotide position 83 (J. Rhandawa, pers. comm). The predicted molecular 
weight of the G protein polypeptide moiety is 39,836 Da. In PVM-infected BSC 1 cells, 
two forms of the AVM G protein are present having observed molecular weights of 
76.4 and 62 kDa, and these are designated G, and G2 (Ling and Pringle, 1989b). These 
polypeptides were both shown to contain common protein sequence by peptide 
mapping. In pulse-chase labelling experiments, a temporal relationship was also 
demonstrated between G, and G2, with G2 apparently being derived from G,. AG 
protein related polypeptide species which is analogous to the PVM G2 protein is also 
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seen in HRSV-infected cells. This form of G, which accounts for about one-sixth of all 
G protein forms is soluble and is secreted from infected cells (Hendricks el al., 1987, 
1988). This G protein species is cleaved co or post-translationally at either amino acid 
position 65 or 74, thus separating the hydrophobic amino-terminus from the rest of the 
protein (Hendricks ei al., 1988). However, it has recently been reported that the 
soluble form of G may be expressed by internal initiation from the AUG codon 
corresponding to methionine residue 48 (Roberts ei at, 1993). This amino-terminally 
truncated form of G is believed to be further amino-terminally truncated by proteolytic 
cleavage at the positions previously identified by Hendricks et al., (1988). 
The large discrepancy between the predicted and observed molecular weights 
of the G protein is due to extensive glycosylation. Treatment of the 76.4 kDa G1 
polypeptide with glycopeptidase F, an agent known to specifically remove N-linked 
carbohydrates, gave rise to a polypeptide with a molecular weight of 58.4 kDa. Further 
treatment of the 58.4 kDa species with a range of agents capable of removing O-linked 
carbohydrates gave rise to a polypeptide with an observed molecular weight of 39.6 
kDa, and this species was believed to represent the polypeptide moiety of the PVM G 
protein (Ling and Pringle, 1989b). Similar reductions in observed molecular weight 
were obtained for the G2 polypeptide, and the purportedly unglycosylated G2 species 
was calculated to have a molecular weight of between 37.2 kDa and 44.8 kDa. The 
haemagglutination activity of PVM is associated with the G protein since anti-G 
protein monoclonal antibody strongly inhibits the activity (Ling and Pringle, 1989b). 
At 298 or 292 amino acids, depending on subgroup, the HRSV G protein is 
considerably shorter than the PVM G protein and it has been suggested that the 
additional sequences of the PVM G protein may be responsible for the 
haemagglutination activity which the HRSV G protein lacks. The overall amino acid 
homology that exists between the PVM and HRSV G proteins is poor (J. Rhandawa, 
personal communication). The HRSV G protein is also heavily glycosylated, with an 
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observed molecular weight change of between 8 and 12 kDa being due to N-linked 
sugars and over 40 kDa being due to O-linked sugars, the precise degree of 
glycosylation varying from strain to strain due to a variation in the precise number of N 
and O-linked glycosylation acceptor sites. The HRSV G protein is glycosylated to a 
greater degree than the PVM G protein, with carbohydrate increasing the G protein 
molecular weight by approximately 50 kDa compared with approximately 20 kDa for 
the PVM G protein. The large molecular weight difference attributed to 0-linked 
sugars may however be an artefact due to reduced SDS binding on account of the 0- 
linked sugars (Collins and Mottet, 1992). Investigations by several groups have 
determined that the N-linked sugars are added co-translationally whereas the 0-linked 
sugars are added post-translationally (Fernie el al., 1985, Wertz ei al., 1989). There is 
no sequence homology between the pneumovirus G proteins and the G proteins of 
other Paramyxoviriclae family members, and the only structural feature that these 
proteins share is that they expose their amino-terminal ends on the cytoplasmic side of 
the membrane into which they are inserted (type 11 membrane orientation; Haeuptle et 
al., 1989). 
As for PVM, the first initiation codon of the HRSV G ORF is followed soon 
after by a termination codon, and so initiation on the second in-frame AUG codon is 
believed to give rise to the HRSV G protein. In both viruses, this arrangement of 
initiation codons is likely to down-regulate expression of the G protein as scanning 
ribosomal 40S subunits will probably initiate at the 5' proximal AUG. Interestingly, the 
first AUG of the TRTV G gene is not followed soon after by a termination codon, and 
thus expression of TRTV G is not down-regulated. However, similar down-regulation 
of TRTV G protein expression relative to other TRTV proteins may occur as a 
consequence of the position of the G gene on the TRTV genome, since in TRTV the G 
gene is further from the 3' proximal promoter region (Yu el al., 1992c) and therefore is 
less frequently transcribed. 
33 
Introduction 
Attachment of HRSV to cells was shown to be inhibited by mono-specific anti- 
G protein antisera thus implicating G as the attachment protein (Levine el al., 1987). 
The receptor responsible for G protein attachment has still not been identified although 
it appears to be a ubiquitous cell membrane component since Walsh ei al., (1984) were 
unable to saturate the receptor using purified G protein. The similarities that exist 
between G proteins of HRSV and PVM suggest that in PVM, G is also the attachment 
protein. The G proteins of PVM and of strains from both HRSV subtypes share certain 
structural elements to which functions have been defined. The G protein amino- 
terminus contains a single major hydrophobic domain which for several reasons is 
believed to specify the functions of membrane insertion and anchorage. Firstly, a 
peptide expressed from a recombinant vaccinia vector representing the amino-terminal 
71 amino acids of the 1-IRSV G protein was transported to, and inserted and anchored 
into, the cell membrane (Olmsted el al., 1989). Secondly, expression of HRSV and 
PIV-3 attachment proteins in which the amino-terminal hydrophobic regions had been 
interchanged were processed in an authentic manner (Collins, 1991). Finally, peptide 
sequence analysis has revealed that the soluble form of the HRSV G protein which is 
not inserted into the membrane (analogous to the PVM G2 protein) is lacking the 
amino-terminal hydrophobic element of the full-length G protein (Hendricks et al., 
1988). It has been suggested that the amino-terminal hydrophobic element of the G 
protein can be divided into two domains, one of which is dispensable for membrane 
insertion (Lichenstein et al., 1991). The region of the G protein on the carboxyl- 
terminal side of the membrane anchor is believed to represent the ectodomain. This 
region shows lower amino acid conservation between both inter-subgroup and intra- 
subgroup HRSV isolates than is exhibited between the relatively conserved 
transmembrane and cytoplasmic regions. The region of the G protein bounded by 
amino acids 101-133 which lies immediately carboxyl-terminal to the transmembrane 
region shows greatest intra-subgroup variation and for this reason is known as the 
hypervariable region. This portion of the G protein is separated from another variable 
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region located at the carboxyl-terminal third of the G protein by a small conserved 
region between amino acids 147 and 207 (Cane el (l., 1991). The observation that 77 
of the 91 potential O-linked glycosylation sites and all of the N-linked sugar 
attachments sites are located on the carboxyl-terminal side of the membrane anchor 
supports the suggestion that this is the proposed ectodomain of the G protein 
(Sullender and Wertz, 1991). 
The presence of O-linked glycosylations on the G proteins is a feature that 
within the Paramyxoviridae family of viruses, is unique to the pneumoviruses. The 
ectodomains of the G proteins of both HRSV subgroups contain over 90 potential 
acceptor sites for O-linked glycosylation clustered predominantly into two domains, 
one at the carboxyl-terminus and one adjacent to the membrane anchor, however the 
exact location of these sites is not well conserved (Olmsted et al., 1989). The absence 
of either the N-linked or the O-linked glycosylations reduces the level to which the 
HRSV G protein is expressed on the cell surface to about 50% that of fully 
glycosylated G protein (Wertz el at, 1989). Completely unglycosylated G protein is 
also expressed on the cell membrane but this time at a level only 10% that of mature G. 
By using three inhibitors specific for different steps of exocytosis, Collins and Mottet 
(1992) determined that initial addition of O-linked sugars begins in the trans-Golgi 
compartment with final maturation occurring in another compartment of unknown 
location. The HRSV G protein is believed to associate to form homo-oligomers 
(Lambert, 1988) and this association seems to occur when the G protein is devoid of 
N-liked sugars. Removal of N and O-linked oligosaccharides from the G protein 
drastically reduces the potential infectivity of virus particles which suggests that the 
oligosaccharide component of the G protein exerts considerable influence on the 
attachment process (Lambert, 1988). The presence of 0-linked sugars is not thought 
to affect the folding and oligomerisation of the G protein, however, the presence of 0- 
linked sugars on the G protein may be important to confer stability of an already 
formed oligomeric structure (Collins and Mottet, 1992). 
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The extensive glycosylation to which the G protein is subjected may serve to 
alter its antigenicity, and thus evade the host immune response. Out of a panel of 18 
monoclonal antibodies raised against the HRSV G protein, only five recognised 
unglycosylated G protein whilst the majority recognised G protein glycosylated only 
with O-linked sugars (Palomo et al., 1991). Of these 18 antibodies only those that 
recognised unglycosylated G protein were able to neutralise HRSV infectivity to any 
degree (Garcia-Bareno et al., 1989). G protein monoclonal antibodies are 
characteristic in their poor neutralising ability and this may reflect the heterogeneity of 
the G protein population, such that a large non-neutralisable fraction of virus is often 
present even from a population of virus that is genetically homogeneous. 
Characterisation of neutralisation resistant mutants of HRSV has highlighted the 
heterogeneity of the G protein population (Garcia-Barreno et al., 1990,1992, Rueda 
et al., 1991). Escape mutants which were resistant to anti-G protein monoclonal 
antibodies arose by way of a mechanism which generated either point mutations, 
premature stop codons or frameshift mutations in the G gene. Many of the mutant G 
proteins were caused by addition or removal of adenosine residues in A runs of the 
corresponding G gene probably by polymerase slippage during genome replication. 
The mechanism is probably similar to that which allows access to alternative reading 
frames in the P genes of many Paranmyxuririclae family members. Interestingly, the 
majority of mutations in the G proteins of these escape mutants affected the carboxyl- 
terminal region of the protein and this indicated that the carboxyl-terminal of G can 
accommodate sequence changes and still remain functional. Naturally occurring 
isolates of HRSV also show considerable variation in the sequence of G proteins (Cane 
et al., 1991; Sullender et cal., 1991). 
1.4.10: The SH (1A) protein. 
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The SH protein gene of PVM is 390 nucleotides long and can encode a 
polypeptide 92 amino acids in length with a predicted molecular weight of 9,582 Da. 
The nucleotide sequence of the SH protein gene revealed the presence of four N-linked 
glycosylation sites, with two located at the amino-terminal end and two located at the 
carboxyl-terminal end of the protein. The predicted amino acid sequence of the TRTV 
SH protein has revealed the presence of a potential N-linked glycosylation site and this 
site is thought to be used (Ling el al., 1992). The SH polypeptide has not yet been 
unequivocally identified in AVM-infected cell material although Ling and Pringle 
(1989b) identified a 12 kDa glycosylated polypeptide that could have represented this 
species. The SH protein of HRSV has been shown to be synthesised in four different 
monomeric forms with molecular weights of 4,500 Da, 7,500 Da, 13,000-15,000 Da 
and 21,000-30,000 Da (Olmsted and Collins, 1989) The 7,500 Da species appears to 
represent the full-length unglycosylated form of SH. The 4,500 Da form of SH is also 
unglycosylated and is believed to arise through translational initiation from an AUG 
codon located 22 codons downstream of the AUG codon responsible for the full- 
length SH species. The 13,000-15,000 Da species represent N glycosylated forms of 
SH, and a proportion of these are further modified by the addition of 
polylactosaminoglycan to the N-linked carbohydrate to form the 21,000-30,000 Da 
species. All four of these forms are found associated with the cell membrane of HRSV- 
infected cells (Olmsted and Collins, 1989). In addition, the 7,500 and the 21,000- 
30,000 Da species were found in purified virions suggesting that these two forms of 
SH are structural (Collins, 1991). Amino acids 23 to 41 of the SH protein are 
responsible for membrane anchorage which suggests that the amino-terminal 22 amino 
acids are either membrane embedded or exposed to the cell interior (Collins and 
Mottet, 1993). Interestingly, comparison of the amino acid sequence of the SH 
proteins of HRSV strain A2 and 18537 isolates (from subgroups A and B respectively) 
showed a high degree of conservation in the membrane and cytoplasmic region of SH 
(88%), but more divergence in the carboxyl-terminal region (50%; Collins et al., 
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1990). Chemical cross-linking experiments have suggested that the full-length 
unglycosylated SH protein is able to form homodimers, homotrimers, homotetramers 
and homopentamers (Collins and Mottet, 1993). An additional species with a 
molecular weight of 180 kDa was also identified and believed to represent an oligomer 
composed of four or five cross-linked pentameric subunits. The function of the 
pneumovirus SH protein is presently unknown. 
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1.5: PNEUMOVIRUS MOLECULAR BIOLOGY. 
1.5.1: The pneumovirus genome. 
The molecular cloning of PVM has been achieved and this has provided the 
means by which to rapidly further the understanding of this virus (Chambers et al., 
1990a). Nine genes have presently been identified on the PVM genome and their 
nucleotide sequences have been determined. Coding assignments have been made for 
these genes by both hybrid-arrested translation experiments, and also by comparison of 
the nucleotide sequence with HRSV genes for which assignments have already been 
made. The order in which the genes are arranged on the PVM genome was confirmed 
by determination of the nucleotide sequence of the intergenic regions in polycistronic 
cDNA clones. The gene order of PVM is identical to the gene order of HRSV. Like 
HRSV, it is believed that the PVM genome consists of a total of 10 genes, and the 
remaining PVM gene that has not been identified is believed to correspond to the large, 
or L, protein of HRSV which has been identified as a component of the viral RNA 
dependent RNA polymerase. The genome of HRSV has been shown to be of negative 
sense (Huang and Wertz, 1982) and by analogy, the genome of PVM is also believed 
to be of negative sense. The HRSV genorne has been completely sequenced and has 
been determined to be 15,222 nucleotides in length (Collins, 1991). At the extreme 3' 
and 5' termini of the HRSV genome are the leader and trailer sequences respectively 
(Mink el al., 1991) and regions which correspond to these are expected to be present 
at the 3' and 5' ends of the PVM genome. The leader and trailer regions are involved in 
transcription and replication of the viral genome and this is discussed in sections 1.5.2 
and 1.6.4. The recent molecular cloning of TRTV has revealed that the order of genes 
on the TRTV genome is different to that of the PVM and HRSV genomes (Yu et al., 
1992c, Ling el al., 1992). In TRTV, the SH and G genes have been moved 
downstream of the F and 22K genes, and this is shown diagrammatically in figure 1. 
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The different order of genes on the TRTV genome represents a fundamental 
divergence of this virus from the other pneumoviruses. 
1.5.2: The leader and trailer regions. 
By analogy with other Paramyxoviridae and Rhahdoviridae family members, 
the sequences at the 3' and 5' ends of the pneumovirus genome (the leader and trailer) 
are believed to harbour signals involved in pneumovirus RNA synthesis. The HRSV 
leader region is 44 nucleotides long and, as with other negative sense single stranded 
RNA viruses, is thought to encode at least two distinct nucleotide signals (Mink et al., 
1991). These are the regions responsible for binding the polymerase complex prior to 
RNA synthesis and a site responsible for initiating encapsidation of nascent, negative 
sense genome copies (vRNAs). In terms of nucleotide sequence, the HRSV leader 
region is distinct from the leader regions of other negative sense single stranded RNA 
viruses. The HRSV leader shares nucleotide identity between other members of the 
Paramyxoviridae family only at the first two nucleotide positions, and in only the first 
three or four nucleotide positions of the leader sequences belonging to rhabdoviruses, 
VSV and rabies virus, respectively (Mink el al., 1991). At 155 nucleotides, the HRSV 
trailer region is much longer than any other equivalent sequence determined to date. 
The degree of nucleotide homology that exists between the HRSV trailer and the other 
trailer regions is similar to the level of homology that was detected between their 
respective leader regions. In common with other viruses from related groups, the 
HRSV leader and trailer regions show complimentarity, and in the case of HRSV this 
extends to 21 of the first 26 nucleotides. The complimentarity is essential for the RNA 
synthetic procedures since the 5' trailer of the (-) vRNA encodes the 3' leader of the 
positive sense genome copy (vcRNA) which is thought to be functionally analogous to 
the 3' leader of the vRNA. Many functional aspects of the leader and trailer regions 
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have been elucidated for VSV and to a lesser extent the paramyxoviruses SEN and 
NDV and these functions are discussed in sections 1.6.4 and 1.6.5. 
1.5.3: Gene start and end sequences. 
During HRSV transcription the polymerase initiates gene transcription at the 
gene start signal (Collins el cil., 1986). The HRSV gene end signals are believed to 
cause the viral polymerase to stall and, by reiterative copying of short poly(U) tracts, 
synthesise a poly(A) tail. It is believed that no other gene sequences other than those 
identified as gene start and gene end sequences are able to act as structural signals 
since these are the only regions that display conservation between HRSV subgroups 
(Collins, 1991 and references therein). The gene start and gene end sequences of nine 
PVM genes have been determined and these sequences, along with the overall start and 
end consensus sequences, are shown in table 2. The gene start and gene end sequences 
for HRSV are also shown, Although the HRSV and PVM consensus sequences are not 
identical, they are clearly related, and for this reason the PVM gene start and end 
sequences are expected to be functionally analogous to the HRSV sequences. The 
PVM gene start and stop sequences are fairly well conserved between genes, and this 
contrasts to HRSV in which the gene starts are well conserved but the gene ends show 
considerable variation. Interestingly, many of the PVM genes possess a sequence that 
is complementary to the rnRNA start close to their 5' termini (TCCT at positions 15-18 
which are complimentary to AGGA at positions 1-4, Barr el al., 1991). The 
significance of this complementarity is unknown but it may relate to RNA secondary 
structure. 
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Gene Gene start 
PVM 
sequence 
HRSV* 
GGGGCAAAU 
GGGGCAAAU 
GGGGCAAAU 
GGGGCAAAU 
GGGGCAAAU 
GGGGCAAAU 
GGGGCAAAU 
GGGGCAAAU 
GGGGCAAAU 
GGGACAAAA 
Gene end sequence 
1C AGGACAAGU 
1B AGGAUAAAU 
N AGGAUAAAU 
P AGGACAAAU 
M AGGAUAAAU 
SH AGGAUAAGU 
G AGGACAAAU 
F AGGAUGAGU 
22K AGGACAAAU§ 
L ND 
consensus AGGAuaAau GGGgCAAAU 
PVM 
UAGUUAAUU 
UAGUUAUAG 
UAUUUAAUU 
UAUUUAAUU 
UAGUUAAAU 
UAGUUAAC 
UAGUUAAUG 
UAGUUAAUU 
UAGUUAUAU 
ND 
HRSV* 
UAGUUAAAU 
UAGUAAUUU 
GAGUUAAU 
UAGUUAC 
AAGUUAAU 
UAGUUAAUU 
UAGUUACUU 
UAGUUAUAU 
UAGUUAUU 
AUCUUAUAAU 
uaguuaauu uAguuAauu 
Table 2: Gene start and end sequences for the 10 genes of HRSV and PVM. 
The consensus sequences for these sequences are shown below the 
relevant columns. Upper case letters denote total conservation of a residue at that 
position in the sequence and lower case letters identify the most common residue at 
positions where conservation was not total. * The gene start and end sequences are for 
HRSV strain A2. §. The L gene start is located within the 22K gene. ND: not 
determined (adapted from Chambers et ul., 1990a). 
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1.5.4: Intergenic regions. 
The intergenic regions of many paramyxoviruses such as SEN, PIV-3 and MV 
are amongst the most highly conserved regions both within each virus and also 
between the viruses and this high level of conservation implies that these sequences 
possess important roles. In contrast, the intergenic regions of PVM and HRSV show 
considerable variation both within each virus and between each other (Collins el al., 
1986; Chambers ei al., 1990b). This lack of homology in the pneumovirus intergenic 
regions may represent a difference in transcriptional function compared with the 
corresponding regions of many paramyxoviruses. 
1.5.5: Pneumovirus RNA synthesis. 
In contrast to other 1'aramyxovirickw family members, study of the processes 
of pneumovirus RNA synthesis has only recently begun and consequently these 
processes are not well understood at present. Herman (1989) developed a system 
capable of supporting transcription of the HRSV genome in vitro which employed a 
total extract of virus infected cells and was able to transcribe all the viral mRNAs. 
However attempts to transcribe purified nucleocapsids were not successful. Purified 
HRSV nucleocapsids were shown to be transcriptionally active after the addition of 
mock-infected cell extract (Bank, 1992) which suggested that a cellular factor was an 
obligate requirement of HRSV transcription. Inhibition of HRSV transcription using 
specific antibodies suggested that the cellular factor may be actin (Huang et al., 1993). 
An extremely powerful system has been developed for studying the genetics of 
HRSV which promises to greatly advance the understanding of processes involved in 
expression of the pneurnovirus genorne. Chimeric cDNAs were constructed which 
comprised (in 3' to 5' order) the HRSV leader sequence, the open reading frame of the 
chloramphenicol acetyltransferase (CAT) gene under the control of the HRSV gene 
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start and gene end signals, a one nucleotide Tong intergenic region, the complete 
HRSV L gene including the gene start and gene end signals and the 5' trailer region. 
The vRNA analogue encoded for by this cDNA was 7502 nucleotides long which in 
size represents almost half of the wild type HRSV genome (49.2%, Collins et al., 
1993). These cDNAs were transcribed in vitro and transfected into cells infected with 
wild-type HRSV. The synthetic vRNAs were amplified, expressed and packaged into 
virus particles by utilising the components supplied by the wild-type helper virus. The 
rescued particles were then used to infect fresh cells. A single nucleotide substitution in 
the 3' leader region of the vRNA analogue was shown to increase the efficiency of 
vRNA analogue rescue. By incorporating additional alterations of the vRNA analogue, 
this system allows characterisation of both cis-acting RNA sequences and trans-acting 
proteins involved in transcription, replication and packaging of the HRSV genome. 
This accomplishment paves the way for rescue of full-length synthetic HRSV genomes 
which will allow study of HRSV as a biological unit (Collins et al., 1993). Hopefully, 
this system will allow the elucidation of the mechanisms involved in many aspects of 
pneumovirus genome expression and will consequently allow the structural differences 
between the pneurnovirus and pararnyxovirus genomes to be rationalised. 
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1.6: RNA SYNTHESIS IN NEGATIVE SENSE, SINGLE STRANDED RNA VIRUSES 
1.6.1: Introduction. 
The ribonucleocapsid complex of the non-segmented negative strand RNA 
viruses is composed of the vRNA, and the L, P and N proteins. In these viruses, the L 
and P proteins have been identified as representing subunits of the viral RNA 
dependant RNA polymerase, and the N protein has been identified as the major 
structural component of the ribonucleocapsid complex which is responsible for 
encapsidation of the viral genome. In contrast to the N, P and L proteins of many 
members of the other major groups of non-segmented negative sense RNA viruses, the 
pneumovirus N, P and L proteins have not been fully characterised, however it is 
generally assumed that they perform analogous functions. Consequently, the overall 
mechanism of RNA synthesis in which the ruucleocapsid components of these groups of 
viruses are involved is expected to be similar, if not entirely, at least in broad outline 
(Banerjee and Barik, 1992). 
1.6.2: RNA synthesis in VSV. 
Vesicular stomatitis virus has become the model non-segmented negative 
strand RNA virus due to the knowledge that has been amassed concerning its 
replicative and transcriptive processes. Emerson and Yu, (1975) initiated study of VSV 
RNA synthesis using a system that involved reconstituting purified nucleocapsid 
components in vitro to form a transcriptionally active ribonucleocapsid complex that 
was able to faithfully reproduce all the features of VSV transcription . 
Although this in 
vitro transcription system allowed many features of the N, P, and L proteins to be 
elucidated, the obligate requirement of both the L and P proteins for faithful 
transcription of mRNA species led to difficulties in assigning specific functions to each 
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of these protein species. A more recent and significant advance has been the 
opportunity to study the replication of VSV in vivo using a recombinant vaccinia virus 
T7 polymerase system capable of co-expressing all five genes of the VSV genome 
from cloned cDNA (Pattnaik and Wertz, 1990). By super-infecting cells with VSV 
defective interfering (DI) particles, this system is able to study the function each of 
these proteins performs in the process of VSV replication. The natural predisposition 
of DI particles for efficient replication means that study of the switch between 
transcription and replication is not possible using this system. The means with which to 
investigate VSV transcription was recently accomplished with the development of an 
in vitro reconstitution assay capable of faithfully transcribing purified nucleocapsid 
templates (Canter et cri., 1993). 
1.6.3: Components of the VSV nucleocapsid. 
(a) The VSV L protein. 
The L protein has been suggested to encode all RNA transcriptional activities, 
namely, ribonucleotide polymerase (De and Banerjee, 1985), cap methylase (Hercyk et 
al., 1988) and poly(A) polymerase (Hunt et cal., 1984). Less certain however is 
whether the L protein also encodes the protein kinase activity that phosphorylates the 
P protein. Highly purified L protein preparations made from VSV-infected cells 
contain an activity that specifically phosphorylates P protein and that is distinguishable 
from cellular kinases, thus suggesting that the activity came from the L protein itself 
and not a contaminating component (Barik and Banerjee, 1992). Work using a 
photoreactive analogue of ATP also suggested that a protein kinase activity resides on 
the native VSV L protein (Hammond et al., 1992a). P protein phosphorylation was 
studied by Barik and Banerjee (1991) who used bacterially expressed and consequently 
unphosphorylated P protein as substrate for both cell-associated and L-associated 
protein kinase activity. The P protein was shown to exist in three different forms with 
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respect to their state of phosphorylation, namely the unphosphorylated Po, a partially 
phosphorylated P, and a more extensively phosphorylated P2. The Po form was 
converted to the P, form by a cell-associated kinase and P, was converted to P2 by a 
purified L protein preparation. Studies by Chattopadhyay and Banerjee, (1987) 
revealed that the L protein kinase phosphorylated two serine residues located in the 
carboxyl-terminal region of the P protein, whereas the cell-associated kinase 
phosphorylated residues in the amino-terminus of the P protein. The substrate 
specificity exhibited by these two kinases necessitates that they act sequentially 
catalysing a cascade phosphorylation pathway. The L protein associated kinase appears 
to be a serine kinase (Hammond el at., 1992b), although analysis of the L protein 
amino acid sequence fails to reveal any characteristic motifs indicative of serine or 
threonine kinase activity (Banerjee and Bank, 1992). It has been suggested that two P 
protein phosphorylating activities are present in the VSV virion, one of which 
resembles casein kinase II and is believed to be derived from the host cell (Beckes and 
Perrault, 1992). 
(b) The VSV P protein 
Reconstitution experiments have shown that whilst the L protein alone can 
initiate transcription on N-RNA templates to produce short oligonucleotide products, 
the P protein is required for the synthesis of authentic RNA products, suggesting that 
the P protein functions as a polymerase accessory factor or transcriptional activator 
(De and Banerjee, 1985). Additionally, in vitro studies have revealed that the P protein 
functions in maintaining the N protein in a replication competent state. This is 
accomplished by binding to and preventing N protein monomers from forming 
insoluble aggregates which are unable to support genorne encapsidation (Howard and 
Wertz, 1989). It is in the form of the N-P complex that the N protein is believed to 
encapsidate nascent RNA molecules (Peluso and Moyer, 1988). N-P complexes able to 
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support in vitro genome encapsidation were only formed when the N and P proteins 
were concurrently synthesised. These complexes form in a variety of molar ratios 
(Masters and Banerjee, 1988), however a molar ratio of 1: 1 was found to be essential 
for efficient genome replication (La Ferla and Peluso, 1989), and complexes of this 
ratio have been identified in VSV-infected cells (Moyer, 1989). The VSV P protein is 
one of the most highly phosphorylated proteins known, with over a sixth of the P 
protein amino acids representing potential phosphorylation sites. The phosphorylated 
amino acids are mainly concentrated in domain 1, which is a negatively charged region 
spanning the amino-terminal third of the P protein (Bell and Prevec, 1985) and it has 
been suggested that this domain may act as a transcriptional activator of the L protein 
(Takacs el al., 1991). Phosphorylation of residues in this region is believed to be 
mediated by the cellular kinase (Takacs et ul., 1991). The L protein of VSV is only 
able to bind to the N-RNA template in the presence of P protein (Mellon and Emerson, 
1978). An L protein binding site has been located in domain I (Emerson and Schubert, 
1987) and also between amino acids 213 and 247, designated domain 11 
(Chattopadhyay and Banerjee, 1987). The carboxyl-terminal 21 amino acids of P is 
designated domain III and this region is required for binding to the N-RNA template 
(Emerson and Schubert, 1987). Phosphorylation studies have ascertained that serine is 
the major phosphate acceptor indicating that a serine kinase, a function that has been 
suggested for the L protein (Hammond el al., 1992b), is responsible for 
phosphorylation of this protein. Reconstitution experiments have shown that only the 
fully phosphorylated form of P (P2) is transcriptionally active, and that phosphorylation 
at serine residues 59 and 61 by a cellular kinase are essential for L protein 
phosphorylation that leads to functional activity of the P protein in the reconstituted 
transcription assay (Takacs el crl., 1992). This observation indicates that both the cell- 
associated and the L protein-associated kinases are essential for formation of 
functional P protein, a suggestion supported by restricted VSV replication in T- 
lymphocytes deficient in cellular protein kinase activity (Sleat el al., 1992). The finding 
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that optimum transcriptional activity is only attainable with highly phosphorylated P 
protein is not in agreement with the findings of Beckes and Perrault (1992) who 
observed no loss in transcriptional activity when the P protein population was largely 
unphosphorylated. The phosphorylation status of the P protein was shown to regulate 
its ability to bind to the N-RNA template in the presence of L protein which is a crucial 
prerequisite for RNA synthesis (Chattopadhyay and Banerjee, 1987). 
1.6.4: The model of RNA synthesis in negative sense single stranded RNA 
viruses. 
Kinetic studies have shown that the five VSV mRNA species are synthesised in 
the same order as their corresponding genes appear on the VSV genome and 
additionally that these rnRNAs are transcribed in quantities that decrease as the 
distance of the corresponding gene from the 3' end of the genorne is increased. The 
method by which the five VSV mRNAs are transcribed has not been elucidated, 
although two models are favoured (reviewed in Baneijee, 1987). Firstly, the stop-start 
model suggests that the polymerase binds to the genome at the 3' polyrnerase entry site 
and initially synthesises the leader sequence. The same enzyme then re-initiates RNA 
synthesis at the beginning of the N gene and continues until it meets the termination 
signal at which point the polyrnerase adds the poly(A) tail. The same enzyme either 
dissociates from the template or again re-initiates, this time at the beginning of the P 
(or NS) gene and so the process goes on. The important feature of this model is that 
once a polymerase molecule becomes removed from the genome, it may only re-attach 
to the genome at the 3' entry site. In this way, 3' proximal genes are abundantly 
represented by mRNA while 5' proximal genes are considerably less so. The other 
method, known as the multiple initiation model, supposes that rather than have a single 
3' polymerase entry site, the polymerase may enter at several sites throughout the 
length of the genome. This model largely agrees with the stop-start method of 
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transcription in that rnRNA synthesis results from separate initiation events, however it 
differs in that these initiation events are thought to be independent of one another. 
Consistent with these models, initiation of both mRNA transcription and 
genome replication begins when the nucleocapsid complex binds to the 3' end of the 
genome and begins to synthesise the 47 base long leader sequence. The 3' terminal 15- 
17 nucleotides are required for optimal genome transcription and whilst certain 
changes are tolerated in this region, changes in the 3' terminal three nucleotides 
completely diminishes translational activity (Sherwood and Moyer, 1993). The finding 
that preservation of the initial 3' nucleotides is essential for transcription is consistent 
with the model that proposes a single 3' polymerase entry site. Up until this point, the 
events that have occurred are believed to be the same for both transcription and 
replication, and additionally, both the polymerase complex and also the RNA template 
are believed to be the same for both operations. The processes of transcription and 
replication have a fundamental difference in that genome replication requires 
concomitant protein synthesis whereas transcription does not (Wertz and Levine, 
1973). The requirement for ongoing protein synthesis is met entirely by synthesis of the 
nucleocapsid protein (Patton el al., 1984) and this led to the postulation of a 
mechanism for the switch between transcription and replication that depended upon the 
concentration of the N protein (Blumberg el al., 1981). This mechanism relies upon 
the ability of the N protein to encapsidate the nascent RNA genome as it is synthesised. 
In this model, the polymerase complex begins to synthesise the positive polarity 
nascent leader RNA to which N protein molecules bind by recognition of an 
encapsidation signal (Blumberg ei al., 1983). The encapsidation signal is believed to 
reside within the first 10 nucleotides of the leader sequence, although for optimal 
encapsidation the first 19 nucleotides are needed (Moyer ei al., 1991). The 
encapsidation site is still active when nucleotide sequences are placed upstream of it, 
thus indicating that encapsidation by N protein molecules may proceed in both the 3' 
and 5' directions. Each N protein monomer is believed to associate with 6 nucleotides 
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(Blumberg el al., 1983), a suggestion supported by Calain and Roux (1993) using 
SEN. As the polymerase complex passes down the genome, the growing RNA 
molecule is encapsidated by associating N protein molecules which somehow suppress 
a transcriptional termination signal which is thought to be located at the leader-N 
junction. The precise way in which the signal is suppressed is not known. The 
polymerase complex is thus able to continue RNA synthesis and eventually give rise to 
a full-length anti-genome molecule fully encapsidated in N protein molecules. If on the 
other hand, N protein was not present at an appropriate concentration, the leader RNA 
species would be synthesised but would not be encapsidated and consequently the 
transcription termination signal could not be suppressed, leading to the generation of 
the 47 base long leader. The polymerase would then either exit the genome or re- 
initiate transcription at the beginning of the N gene. This model suggests a self- 
regulating system where insufficient N protein stimulates increased mRNA synthesis to 
produce more viral proteins, and excess N protein triggers genome replication which 
will deplete the pool of viral proteins. Several observations have been made which give 
crucial support to this model such as the presence of tiny nucleocapsid structures 
containing the leader sequence alone (Blumberg et al., 1981), and the presence of 
unencapsidated leader which represents the initial product of genome transcription. 
The existence of negative sense leader sequences also supports this model since it 
suggests that the polymerase complex initiating on anti-genomes (which are not 
templates for mRNA synthesis) is able to switch between a mode which makes full- 
length genomes to a mode in which genorne synthesis is prematurely terminated at the 
postulated termination site, with the subsequent synthesis of a (-) leader. No provision 
has been made in this model for the role of the VSV matrix protein, which has been 
shown to inhibit transcription of the VSV genome both in vitro and in vivo (Kaptur et 
al., 1991), although the recent existence of in vivre assays capable of studying viral 
transcription (Canter et al., 1993) may soon allow the role of the M protein in 
transcription to be investigated. 
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1.6.5: The modified model of Paramyxoviridae RNA synthesis. 
The level of understanding surrounding the mechanism of RNA synthesis in 
SEN is rapidly increasing and the recent development of in vitro assays which are 
capable of studying SEN replication (Calain and Roux, 1993) and transcription 
(Curran et a!., 1992) only serve to enhance this understanding. In some areas of study, 
the knowledge for SEN exceeds that which is known for any other negative sense, 
single stranded RNA virus. The information that is available for SEN suggest that 
whilst the replicative and transcriptive processes are similar to those of VSV, they do 
not precisely fit the model. For this reason a modified model for paramyxovirus 
transcription and replication has been proposed. Perhaps the most important difference 
between the RNA synthesis mechanisms of VSV and paramyxoviruses, such as MV 
and SEN, concerns the abundance of the leader sequence. In NDV, SEN and MV- 
infected cells, (+) leader sequences have only been identified in extremely low 
abundance, as have (-) leaders sequences (Kolakofsky et a!., 1991). In addition, two 
groups have identified large amounts of leader-N readthrough RNAs in MV-infected 
cells at an abundance 20-fold greater than that found for leader RNAs (Castadenda and 
Wong, 1989, Chan et a!., 1989). These results have been interpreted to suggest that 
the leader termination signal is either weak or absent in paramyxoviruses, and that the 
leader RNAs are not an essential operational element for paramyxovirus RNA 
synthesis (Blumberg et a!., 1991). Experiments using the Z and the H strains of SEN 
(both of which are considered to be wild type) have lead to the proposal that the 
polymerase responsible for transcription is distinct from the polymerise responsible for 
genome replication, since in the Z strain, they are distinguishable by the ability of the Z 
strain replicase, but not the Z strain transcriptase, to abort RNA synthesis at a point 
after the location of the leader-N junction (Vidal and Kolakofsky, 1989). The lesion 
responsible for the increased frequency of leader readthrough in the Z strain of SEN 
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has been mapped to the N protein gene, and not to the P or L genes, suggesting that 
the N protein plays a more active role in RNA synthesis besides that of a structural 
element (Curran el al., 1993). It has also been proposed that whereas replication is 
believed to begin on the 3' end of the genome, transcription is believed to begin at an 
internally located site within the leader sequence, thus the paramyxovirus modified 
model employs an additional polymerise binding site to the VSV model. 
The host cell factor tubulin has been shown to be an obligate requirement for 
transcription and replication in many negative sense, single stranded RNA viruses 
including measles, SEN and VSV (Moyer et al., 1986,1990). In contrast, actin is an 
obligate requirement for transcription of the HPIV-3 genome and the overall negative 
charge of the actin is thought to be the crucial factor affecting the transcriptional 
processes (De el (il., 1991). Using gel retardation techniques unidentified cellular 
factors have been shown to bind to the (+) strand leader and 3' non-coding region of 
the MV genome, although it is unknown if the association of these cellular factors with 
the genome was able to modulate the RNA synthetic capabilities of MV (Leopardi el 
al., 1993). It has been suggested that cellular factors are also able to influence the 
mechanism that results in the production of edited P gene mRNA species (Horikami 
and Moyer, 1991). It is thus clear that cellular factors are able to influence viral 
mechanisms and because of this, the modified model does not suppose that all the 
processes of RNA synthesis are mediated exclusively by viral components. 
The rhabdoviruses do not appear to be able to express proteins which are 
analogous to the V or C proteins of the paramyxoviruses, a situation that, given the 
ability of these proteins to interact with SEN nucleocapsid components (Yamada et al., 
1990) and influence RNA synthetic operations (section 1.4.3.1 ), would suggest 
possible subtle differences in the mode of RNA synthesis between these groups of 
viruses. The SEN C and C' proteins, which have been shown to be structural 
components of the SEN nucleocapsid (Yamada el al., 1990), are capable of interacting 
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with nucleocapsid components and in particular to the P protein (Curran el al., 1992). 
Whilst having no apparent affect on replication, the C proteins are capable of causing 
inhibition of transcription (Curran el al., 1992). These workers speculated that the C 
proteins were, like N protein, able to act as transcriptional inhibitors, aiding the switch 
from transcription to replication. Two other products of the SEN P gene, namely the V 
and W proteins have been found to act as inhibitors of genome replication (Curran et 
al., 1991a) and so perhaps only the P protein is essential for SEN RNA synthesis, the 
negative effectors being accessory factors which are dispensable. The suggestion that 
the role played by these proteins is non-vital is supported by the finding that several 
paramyxoviruses (including members of the SV5 and mumps group of 
paramyxoviruses, and also NDV) do not contain aC ORF, and PIV-1 which is very 
closely related to SEN (Lyn el al., 199 I) does not encode aV protein (Matsuoka el 
al., 1991). It has been suggested that the V and C proteins may play an important role 
in establishing persistent MV-infections (Catteneo ei al., 1989), and clearly any model 
for RNA synthesis will have to consider the role played by these species. 
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1.7: THE AIMS OF THIS STUDY. 
The P genes of most /'aramyxmviridae family members are able to direct the 
synthesis of at least one polypeptide, and in the case of the SEN P gene as many as 
eight (Curran et at, 1991 a). Previous studies have suggested that the PVM P gene is 
responsible for directing the synthesis of two polypeptides both in vivo (Ling and 
Pringle, 1989a), and in vitro (Chambers el cr/., 1990a). The precise identity of these 
two polypeptides was not known but they were thought to either represent a single 
protein that underwent post-translational modification or the products of initiation on 
two in-frame P gene AUG codons. Confirmation that these two polypeptides were 
encoded by the PVM P gene would represent the first incidence of a pneumovirus 
being able to express more than one polypeptide from the P gene. 
By determining the nucleotide sequence of a previously generated PVM P gene 
cDNA clone (Chambers el ai., 1990a) and by employing cell-free transcription and 
translation systems it was intended that the ill Pill? ) expressed polypeptide products of 
the PVM P gene could be characterised. The findings of the in vitro expression studies 
may then help elucidate the identity of the polypeptides expressed by the PVM P gene 
in vivo. 
In contrast to the P gene, the N gene of Paramyxoviridae family members are 
believed to only to express one polypeptide product. Preliminary in vitro expression 
studies suggested that the PVM N gene was able to direct the synthesis of at least two 
polypeptides (Barr et at., 1991). Further study of the in vitro expression characteristics 
of the N gene were undertaken to enable the precise identity of these species to be 
determined along with the mechanisms responsible for their synthesis. 
An ability of the N and P proteins to interact has been demonstrated in many 
virus systems, although it has been particularly well studied in SEN (Homann el al., 
1991, Ryan and Kingsbury, 1988; Ryan and Portner, 1990; Ryan ei at., 1990; Ryan ei 
al., 1991). The development of an in nitro assay system to study the interaction 
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between the N and P proteins of PVM would identify the regions of each protein 
involved in the binding process. 
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MATERIALS AND METHODS. 
Materials and Methods 
2.1: GROWTH OF PVM IN CELL CULTURE. 
2.1.1: Growth of BSCI cells. 
BSC 1 cells were cultured at an incubation temperature of 37°C in 1.5 litre glass 
roller bottles using GMEM (Glasgow modification of Eagles medium) growth medium 
supplemented with L-glutamine (4 mM), 5% [v/v] foetal calf serum, penicillin (IU/ 
ml), and streptomycin (100 mg/ml), GMEM supplemented as such was referred to as 
complete GMEM. Cells were passaged by trypsinisation at 4 day intervals at a ratio of 
1: 4. The cells to be passaged were rinsed twice with 25 mis of versene, and then once 
with 25 mis of 20% (v/v) trypsin/versene solution. A further 10 mis of 20% 
trypsin/versene was added to the roller bottle which was rotated and agitated by hand 
until the cells became detached. The suspended cells were diluted in complete GMEM 
medium, and the appropriate amount of this suspension was introduced into a new 
roller bottle which was gassed with CO2. 
2.1.2: Growth of virus stocks. 
The growth medium was poured off a roller bottle of sub- or just-confluent 
BSCI cells and a small volume, typically 10-15 mis, of previously generated PVM 
stock was added to give a multiplicity of infection of between 0. I and 0.5 plaque 
forming units (pfu) per cell. The bottle was incubated, with rolling, at 33°C for 2 hours 
after which 20 mis of GMEM (supplemented as above except for the addition of only 
2% [v/v] foetal calf serum) was added. The PVM-infected BSC I cells were incubated 
at 33°C until cytopathic effect (CPE) became extensive which typically took 4-6 days. 
The PVM-infected BSCI cells were removed from the surface of the bottle by 
vigorous agitation and then stored at -70"C until needed. 
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2.1.3: Plaque assay titration of PVM stocks. 
Virus stocks were serially diluted in complete GMEM to give a range of 
dilutions from 10"' to 10-6. AI ml volume of the diluted PVM stock was applied to 
confluent monolayers of BSCI cells in 12 well tissue culture clusters (Costar). The 
monolayers were incubated for 2 hours at 33"C after which they were overlaid with 
complete GMEM containing 1% (w/v) Noble agar. When this had set, the clusters 
were incubated for 7 days at 33°C in a CO2 gassed incubator. The cells were fixed for 
3 hours by the addition of 1% (v/v) glutaraldehyde, after which the overlay was 
removed and the cells stained for 5 minutes with crystal violet (0.15% [w/v] in ethanol, 
diluted 1: 20 before use). Excess stain was carefully rinsed away and the darkly 
coloured foci of PVM-infected BSCI cells were counted using a low powered 
microscope. 
2.1.4: Preparation of PVM-infected BSCI cell material 
BSC I cells were grown and infected with PVM stocks as described in section 
2.1.2. After the CPE became extensive, the PVM-infected BSC 1 cells were removed 
from the roller bottle using sterile glass beads and pelleted by centrifugation at 1000 g 
for 5 minutes at 4"C. The pelleted cells were resuspended in I ml of isotonic lysis 
buffer (150 mM NaCl, 20 mM Tris-HCI [pH 7.5], 2 mM EDTA, 1% Nonidet P-40 
[BDH laboratory supplies]) and incubated on ice for 15 minutes. The suspended cell 
material was centrifuged at 5000 g for 5 minutes. The supernatant fraction which 
contained the solubilised PVM-infected BSC I cell proteins was retained and divided 
into 100 pl aliquots which were stored at -20"C. 
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2.2: PROTEIN ANALYSIS. 
2.2.1: Polyacrylamide gel electrophoresis. 
The discontinuous buffer system of polyacrylamide gel electrophoresis first 
described by Laemmli (1970) was utilised. In all the polyacrylamide gel electrophoresis 
analyses described in this thesis, a single concentration 10% (w/v) resolving gel was 
used. The composition of the resolving and stacking gels used for electrophoresis is 
shown below. 
Reagent volume in resolving gel volume in stacking gel 
30% (w/v) acrylamide: bisacrylamide (29: 1) 16.7 ml 4 ml 
Tris-HCI (3 M, pH 8.8) 6.7 ml ---- 
Tris-HCI (0.5 M, pH 6.8) ---- 5 ml 
10% (w/v) sodium lauryl sulphate 0.5 ml 0.2 ml 
10% (w/v) ammonium persulphate 0.5 ml 0.1 ml 
TEMED 0.006 ml 0.003 ml 
distilled water 25.6 ml 10.7 ml 
The resolving gel acrylamide mixture was poured between glass plates and overlaid 
with water saturated butanol and allowed to polymerise. After the gel had set, the 
butanol was flushed off and the stacking gel acrylamide mixture was added, into which 
a comb was inserted to form the sample loading wells. Samples were prepared for 
electrophoresis by the addition of the appropriate volume of 5x SDS-PAGE sample 
buffer (15% [v/v] ß-mercaptoethanol, 15% [w/v] SDS, 50% [w/v], glycerol, 
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bromophenol blue), and then boiled for 3 minutes. The samples were loaded onto the 
gel which was electrophoresed in SDS running butler (192 mM glycine, 25 mM Tris, 
50 mM SDS, pH 8.3) using a Protean® II xi gel apparatus (Biorad) for a time period 
and current rating that caused sufficient separation of the polypeptides under 
examination. This was typically 14 hours at a current of 12 mA. Depending on the 
nature of the analysis, the electrophoresed gels could then be processed in one of three 
ways. Firstly, gels could be stained using Coomassie blue R-250 (0.1% [w/v] in 16% 
[v/v] acetic acid, 42% [v/v] distilled water, 42% [v/v] methanol) to directly visualise 
the separated polypeptides. Secondly, gels on which radioactively labelled polypeptides 
were electrophoresed were fixed for 45 minutes in a solution composed of 10% (v/v) 
acetic acid 45% (v/v) methanol and 45% distilled water, dried and exposed to X-ray 
film (Fuji photographic film Co. Ltd. ). Or thirdly, the polypeptides separated on the gel 
were transferred to a PVDF membrane for Western or west-western blotting, 
described in section 2.2.2. 
2.2.2: Transfer of proteins from polyacrylamide gel to PVDF membrane. 
Following electrophoresis, the polyacrylamide gel was placed in 500 mis of 
transfer buffer (192 mM glycine, 25 mM Tris, 20% [v/v] methanol, pH 8.3) and gently 
agitated for 30 minutes at room temperature. The gel was then placed in contact with a 
similar sized piece of ImmobilonTM PVDF membrane (Millipore Corporation) which 
had been prepared according to the manufacturers recommendations. All bubbles and 
air pockets that had become trapped between the gel and membrane were carefully 
removed and the gel/membrane sandwich was positioned in a Biorad TransblotTM 
apparatus according to instructions supplied by the manufacturer. Proteins were 
transferred by electrophoresis for 3 hours at 70 V. In order to visualise the immobilised 
proteins, the membrane was incubated for 5 minutes in the general protein stain 
ponceau-S (0.5% Ponceau S [w/v] in 1% [v/v] acetic acid 99% [v/v] distilled water) 
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and then destained in distilled water. The position of lanes and molecular weight 
standards were lightly marked using a pencil. Any residual stain was removed by 
further washing in distilled water. At this point, the membrane could either be used for 
Western blot analysis, west-western blot analysis or could be stored at -20°C for future 
use 
2.2.3: Western blot analysis. 
Proteins separated by SDS-PAGE were transferred to ImmobilonTM PVDF 
membrane as described above. In order to minimise non-specific binding of antibody to 
the membrane matrix, the membrane was incubated for 20 minutes at room 
temperature in Tris-buffered saline (TBS, 100 mM Tris, 150 mM NaCl, [pH 7.6]) 
containing 5% (w/v) MarvelTM dried milk powder (Premier brands Ltd. ). The 
membrane was thoroughly washed in TBS containing 0.1% (v/v) poly-oxyethylene- 
sorbitan-monolaurate (Tween-20, Sigma Chemical Co. ) and then incubated with the 
appropriate antibody at an optimal dilution that had been previously determined. 
Unless otherwise indicated, membrane washes consisted of 3 washes for 1 minute 
followed by four washes for 4 minutes. The incubations involving antibodies were 
usually carried out in heat-sealed plastic bags which allowed volumes to be kept to a 
minimum. The membrane was incubated with the antibody for periods of time ranging 
from 1 hour to 16 hours. The 16 hour antibody incubations were performed at 4°C. 
The membrane was washed as described above and incubated for between 20 minutes 
and 1 hour at room temperature with a biotinylated second antibody, which was 
diluted in TBS by a previously determined factor which gave the optimal signal above 
background. The membrane was washed as before, and incubated for 20 minutes with 
an alkaline phosphatase linked streptavidin conjugate (Arnersham International plc. ) 
diluted 1: 3000 in TBS. After washing, the membrane was incubated with alkaline 
phosphatase substrates (Nitro-blue tetrazolium and 5-bromo-4-chloro-3-indolyl 
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phosphate). As soon as the required intensity of the appropriate bands was reached, 
the reaction was stopped by the addition of distilled water. 
2.2.4: The west-western blot assay. 
The west western protein binding procedure described here is based on the 
method described in Homann et al., (1991). The procedure described here was able to 
study the interactions that occurred between PVM protein species which were 
immobilised onto a membrane support and radiolabelled PVM nucleocapsid protein 
that was applied to the membrane. The assay relied upon the gradual removal of 
detergent to hopefully allow the immobilised protein species to regain their functional 
conformation. 
Proteins separated by SDS-PAGE were transferred to PVDF membrane in a 
method identical to that used in the transfer of proteins for Western blot analysis 
except for the exclusion of methanol from the transfer buffer. Proteins immobilised on 
the membrane were renatured for 12 hours in standard binding buffer (SBB, 10 mM 
HEPES [N-2-hydroxyethylpiperazine-N-2-ethane-sulphonic acid] [pH 7.4], 10 mM 
MgCI2,50 mM NaCl, 0. I mM EDTA, I mM dithiothreitol, 10% glycerol). Following 
this incubation, the membrane was incubated for 3 hours at room temperature in SBB 
containing 5% (w/v) dried milk powder in order to saturate free binding sites present 
on the membrane matrix. The blot was rinsed in SBB and cut into strips, each of which 
had a PVM-infected BSC I cell track and a mock-infected BSC I cell track. Each strip 
was incubated for 24 hours at 4°C in I ml of SBB containing 30,000 cpm of 
trichloroacetic acid precipitable activity of in vi/r-u translated N protein or N protein 
related product. Following this incubation, the strips were each washed 10 times for 10 
minutes in SBB, dried in a 70°C oven, and exposed to pre-flashed X-ray film overnight. 
The extent of binding that had occurred was assessed by densitometric analysis. 
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2.2.5: Densitometric analysis. 
Pre-flashed autoradiographs generated by the west western blotting procedure 
were analysed using Image-Quant (version 3.0) software running on a Molecular 
Dynamics computing densitometer. 
2.3: MANIPULATIONS IN BACTERIA. 
2.3.1: Bacterial Strains. 
(a) Escherichicr cull TG2. 
hscherichiu co/i K12 strain TG2 was used for all general cloning procedures. 
The TG2 genotype is supE hsd°5 thi °(Iac-proAB) °(srl-recA)306:: Tn10(tetr) 
F'[traD36 proAB+ lael" IacZ°M 15] (Sambrook ei al., 1989). A. soli strain TG2 was 
maintained on 2YT agar plates (16 g bacto-tryptone, 10 g bacto-yeast extract, 5g 
NaCl, 1.5% [w/v] agar, in I litre distilled water) which were stored at 4"C. To initiate 
cultures of E. co/i TG2, a single colony of bacterial cells was picked from a 
maintenance plate using a sterile toothpick, and used to inoculate a5 ml volume of 
2YT media (as above, without agar) contained in a sterile glass universal bottle. 
Cultures were incubated overnight at 37"C in an orbital shaker. 
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(b) I: scherichicr culi BL21. 
E. coli strain BL21 was used for the in vitro expression of PVM P protein and 
P protein related species. This bacterial strain contains a chromosomal copy of the T7 
RNA polymerise gene under the control of the isopropyl-ß-D-thiogalactoside (IPTG) 
inducible /ac promoter (Studier and Moffat, 1986). The genotype is hsdS gal (Xclts857 
indlSam7 nin5 IacUV5 T7 genel) E. co/i strain BL2I was maintained on 2YT agar 
plates which were kept at 4°C. 
(c) Escherichia coli M 15 [pREP4]. 
E. coli K 12 strain M 15 [pREP4] was used for the high level expression of 
recombinant proteins using the pQE series of plasmids (Qiagen Inc. ). The genotype of 
the strain is Nal`, Str`, rif, lac-, ara gal-, mtl-, F, recA+, uvr+. I. coli strain M 15 
included multiple copies of the plasmid pREP4 which contains the lac I gene ensuring 
high levels of lac repressor and tight regulation of protein expression. 
2.4: ROUTINE MANIPULATIONS OF DNA. 
2.4.1: Phenol and chloroform extraction. 
Phenol extractions were performed to remove contaminating protein from 
samples of nucleic acid. An equal volume of phenol (BDH lab. supplies) equilibrated 
with THE (100 mM NaCl, 50 mM Tris-HCI [pH 7.5], I mM EDTA) was added to the 
sample to be extracted which was then vortexed for 30 seconds. The sample was 
centrifuged to separate the phases and the upper aqueous layer was transferred to 
another tube to which an equal volume of chloroform was added. The sample was 
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vortexed and centrifuged and again the upper aqueous layer taken for further 
manipulation. 
2.4.2: DNA and RNA precipitations. 
Nucleic acid containing solutions were made 0.3 M with respect to sodium 
acetate (pH 5), and 2.5 volumes of absolute ethanol were added. Nucleic acid was 
precipitated by incubating the samples at -20°C overnight or in a dry-ice and ethanol 
bath for 3-5 minutes. Nucleic acid was pelleted by centrifugation. 
2.5: BACTERIAL TRANSFORMATION AND PREPARATION OF PLASMID DNA. 
2.5.1: Preparation of competent bacteria. 
AI ml aliquot of an overnight culture of I. co/i TG2 was used to inoculate 70 
mis of 2YT medium in a sterile conical flask. The resulting culture was incubated with 
shaking in a 37"C incubator. When the optical density (measured at 590 nm) of the 
culture reached 0.4, the culture was removed from the incubator and placed on ice for 
30 minutes. The cooled culture was centrifuged at 2,500 g for 5 minutes to pellet the 
bacteria. The bacteria were resuspended in 10 mis of sterile, ice cold, 0.1 M MgCI2 and 
then immediately repelleted by further centrifugation at 2,500g for 5 minutes. The 
pelleted bacteria were resuspended in 2 mis of sterile, ice cold, CaCI2 and placed on 
ice. After 1 hour the L'. soli TG2 were sufficiently competent to be used for plasmid 
transformation. 
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2.5.2: Transformation of E. coli TG2 with plasmid DNA. 
Aliquots (100 pl) of competent E. coil TG2 were dispensed into ice cold sterile 
Falcon tubes (Beckton-Dickenson labware). Plasmid DNA generated as a result of 
ligation reactions, typically 25 p. 1 in volume, was added to the E. coli TG2 cells and the 
tubes were returned to ice for 30 minutes. The E. coli TG2 were heat shocked by 
placing the tubes in a 42"C water bath for 2 minutes, and then returned to ice for 
between 1 and 5 minutes. 2YT medium (0.5 ml) was added to each tube which was 
then placed in a 37°C shaking incubator for 20 minutes. The resulting cultures were 
spread onto 2YT plates supplemented with a selective antibiotic which was most 
commonly ampicillin (100 pg/ml final concentration). Once they had dried, plates were 
placed in a 37°C incubator overnight. 
2.5.3: M13 DNA transformation. 
Transformation of M 13 DNA into E. coli TG2 was performed using a method 
essentially the same as that described for transformation of K. coli TG2 with plasmid 
DNA, until after the heat shock stage. At this point, M 13 transformed E. coli TG2 
were chilled on ice for 5 minutes and then warmed to room temperature. A2 ml 
aliquot of top agar (2YT containing 0.6% [w/v] agar) at a temperature of 45°C was 
then added to the transformed bacteria. The top agar contained both X-gal (3 mg/ml) 
and IPTG (2.4 mg/ml) for chromogenic identification of recombinants, and also 100 j. il 
of early log phase K. coli TG2 to provide a bacterial lawn. The Falcon tube was briefly 
agitated and the contents poured on a warm 2YT agar plate which was left to set on a 
level surface. Plates were incubated overnight at 37"C. 
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2.5.4: Small scale plasmid preparations. 
Plasmid DNA was extracted from bacterial cultures using a modified version of 
the alkaline lysis method described by Sambrook ei ad., (1989). Transformed colonies 
were picked from agar plates using sterile toothpicks and inoculated into 2 mis of 2YT 
medium supplemented with the appropriate antibiotic. Cultures were incubated at 37°C 
overnight in a shaking incubator. 1.5 ml of each culture was centrifuged at 10,000 g 
for 2 minutes in an microfirge (Eppendorf Geratebau Netheler+Hinz GmbH) to pellet 
the bacteria, and the supernatant was discarded. The resulting pellet was resuspended 
in 100 pl of lysozyme solution (10 mg/ml in distilled water) and placed on ice for 10 
minutes. 200 pl of SDS-lysis buffer (0,2 M NaOH, 1% [w/v] SDS) was added to the 
cells and the resulting suspension was mixed by gently agitating and flicking the tubes. 
The tubes were incubated on ice for 20 minutes, after which 150 pl of 3M sodium 
acetate (pH 5) was added. The resulting viscous material was mixed by gentle agitation 
as before. The precipitate of cell debris was pelleted by centrifugation at 10,000 g for 5 
minutes and the supernatant fraction was transferred to a fresh Eppendorf tube 
containing I ml of ethanol. DNA was precipitated by incubating the tube in dry- 
ice/ethanol for 3 minutes and the DNA was pelleted by centrifugation at 10,000 g in a 
microcentrifüge. The DNA pellet was dried in a vacuum desiccator, resuspended in 
100 pl of distilled water and stored at -20"C. This basic method of plasmid preparation 
was occasionally modified to accommodate larger cultures up to 60 mis in volume by 
scaling up the quantities of reagents such that their proportions to one another 
remained the same as above. 
2.5.5: Large scale plasmid preparations. 
The alkaline lysis method of Sambrook el at (1989) was used. An overnight 
culture of the appropriate transformed E. cry/i TG2 colony was used to inoculate 500 
mis of 2YT medium containing the appropriate antibiotic. The culture was incubated in 
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an orbital shaker at 37"C for 6 hours. After this period, chloramphenicol (20 pg/ml, 
final concentration) was added in order to amplify plasmid numbers (Sambrook e> al., 
1989). The culture was incubated overnight and the bacteria were harvested by 
centrifugation at 2,000 g for 30 minutes. The resulting pellet was resuspended in 7 mis 
of solution I (25 mM Tris-HCI [pH 8.0], 50 mM glucose, 10 mM EDTA, 5 mg/mI 
lysozyme), transferred to an Oakridge tube and then incubated for 5 minutes at room 
temperature. The bacteria were lysed by the addition of 14 mis of solution 11 (0.2 M 
NaOH, 1% [w/v] SDS) and the tube was gently agitated to ensure thorough mixing of 
the contents. After a 10 minute incubation on ice, 10 mis of solution III (5 M sodium 
acetate, [pH 5.0]) was added and once again, the tube contents were gently mixed and 
then incubated on ice for 10 minutes. The mixture was centrifuged at 5,000 g for 30 
minutes to pellet cell debris and chromosomal DNA. The supernatant was mixed with 
0.6 volumes of isopropanol, and after a 10 minute incubation at room temperature, the 
DNA was precipitated by centrifugation at 2,500 g for 20 minutes. The DNA pellet 
was dried in a desiccator and resuspended in 25 mis of distilled water to which 26.5 g 
of caesium chloride and 3 mg of ethidium bromide were added. The solution was 
introduced into a Beckman 38 ml quick seal"" tube (Beckman Instruments Inc. ), and 
the tube was filled with paraffin. The tube was heat sealed and centrifuged for 16 hours 
at 60,000 g in a Beckman VtiSO rotor. The closed circular plasmid DNA band was 
located using long wave (366 nm) UV light and the band was removed by piercing the 
tube with a syringe. The ethidium bromide was removed by four extractions using an 
equal volume of water saturated butanol. The CsCI was removed by dialysis against 
three 3 litre volumes of TE (1 mM Tris-HCI [pH 7.8], I mM EDTA [pH 8.0]). The 
DNA was recovered by ethanol precipitation and resuspended in I ml of distilled 
water. The yield was calculated by measuring the OD260 (an OD2c, () of 1.0 equates to 
50 pg/ml of ds DNA). 
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2.5.6: Single strand template preparation. 
Turbid plaques were transferred into 2 mis of 2YT medium which contained 60 
µl of an overnight E. coli TG2 culture. To achieve good aeration, glass test tubes with 
loose fitting aluminium tops were used (Difco Laboratories). Cultures were shaken at 
200 rpm. for between 4 and 6 hours. After incubation, the culture medium was 
decanted into a 1.5 ml Eppendorf tube and the bacteria were pelleted in an Eppendorf 
microfuge. Approximately I rnl of supernatant was transferred to a clean Eppendorf 
tube to which 250 pl of a solution of PEG 6000 (20% [w/v]) and NaCl (2.5 M) was 
added and mixed. The tube was incubated at room temperature for 15 minutes after 
which M13 bacteriophage were pelleted by centrifugation at 10,000 g for 5 minutes. 
The pellet was resuspended in 120 pl of TE buffer (10 mM Tris-HCI [pH 8.0], 0.1 mM 
EDTA) and extracted with 50 pl of THE equilibrated phenol. A 100 pl volume of the 
aqueous phase was removed and extracted with 50 p1 of chloroform. Following 
chloroform extraction, 80 pl of the aqueous phase was removed and the DNA 
precipitated as described previously. The DNA pellet was resuspended in 30 p1 of 
sterile distilled water. 
2.6: MODIFICATION OF DNA. 
2.6.1: Restriction enzyme digestion of DNA. 
Double stranded DNA was specifically cleaved using various restriction 
endonucleases obtained from commercial sources. Optimal cleavage of DNA was 
achieved by performing the digestion under the conditions recommended by the 
manufacturer. Typically restriction enzyme digestions were carried out in a 10 p. l 
volume, comprising approximately 0.1 pg of plasmid DNA, sufficient restriction 
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enzyme to ensure complete cleavage of the DNA and the correct concentration of the 
appropriate buffer. If the plasmid DNA was obtained using the small scale preparative 
method then RNase A (Sigma Chemical Co. ) was also included in the restriction 
reaction at a final concentration of 100 pg/ml. 
2.6.2: End-filling of DNA fragments. 
Ends of DNA fragments were made blunt either by nibbling back a 3' 
protruding strand or by filling in a S' protruding strand to make it flush. Both 
manipulations were performed using DNA polymerase I Klenow fragment (Bethesda 
research laboratories) and 100 pm dNTPs (Pharmacia LKB), in IX ReactTM 2 enzyme 
buffer (Bethesda research laboratories). The reactions were incubated for 30 minutes 
at 3 7°C 
2.6.3: Ligations. 
Fragments of DNA generated by the fragment preparation method described 
below were inserted into linearised plasmid vectors by ligation using T4 DNA ligase 
(Amersham international plc. ). Typical ligation reactions were carried out in a volume 
of 50 lii which comprised linearised plasmid vector, purified DNA fragment, a 
sufficient quantity of T4 DNA ligase and an appropriate quantity of T4 DNA ligase 
buffer (Bethesda research laboratories). Reactions were performed at room 
temperature for between 3 and 16 hours. 
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2.7: ELECTROPHORESIS OF DNA. 
2.7.1: Agarose gel electrophoresis. 
This technique was used analytically to resolve the products of restriction 
enzyme digestions and also preparatively to isolate specific DNA fragments. Agarose 
(Sigma Chemical Co. ) was dissolved in near boiling TAE buffer (40 mM Tris-acetate 
[pH 7.0], 1 mM EDTA). The molten agarose was cooled and ethidium bromide was 
added to give a final concentration of 0.5 pg/ml. The agarose concentration within the 
gel varied between 0.6% and 2.0% depending on the size of DNA fragments that had 
to be resolved. The relationship between agarose concentration and the resolving 
characteristics of a gel are detailed in Sambrook el a/. (1989). The cooled agarose was 
poured into a gel casting assembly and combs were inserted in order to create sample 
wells. DNA samples to be analysed were mixed with loading buffer and applied to the 
sample wells. In order to determine the molecular weight of resolved bands, I kb 
ladder markers (Bethesda Research Laboratories) were loaded alongside the samples 
under analysis. Set agarose gels were electrophoresed in one third strength TAE buffer 
which also contained ethidium bromide (0,5 pg/nil). Gels were usually electrophoresed 
at a power rating of 45 W for a period of time which allowed sufficient separation of 
the DNA fragments. Resolved DNA bands were visualised by placing the gel on a UV 
transilluminator (UVP Inc. ). Photographs were taken using Polaroid 667 instant black 
and white film in a Polaroid DS-34 camera. 
2.7.2: Polyacrylamide ;; el electrophoresis. 
Acrylamide and bis-acrylamide in a ratio of 29: I were dissolved in a solution of 
TBE (89 mM Tris-HCI [pH 7.5], 89 mM Boric acid, 10 mM EDTA) and 8M urea to 
give and overall acrylamide concentration of 6%. To ensure rapid polymerisation of 
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the gel, 120 pl of TEMED and 600 pl of' IU°/o (w/v) ammonium persulphate were 
added. The gel was poured between clean glass plates separated by spacers designed to 
give a wedge shaped gel 0.4 mm thick at the top and 1.0 mm thick at the bottom. 
Shark tooth gel combs (Gibco-BRL) were placed at the top of the gel to form a 
straight edge on which the samples could later be applied, and the gel was left to 
polymerise for 1 hour. Before samples were loaded, the gel was pre-electrophoresed 
for 15 minutes at a constant power rating of 80 W. Samples were prepared as 
described in the protocol supplied with the SequenaseTM version 2.0 kit (United States 
Biochemical Corp., see section 2.9) and then were electrophoresed for periods of time 
of between 1.5 hours and 6 hours depending upon the position of the required 
sequence in relation to the -20 primer. When electrophoresis was complete, plates 
were separated and the gel was fixed in a solution of 10% acetic acid (v/v). The gel 
was dried on a vacuum drier (Biorad) and then exposed to x-ray film (Fuji 
photographic Film Co. Ltd. ). 
2.7.3: Fragment preparations. 
Restriction endonuclease generated DNA fragments were recovered from 
agarose gels by a method based on the freeze-squeeze procedure described by Thuring 
et al. (1975). An agarose slice containing the appropriate DNA band was cut from the 
gel, chopped into small pieces, and then placed in a 1.5 ml Eppendorf tube. DNA was 
extracted from the agarose by repeated freezing and thawing of the tube contents 
which released DNA into the expelled liquid. Once extraction of liquid from the 
agarose became difficult the gel pieces were wetted with a small quantity of distilled 
water (100 p1) and subjected to further freeze-thaw cycles. The resulting liquid was 
extracted three times with phenol and once with chloroform, as described in section 
2.4.1 after which the DNA was precipitated as described in section 2.4.2. 
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2.7.4: Polymerase chain reaction. 
The polymerase chain reaction (PCR) amplification technique used in this study 
was based on a method described by Saiki cal cii. (1989). Elongation of the DNA 
strands was performed by Tcrq I polyrnerase (Promega Corporation) in reaction 
conditions stipulated by the manufacturer. A typical PCR amplification was performed 
in a 100 }tl volume consisting of the following reagents. 
MqI polyrnerase (Promega Corporation) 0.2 pI 
100 mM MgCI2 (Promega Corporation) 10.0 pl 
10x Taq I buffer (Promega Corporation) 6.0 p1 
dNTP mix (dGTP, dCTP, dTTP, dATP, all at 25 mM) 1 .0 p1 
oligonucleotide primers (approximately 40 pg/mI) 1.0 PI 
DNA template (I ng/ml) 2.0 pI 
distilled water 80.0 p. 1 
The PCR reaction components were overlaid with 100 pl of white paraffin to limit 
volume changes due to evaporation. The samples were placed in a thermal reactor 
(Hybaid) and subjected to a 30 cycle programme which involved a 45 second melting 
step (94"C), a 45 second annealing step (55"C) and a 90 second elongation step (74°C) 
2.8: CHARACTERISATION OF PVM GENE 4 cDNA CLONES. 
A library of double stranded cDNA clones generated from mRNA extracted 
from PVM-infected BSC I cells was constructed by Dr. P. Chambers (Chambers et a!., 
1990a). A group of cDNA clones was identified which had a high relative abundance 
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of members and which hybridised with virus specific RNA with an approximate 
molecular weight of 1200 bases. This group was assigned to the PVM N gene. 
Nucleotide sequence analysis of cDNA clones from the group confirmed this 
assignment (Barr el al., 1991). By nucleotide sequence analysis of polycistronic clones, 
the group that represented the proceeding gene to the N gene was identified. One of 
the cDNA clones from this group (clone 4.48) represented the full length of PVM gene 
4 although this clone contained a sequence inversion at its 5' end (Barr el at., 1991). 
A population of oligo(dG) tailed cDNA-RNA hybrid molecules generated from 
PVM-infected BSCI cell extracted RNA (Barr et a/., 1991) were used as a template 
for the amplification of a cDNA segment corresponding to nucleotides I to 139 of the 
PVM P gene using PCR. One of the PCR oligonucleotide primers (designated 
PVMPI, GGTGACATGAGTAGTGGCAGTGTT('GG) was designed to hybridise to 
a region of the P gene spanning nucleotides 115 to 139, whereas the other primer 
(designated oli C, CCCGAGCTCTGCAGGATCC('CCCCCCCCC) was designed to 
hybridise to the poly(dG) tract. The DNA segment was amplified and purified as 
described in Barr el cr/., (1991). The inverted S' sequence of cDNA clone 4.48 was 
removed by digestion with restriction enzymes Acc I and Psi I and this sequence was 
replaced with the PCR generated segment, previously cleaved with Ace I and Psi I 
This plasmid, containing a full-length cDNA copy of the PVM P gene, was designated 
pUC 13-P. 
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2.9: NUCLEOTIDE SEQUENCE ANALYSIS. 
Nucleotide sequence was determined using the principle of dideoxy chain 
termination developed by Sanger el a1. (1980). The protocol and reagents excepting 
radioactive label were supplied in the SequenaseTM kit version 2.0 (United States 
Biochemical Corp. ) The 35S-dATP radioactive label was supplied by Amersham 
International plc. The -20 sequencing primer supplied in the SequenaseTM kit was used 
for all sequence determinations. 
2.10: IDENTIFICATION OF ANTI-PVM P PROTEIN SPECIFIC MONOCLONAL 
ANTIBODIES. 
Approximately two hundred monoclonal antibody secreting hybridoma cell 
lines were generated by Dr. R. Ling (Ling and Pringle, 1989a). Tissue culture fluids 
from each of the cell lines, collected and stored at -20"C by Dr. Ling, were available 
and were screened either for the ability to recognise bacterially expressed PVM P 
protein by Western blot analysis or for the ability to immunoprecipitate 35S methionine 
labelled, in viIro translated, P protein. In this way, several cell lines capable of 
secreting anti-P protein monoclonal antibodies were identified, and for one of these cell 
lines, 26/3B5, the original liquid nitrogen-stored cell culture was resurrected. Frozen 
cells were quickly thawed and transferred to a sterile universal containing 5 mis of 
RPMI 1640 medium (Gibco-BRL) supplemented with foetal calf serum (10% v/v), 
penicillin (100 U/mI), streptomycin (100 pg/mI), g lutamine (2 mM), HEPES (40 mM), 
and sodium hydrogen carbonate (0.2% w/v). Medium containing these additions was 
referred to as complete. The tube was immediately centrifuged at 500 g for 2 minutes 
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to pellet the hybridoma cells. The cell pellet was gently resuspended in 100 µ. l of 
complete RPMI 1640 medium and dispensed onto macrophage feeder cell cultures, in 
a 96 well tissue culture dish. The macrophage feeder cells were obtained by rinsing the 
peritoneal cavity of a freshly killed mouse with 5 mis of PBS, withdrawing the PBS 
with a syringe, and centrifuging the resulting cell suspension at 200 g for 5 minutes. 
The feeder cells were resuspended in complete RPMI 1640 medium and cultures were 
initiated by dispensing aliquots of the cell suspension into a 96 well dish (Costar). The 
hybridoma cells were incubated at 37°C in a 5% CO2 atmosphere and after 4 days were 
transferred, using a Pasteur pipette, for culture into 12 well dishes without the feeder 
cells. As cell numbers increased the cells were transferred to progressively larger 
culture flasks using a cell splitting procedure identical to that used for BSC I cells 
described in section 2.1.1. Cell culture medium was removed each time the cells were 
split and used in Western blot analysis. 
2.11: EXPRESSION OF RADIOLABELLED POLYPEPTIDES IN VITRO. 
2.11.1: Transcription of rRNA in vitro. 
mRNA was transcribed in Wiro from derivatives of the T7 transcription 
plasmid pGEM I (Promega Corp. ). Transcription plasmids were linearised by digestion 
with an appropriate restriction enzyme that cut at a site downstream from the 
termination codon of the coding region present on each plasmid. Messenger RNA was 
transcribed from the T7 promoter using T7 RNA polymerase under reaction conditions 
recommended by the enzyme manufacturer (BRL). Typically, transcription reactions 
were performed in 50 pl volumes consisting of the following reagents. 
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linearised plasmid (approx. 0.1 rg ml) 10.0 p1 
5x T7 buffer (supplied by BRL) 10.0 p1 
ATP, UTP, CTP, GTP combined stock, each at 25 mM 2.0 p. l 
T7 RNA polyrnerase (10 U/pl) 1.0 pl 
distilled water 27.0 p. 1 
The transcription reactions were allowed to proceed at 37°C for I hour after which a 
further 5 units of T7 RNA polyrnerase was added. After incubation for a further 30 
minutes, the volume of the transcription reactions was increased to 200 PI by the 
addition of distilled water. The transcription products were extracted once with phenol 
and once with chloroform, (as described in section 2.4.1) and the m-RNA was 
precipitated by the addition of 500 ii of ethanol and incubation for 30 minutes at - 
70°C. The RNA was harvested by centrifugation at 10,000 g for 10 minutes and the 
pellet was dried and resuspended in 50 pl of distilled water. 
2.11.2: In vitro translation using rabbit reticulocyte lysate. 
Messenger RNA species transcribed from the pGEM I derived plasmids 
described above, were used in conjunction with a rabbit reticulocyte lysate system 
(Amersham International plc. ) to programme the in vile-o translation of radioactively 
labelled polypeptides. The constituents of a typical in vita, translation reaction are 
shown below. 
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rabbit reticulocyte lysate 10.0 µl 
mRNA 1.0 µl 
35S methionine 1.0 N1 
distilled water 0.5 pl 
If larger amounts of in vitro synthesised polypeptides were required, these constituents 
were scaled-up such that they remained in these proportions. The translation was 
allowed to proceed for 90 minutes at 30"C. The incorporation of 15S methionine into 
polypeptide translation products was assessed either by subjecting an aliquot of the 
lysate to SDS-PAGE analysis, or by trichloroacetic acid precipitation. The 
concentration of mRNA required in the translation reaction to result in optimal 
synthesis of the desired polypeptide was determined each time a new batch of mRNA 
was transcribed by serially diluting the mRNA added to the reticulocyte lysate and 
analysing the resulting products with SDS-PAGE. 
2.11.3: In vitro translation using wheat germ lysate. 
In addition to rabbit reticulocyte lysate, a wheat germ lysate was sometimes 
used for the in 'i/ro expression of -15S methionine labelled polypeptides. The wheat 
germ lysate and the energy mix were kind gifts of Dr. Martin Hartley, University of 
Warwick, UK. The constituents of a typical wheat germ lysate translation reaction, and 
composition of the energy mix is shown below. 
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(a) Wheat germ translation constituents. 
Wheat germ lysate 
energy mix 
I'S methionine 
distilled water 
mRNA 
Translations were allowed to proceed for I hour at 27"C. 
(b) Energy mix composition. 
HEPES (I M [pH 7.6]) 
ATP (0.1 M) 
creatine phosphate (0.4 M) 
creatine phosphokinase 
spermidine (pH 7.0) 
DTT (0.1 M) 
GTP (2 mM) 
amino acid mix (all at I mM) 
potassium acetate (I. 0 M) 
distilled water 
3.8 µl 
2.4 µl 
1.0 NI 
3.4 µ1 
1.0 NI 
70 pi 
50 µI 
100 N. 1 
20 NI 
100 µI 
85 NI 
50 µI 
25 pi 
20 NI 
420 pi 
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2.11.4: lmnuinoprecipitation of ; 'S methiouine labelled polypeptides. 
Radiolabelled polypeptides were produced by in vitro translation using the 
rabbit reticulocyte system described earlier. The translation mix was diluted by the 
addition of 6 volumes of IVT precipitation buffer (50 mM Tris-HCI [pH 7.6], 5 mM 
EDTA [pH 8.0], 150 mM NaCl, 0.05% [w/v] Nonidet P-40) in a 1.5 ml Eppendorf 
tube and chilled on ice. Antibody originating from either hyper-immune animal serum 
or hybridoma cell culture fluids was added to the diluted translation product and the 
mixture was incubated overnight at 4°C. The precise volume of the antibody solution 
that was added depended on the titre. After the overnight incubation, 100 µl of 
Sepharose CL-4B linked staph)'lococc'u protein A Slurry (Pharmacia LKB), prepared 
according to the manufacturers instructions, was added to the immunoprecipitation 
mixture. The resulting suspension was vigorously agitated for 90 minutes at 4"C, and 
centrifuged at 200 g for 1 minute to pellet the Sepharose Slurry. The slurry was washed 
with I ml of IVT buffer, and pelleted by centrifugation as before. After two more wash 
and centrifugation cycles, 50 l. tl of 5x SDS gel loading dye (15% [v/v] (3- 
mercaptoethanol, 15% [w/v] SDS, 50% [w/v] glycerol and 0.01% [w/v] brornophenol 
blue) was added to the pelleted Sepharose slurry and the suspension was placed in a 
boiling water bath for 2 minutes. The slurry was pelleted and the supernatant removed 
for analysis by PAGE. 
2.11.5: Trichloroacetic acid precipitations. 
The extent to which radioactive label had been incorporated into polypeptide 
products of in vitro translation reactions was assessed using trichloroacetic acid (TCA) 
precipitation. Two I pl aliquots of "S methionine labelled material generated from 
each translation reaction were placed on to individual Whatman 3MM filter paper 
discs. After the aliquots had dried, one of the discs was placed in a beaker containing 
250 mis of ice-cold 10% (w/v) TCA to wash away unincorporated radioactivity. After 
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10 minutes, the TCA was discarded and the disks washed in fresh ice-cold 10% (w/v) 
TCA for a further 10 minutes. The filter disc was then removed and dried. This filter 
paper disc, which represented incorporated radioactivity, and the other filter paper 
disc, which represented total radioactivity, were placed in separate scintillation vials, 
covered with liquid scintillant and then placed in a scintillation counter where the 
radioactivity of the filter discs was measured. The efficiency by which the 35S 
methionine had been incorporated into the polypeptide was determined by expressing 
the incorporated radioactive counts as a percentage of the total radioactive counts in 
each sample. 
2.12: EXPRESSION OF POLYPEPTIDES IN BACTERIAL SYSTEMS. 
2.12.1: Expression and purification of polypeptides using the Qiagen ExpressTM 
system. 
Plasmids derived from pQE32 which contained DNA inserts to be expressed 
(pQE32.24 or pQE32. P2, see sections 9.2.1 and 8.3.2 respectively, for construction 
details) were transformed into E. co/i M15 [pREP4] using the method described in 
section 2.5.2. The pQE32 plasmid carries a gene expressing ampicillin resistance, 
whereas plasmid pREP4 carries a gene expressing kanamycin resistance and so for 
maintenance of both plasmids, all plasmid propagations were performed in the 
presence of ampicillin (100 pg/ml) and kanamycin (25 pg/mI). 
A 200 p1 aliquot of an overnight culture of L. co/i strain M15 [pREP4] 
transformed with a pQE series vector was inoculated into a 10 ml culture of 2YT 
medium in a 100 ml conical flask. The flask was placed in a 37°C shaking incubator 
until the ODs, )() of the culture was 0.6 at which time expression of the desired protein 
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was initiated by the addition of IPTG to a final concentration of 10 mM. The induced 
culture was incubated for a further 3 hours after which the bacteria were pelleted by 
centrifugation at 2,500 g for 5 minutes. The bacterial pellet was resuspended using a 
vortex in 1.6 mis of Buffer B (8 M urea, 0.1 M sodium phosphate, 0.1 M Tris-HCI [pH 
8.0]) and centrifuged at 5,000 g for 10 minutes. The supernatant was transferred to a 
new tube to which 400 it of Ni-NTA binding slurry was added. The tube was 
vigorously agitated for 30 minutes at room temperature and then centrifuged at 200 g 
to pellet the slurry. The slurry was washed in butter C (8 M urea, 0.1 M sodium 
phosphate, 0.01 M Tris-HCI [pH 6.3]) by 3 rounds of pelleting, resuspension and 
centrifugation. In order to release the purified polypeptide from the slurry, 160 . il of 
buffer C containing 100 mM EDTA was added and the mix was incubated at room 
temperature for 2 minutes. The slurry was then pelleted and the supernatent containing 
the purified polypeptide was collected for later analysis by SDS-PAGE. 
2.12.2; Expression of polypeptides Using, E. coli strain BL21. 
pGEM I derived transcription plasmids were transformed into E. coli BL21 in a 
method identical to that used for the transformation of I,. co/i strain TG2 (section 
2.5.2). Cultures of the transformed 1;. co/i BL2I were grown overnight in 2 mis of 
2YT medium supplemented with ampicillin at a final concentration of 100 pg/ ml. A 
200 pi aliquot of the culture was used to inoculate 10 mis of 2YT medium 
supplemented with ampicillin at 100 jig/ml contained in a 100 ml conical flask, and this 
was shaken at 37"C. When these cultures reached an ODs,,,, of 0.8, expression of the 
foreign plasmid was induced by the addition of IPTG to give a final concentration 10 
mM. By inducing cultures with IPTG, the L. co/i BL21 began to synthesise T7 RNA 
polymerase which then transcribed mRNA from the cloned insert. The mRNA was 
then translated using the bacterial protein synthesis machinery to produce the desired 
protein species. Cultures were incubated for a further 3 hours after which the bacteria 
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were pelleted by centrifugation at 2,500 g for 5 minutes. The bacterial proteins were 
solubilised by resuspending the pellet in I ml of isotonic lysis butler (section 2. I. 4). 
Insoluble material was pelleted by centrifugation at 10,000 g for 5 minutes and the 
resulting supernatant fraction was stored at -20"C until needed. 
2.13: GENERATION OF ANTISERA IN LABORATORY ANIMALS, 
2.13.1: Generation of antisera against the 24 kDa N protein related polypeptide. 
Purified 24 kDa N protein species, expressed as described in section 2.12. I, 
was diluted in distilled water to an approximate concentration of 2 pg/ml (estimated by 
SDS-PAGE analysis) and then emulsified in an equal volume of Freund's complete 
adjuvant (Sigma Chemical Co. ) by vigorous vortexing, for 5 minutes. AI ml quantity 
of this emulsion was used to immunise a rabbit by sub-cutaneous injections at four 
sites. Three subsequent boosts of 24 kDa protein emulsified in Freund's incomplete 
adjuvant were performed at three week intervals. Two weeks after the final boost, 
blood was taken from the animal and the resulting serum was used in western blot 
analysis to determine whether the 24 kDa N species, in addition to the 43 kDa full- 
length N protein, was expressed in PVM-infected BSC I cells. 
2.13.2: Generation of antisera aLwainst the PVM P gene second ORF protein 
product. 
An oligopeptide representing amino acids 45-62 of the predicted amino acid 
sequence of the PVM P gene second ORF protein product was synthesised and each 
linked to the carrier protein Keyhole limpet haemocyanin (KLH, Sigma Chemical Co. ) 
according to the method described in Liu CI Of (1979). KLH was dissolved in 
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phosphate buffered saline (PBS, 10 mM, p1-f 72) to a concentration of 15.6 mg/ml and 
dialysed against the same butler for 24 hours. KLH (320 pl) was activated by slow 
addition of 55 pl of m-maleimidobenzoyl N-hydroxysuccinimide (MBS, Sigma 
Chemical Co., 12 mg/ml, dissolved in dimethylformamide) and incubated for 30 
minutes at room temperature. The activated KLH was applied to a 20 ml column of 
Sephadex G-25 (Pharmacia LKB) previously equilibrated with PBS (50 mM, pH 6) 
and I ml fractions were collected. The OD2 O of the tractions was measured and those 
that comprised the first peak, which contained activated KLH, were pooled (figure 5). 
The pooled fractions were added to an aqueous solution of each synthetic peptide (5 
mg/ml). The reaction mixture was adjusted to pH 7.0 using IM HCI, and incubated 
for 3 hours at room temperature. This solution was emulsified with an equal volume of 
Freund's complete adjuvant (Sigma Chemical Co. ) and used to immunise rats by sub- 
cutaneous injection. Following three boosting injections, separated by 3 week intervals, 
blood was taken from the animals and used in Western blot analysis to determine if the 
PVM P gene second ORF protein product was expressed in PVM-infected BSC I cells. 
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Figure 5. Graph to show the typical elution profile of MBS-activated keyholelimpet 
haemocyanin passing down a sephadex G-25 column. Fractions 13,14 and 15, which 
contained MBS-activated KLH, were pooled for use in coupling to the synthetic 
peptide representing a region of the PVM P2 polypeptide. The second peak comprising 
fractions 22,23 and 24 represents MBS. 
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CHAPTER 3 
DETERMINATION OF THE NUCLEOTIDE SEQUENCE OF THE PVM P 
GENE. 
P Gene Sequence 
3.1: CONSTRUCTION OF M 13 VECTORS FOR SEQUENCING THE PVM P GENE. 
Full-length P gene cDNA was excised from plasmid pUC 13-P, and digested 
using a variety of restriction enzymes to generate a range of truncated cDNA 
fragments which are represented diagrammatically in figure 6. The restriction enzymes 
used to digest the P gene cDNA are shown on the figure. The resulting cDNA 
fragments were purified by agarose gel electrophoresis and fragment preparation and 
inserted into the multiple cloning site of the bacteriophage M 13 derivatives mp 18 and 
mp19 using standard molecular techniques. The resulting constructs were transformed 
into E. co/i TG2. Single strand templates were prepared from these bacteriophage 
derivatives and used for nucleotide sequence analysis of the PVM P gene according to 
the procedures detailed in section 2.9. 
3.2: THE NUCLEOTIDE SEQUENCE OF THE PVM P GENE. 
The sequence of the PVM P gene mRNA and the predicted polypeptide 
sequence of the PVM P protein is shown in figure 8. The complete nucleotide 
sequence was determined by merging the sequence obtained from the range of 
bacteriophage M 13 constructs containing P gene cONA described in section 3.1. The 
PVM P gene is 903 nucleotides long and contains a long open reading frame (ORF) 
which starts from an AUG initiation codon at nucleotide positions 10 to 12 (AUG,, )) 
and which finishes at a termination colon at positions 895 to 897. The size of the 
PVM P gene corresponds well with the estimated size of the mRNA observed in 
Northern blots (Chambers et al., 1990a). The PVM P gene begins with the conserved 
PVM gene start consensus sequence (Chambers et at., 1990a) and for this reason it is 
believed that the first nucleotides of the sequence presented here represents the exact 
5' end of the P gene. The PVM P gene also ends with the PVM gene consensus stop 
sequence (Chambers et al., 1990a) and is followed by a number of A residues. 
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Figure 6. Region of the PVM P gene represented by M13 subclones constructed to 
determine the P gene nucleotide sequence. A fragment representing full-length P gene 
cDNA was removed from plasmid pUC13-P by digestion with resriction enzyme Sac I. 
This fragment was cleaved with restriction enzymes Nsi I, Nhe I and Dra I to create 
truncated cDNA segments which were ligated into the M13 derivatives mp18 and mp19 
that had been cleaved with Sma I and Sac I. The nucleotide sequence of the segments 
was determined as described in section 2.9. In order to determine the 3' end of the PVM P 
gene, the -20 sequencing annealing primer (section 2.9) was substituted by the 
oligonucleotide primer PVMPI (section 2.8). The position of the restriction enzyme sites 
used in these constructions are shown on the figure. The arrows within each cDNA segment 
denotes the direction in which the nucleotide sequence was read from each construct. 
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AGGAUAAAUAUGGAGAAAUUCGCCCCCGAAUUUGUUGGCGAGGAUGCUAACAAGAAGGCAGAGGAGUUUC 
MEKFAPEFVGEDANKKAEEF 
80 90 100 110 120 130 140 
UCAAACAUAGAUCCUUCCCUUCGGAAAAACCACUAGCUGGUAUACCGAACACUGCCACUCAUGUCACCAA 
LKHRSFPSEKPLAGIPNTATHVTK 
MSP 
150 160 170 180 190 200 210 
AUAUAACAUGCCCCCUAUAUUGCGUAGCUCAUUCAAACUCCCUUCCCCGAGAGUUGCUGCAAAUCUUACU 
YNMPPILRSSFKLPSPRVAANLT 
NITCPLYCVAHSNSLPRELL01LL 
220 230 240 250 260 270 280 
GAACCCUCUGCUCCCCCUACCACUCCACCACCCACACCUCCCCA CCAAAGAGU 
EPSAPPTTPPPTPPQNKEEQPKE 
NPLLPLPLHHPHLPRTRKSSPKS 
290 300 310 320 330 340 350 
CUGAUGUUGACAUUGAGACUAUGCAUGUCUGUAAGGUUCCUGACAAUCCGGAACACAGCAAGAAGCCAUG 
SDVDIETMHVCKVPDNPEHSKKPC 
LMLTLRLCMSVRFLTIRNTARSH 
360 370 380 390 400 410 420 
CUGCUCAGAUGAUACCGAUACUAAGAAAACUAGGAAGCCGAUGGUCACCUUUGUGGAACCCGAGGAGAAA 
CSDDTDTKKTRKPMVTFVEPEEK 
AAQMIPILRKLGSRWSPLWNPRRN 
430 440 450 460 470 480 490 
UUUGUCGGAUUGGGAGCUAGCUUGUACAGGGAGACCAUGCAGACCUUUGCUGCUGAUGGUUAUGAUGAAG 
FVGLGASLYRETMQTFAADGYDE 
LS DW ELACTGRPCRPLLLMVMMK 
500 510 520 530 540 550 560 
AAAGCAACCUAUCGUUUGAGGAGACUAACCAAGAGCCGGGUUCUUCAUCUGUAGAACAAAGACUAGAUAG 
ESNLSFEETNQEPGSSSVEQRLDR 
KATYRLRRLTKSRVLHL 
570 580 590 600 610 620 630 
AAUAGAGGAGAAAUUGUCCUACAUAAUAGGCCUUUUAAACACCAUAAUGGUAGCGACUGCUGGACCUACC 
IEEKLSYIIGLLNTIMVATAGPT 
640 650 660 670 680 690 700 
ACUGCUAGAGAUGAGAUUAGAGAUGCCCUUAUAGGCACUAGAGAAGAACUUAUUGAGAUGAUCAAGUCUG 
TARDEIRDALIGTREELIEMIKS 
710 720 730 740 750 760 770 
ACAUCUUGACUGUCAAUGACAGAAUAGUGGCCAUGGAGAAGCUCAGAGAUGAGGAAUGCUCCAGAGCUGA 
DILTVNDRIVAMEKLRDEECSRAD 
780 790 800 810 820 830 840 
CACUGAUGAUGGAUCAGCCUGWAWUAACAGAýUACUAGAUAAGAUAGUGUCCAGCAAU 
TDDGSACYLTDRARILDKIVSSN 
850 860 870 880 890 900 
GCUGAAGAGGCUAAGGAAGAUUUGGAUGUUGAUGACAUCAUGGGCAUUAAUUUUUAGUUAAUU 
AEEAKEDI, DVDDIMGINF 
Figure 7. Nucleotide sequence of the PVM P gene shown in mRNA sense. The sequence 
of the predicted polypeptides encoded by the first ORF (initiation codon AUGio) and the 
second ORF (initiation codon AUGisi) are shown in the single letter code. The numbers 
refer to the nucleotide positions in the gene. 
P Gene Sequence 
Nucleotide sequence analysis of cDNA clones representing polycistronic mRNA 
species has been used to determine the sequence between the PVM P gene and the 
adjacent genes. This analysis indicates that neither of the regions bordering the PVM P 
gene contains sequences similar to the PVM consensus gene start and end sequences 
(Chambers et at., 1990a, 1990b). For these reasons, it is believed that the nucleotide 
sequence presented here is complete. The 5' and 3' non-coding regions that are present 
at the beginning and end of the P gene are very short, being just 9 and 6 nucleotides in 
length respectively. 
3.3: THE PREDICTED PRODUCTS OF THE PVM P GENE. 
The PVM P gene long open reading frame (ORF) has the potential to encode a 
polypeptide 295 amino acids in length. Previous work by Ling and Pringle (1989a) 
identified the PVM P protein as having a molecular weight of 39 kDa by SDS-PAGE 
analysis. The assignment of this 39 kDa polypeptide as the PVM P gene product 
agreed with the results of hybrid arrested translation experiments in which aP gene 
cDNA clone prevented the expression of a 39 kDa polypeptide (Chambers e/ al., 
1990a). The expression of several other polypeptides was also arrested and the nature 
of these is discussed in section 4.3.2. This 39 kDa polypeptide product of the PVM P 
gene is referred to as Pig. The observed molecular weight determined for the PVM P39 
protein is not in close agreement with its predicted molecular weight which is 32,916 
Da, Aberrant migration under SDS-PAGE: seem to be a common feature of the P 
proteins of 1'aramyxon'irickie family members, and possible reasons for this are 
discussed in section 4.3.1. The amino acid composition of the PVM P protein is shown 
in table 3. 
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non-polar number in percentage of 
amino acids P protein total residues 
Ala 21 7.1 
Val 15 5.1 
Leu 19 6.4 
Ile 17 5.8 
Pro 24 8.1 
Met 9 3.1 
Phe 10 3.4 
Trp 00 
polar number in percentage of 
amino acids P protein total residues 
Gly 11 3.7 
Ser 21 7.1 
Thr 23 7.8 
Cys 5 1.7 
Tyr 5 1.7 
Asn 12 4.1 
Gln 5 1.7 
acidic number in percentage of 
amino acids P protein total residues 
Asp 24 8.1 
Glu 34 11.5 
basic number in 
amino acids P protein 
Lys 
21 
Arg 
15 
His 
4 
percentage of 
total residues 
7.1 
5.1 
1.4 
Table 3. Amino acid composition of the PVM P protein as predicted from the PVM P gene 
nucleotide sequence. 
P Gene Sequence 
From this table, the PVM Pz protein can be seen to have it high overall 
percentage of acidic residues (I9.6'%ß of total polypeptide). The predicted pl of P1, is 
5.92. The acidic amino acids are not distributed evenly throughout the PVM P protein. 
In the amino-terminal 85 amino acids there are only 7 acidic residues whereas in the 
carboxyl-terminal 85 amino acids, 24 residues are acidic. Throughout the remaining 
central region, the acidic residues are evenly spaced. This uneven distribution of acidic 
residues will render the carboxyl-terminal negatively charged at neutral pH, and this 
polarity may be a functionally important feature of the PVM P39 protein, especially 
since it is, by analogy with other /'urcrnnxuriric/ue family members, believed to 
associate with many other virus components through electrostatic interaction. There 
are also large numbers of threonine and serine residues which, by virtue of their 
hydroxyl side groups, are potential phosphoºylation sites The serine and threonine 
residues appear to be evenly distributed throughout the length ofthe P protein. 
The PVM P gene also contains a second smaller ORF which is 411 nucleotides 
in length. The coding region of the second ORF extends from an AUG codon located 
at nucleotide positions 131 to 133 of the PVM P gene (AUG131), to a termination 
codon located at nucleotide positions 542 to 544. The second ORF has the potential to 
encode a polypeptide 137 amino acids in length with a predicted molecular weight of 
15,932 Da. The amino acid composition of the predicted second ORF polypeptide 
product, designated P2, is shown in table 4. 
From this table, P2 can be seen to have only three acidic residues which 
represents just 2.21%, of the total polypeptide. This figure contrasts sharply with the 
acidic amino acid content of the PVM f' protein which is I9.6'%o of the total 
polypeptide. This indicates that P2 does not have any regions that at physiological pH 
would be negatively charged, suggesting that this polypeptide may not associate 
electrostatically with a positively charged domain of another polypeptide moiety. The 
P2 polypeptide is composed of a high proportion of basic amino acids with an overall 
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non-polar number in percentage of 
amino acids P2 protein total residues 
Ala 6 4.4 
Val 4 2.9 
Leu 28 20.4 
Ile 5 3.6 
Pro 14 10.2 
Met 7 5.1 
Phe 1 0.7 
Trp 3 2.2 
polar number in percentage of 
amino acids P2 protein total residues 
Gly 2 1.5 
Ser 12 8.8 
Thr 8 5.8 
Cys 5 3.6 
Try 2 1.5 
Asn 6 4.4 
Gin 2 1.5 
acidic number in percentage of 
amino acids P2 protein total residues 
Asp 1 0.7 
Glu 2 1.5 
basic number in percentage of 
amino acids P2 protein total residues 
Lys 6 4.4 
Arg 17 12.4 
His 6 4.4 
0 
Table 4. Amino acid composition of the PVM P2 polypeptide as predicted from the PVM P 
gene nucleotide sequence. 
P Gene Sequence 
content of 21.2%. The basic amino acids are not spread evenly throughout the length 
of the second ORF polypeptide. They are predominantly absent from the amino- 
terminus and there is a small clustering at the immediate carboxyl-terminal end of the 
polypeptide. Despite the low number of acidic amino acids and high numbers of basic 
residues, the predicted pI (6.7) of this polypeptide is close to neutral. 
3.4: DISCUSSION 
3.4.1: The PVM P gene. 
The PVM P gene is 903 nucleotides in length and contains two open reading 
frames (ORFs). The first ORF, which is 885 nucleotides long, begins at an AUG codon 
located at nucleotide positions 10 to 12 (AUG, (, ) and runs until the UAG stop codon 
located at nucleotide positions 895 to 897. This ORF has the potential to encode a 
polypeptide 295 amino acids in length. The second ORF is 411 nucleotides in length, 
beginning on the third AUG codon of the P gene located at nucleotide positions 13 1 to 
133 (AUG131) and ending at the UAG codon at nucleotide positions 542 to 544. This 
ORF has the potential to encode a polypeptide 137 unºinu acids in length. 
3.4.2: Comparison of the PVM P Protein with the P proteins of other 
Paran: yxoviridae family members. 
Significant homology between the amino acid sequence of the PVM P19 protein 
and the P protein of any other negative sense, single stranded, RNA virus, excepting 
HRSV, BRSV and TRTV could not be detected. This finding is in agreement with 
many previous studies which have failed to find amino acid homology between the 
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HRSV P protein and the P proteins of several I'urunnY. vuriridoe family members (Luk 
el at, 1986). Spriggs and Collins (1986) identified a low level of homology between 
the HRSV P protein and a central domain of the PIV-3 and measles virus P proteins, 
but it is not known if this homology is significant. 
By analogy with the other Par"anryxoviridae family members, the nucleocapsid 
complex of PVM, which is composed of the N, P, and L proteins, is believed to 
harbour an RNA dependent RNA polymerase which directs the synthesis of viral 
RNAs during transcription and replication. Recently, in support of this analogy, studies 
have shown that HRSV possesses similar transcriptional machinery to other non- 
segmented, negative stranded RNA viruses (Huang rr at, 1993)). In accordance with 
the overall functional similarity of the PVM nucleocapsid complex to these other 
nucleocapsid complexes, the PVM P protein would he expected to show at least some 
functional similarities to these other P proteins. The P proteins of many 
Paramyxoviridue family members show homology to one another in both the amino 
and carboxyl-terminal regions but show little homology in the central region 
(Matsuoka el a/., 1991). Examination of hydropathy plots of the P proteins of several 
members of the family Parunryxoviricluc has not revealed the presence of obvious 
hydrophobic or hydrophilic motifs common to these P proteins. However the P (or 
NS) proteins of all par"amyxovir"us and mor"hi//ivirrrs genera members are considerably 
larger than the pneumovirus P protein and this feature complicates the identification of 
amino acid and structural homologies that may exist between these proteins. 
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3.4.3: Comparison of the PVM P protein with other pneumovirus P proteins. 
A significant difference between the P proteins encoded by the PVM, HRSV 
and BRSV phosphoprotein genes is their length. The PVM P31, protein is 295 residues 
long whereas the HRSV and BRSV P proteins are both 241 residues in length. The 
amino acid homology between the P proteins of these viruses is not high, with PVM 
P39 and HRSV P proteins (HRSV A2 strain) having 35.3% overall identity and PVM 
P39 and BRSV P proteins having 35.6% overall identity. The amino acid sequence of 
the PVM P protein and the P proteins from three strains of HRSV are compared in 
figure 8. The homology that is seen between the PVM P;,, protein and the HRSV and 
BRSV P proteins is not evenly distributed throughout the length of the proteins, but 
rather is concentrated into two regions of good homology separated by a region of 
poor homology. This homology distribution can be seen in figure 9. During sequence 
analysis of the pneumovirus P genes, all the gap substitutions introduced to generate 
alignment were inserted into the poorly homologous region, a feature that highlights 
the lack of similarities in this internal region of the pneunwvirus P proteins. The first 
region of good homology is located at the extreme amino-terminus of these proteins 
and is only 17 amino acids in length. In this short region there are 14 conserved 
residues between the PVM P3, protein and both the HRSV (strain A2) and the BRSV 
P proteins. The second region of high homology between these P proteins is located 
between residues 181 and 249 on the PVM Pay protein sequence and 134 and 201 on 
the HRSV and BRSV P protein sequences. The percentage identities for this region 
are 64% for PVM and HRSV and 67% for PVM and BRSV. These figures increase to 
84% and 86% respectively when similarities are also considered. Comparison between 
the amino acid sequence of the PVM and TR'l'V P proteins reveals that in TRTV, this 
second region of homology is also conserved, although the first region of homology at 
the amino-terminus is not (Ling e/ al., in preparation) The percentage identity seen 
between the P 
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PVM MEKFAPEFVGEDANKKAEEFLKHRSFPSEKPLAGIPNTATHVTKYNMPPILRSSFKLPSP 60 
RSA2 MEKFAPEFHGEDANNRATKFLES IKGKF 28 
RSN2 MEKFAPEFHGEEANNKATKFLES IKGKF 28 
18537 MEKFAPEFHGEDANNKATKFLES IKGKF 28 
******** **. **.. *.. **. 
.. 
* 
PVM RVAANLTEPSAPPTTPPPTPPQNKEEQPKESDVDIETNHVCKVPDNPEHSKKPCCSDDTD 120 
RSA2 TSPKDPKKKDSIISVNSIDIEVTKESPITSNSTIINPTNETDDTA 73 
RSN2 ASSKDPKKKDSIISVNSIDIEVTKESPITSGTNIINPISEADSTP 73 
18537 ASSKDPKKKDSIISVNSIDIEVTKESPITSGTNIINPISEADSTP 73 
*.. *.. ***... 
. ...... 
*. * 
PVM TKKT RKPMVTFVEPEEKFVGLGASLYRETMQTPAADGYDEESNLSFEETNQEPGSSS 177 
RSA2 GNKPNYQRKPLVSFKEDPTPSDNPFSKLYKETIET FDNNEEESSYSYEEINDQT NDN 130 
RSN2 EAKANYPRKPLVSFKEDLTPSDNPFSKLYKETIET FDNNEEESSYSYEEINDQT NDN 130 
18537 EAKANYPRKPLDSFKEDLTPSDNPFSKLYKETIET FDNNEEESSYSYEEINDQT NDN 130 
* ***. .** ** ** ** *** * **. *... .. 
PVM VEQRLDRIEEKLSYIIGLLNTIMVATAGPTTARDEIRDALIGTREELIEMIKSDILTVND 237 
RSA2 ITARLDRIDEKLSEILGMLHTLWASAGPTSARDGIRDAMIGLREEMIEKIRTEALMTND 190 
RSN2 ITARLDRIDEKLSEILGMLHTLWASAGPTSARDGIRDAMVGLREEMIEKIRAEALMTND 190 
18537 ITARLDRIDEKLSEILGMLHTLWASAGPTSARDGIRDAMVGLREEMIEKIRAEALMTND 190 
... 
***** **** *. * *. *.. ** ****. ***. ****.. * ***. **. *... * 
, 
** 
PVM RIVAMEKLRDEECSRADTDDGSACYLTDRARILDKIVSSNAEEAKEDLDVDDIMGINF 295 
RSA2 RLEAMARLRNEESEKMAKDTSDEVSLNPTSEKLNNLL EGNDSDNDLSLED F 243 
RSN2 RLEAMARLRNEESEKMAKDTSDEVSLNPTSKKLSDLL EDNDSDNDLSLDD F 243 
18537 RLEAMARLRNEESEKMAKDTSDEVSLNPTSKKLSNLL EDNDSDNDLSLDD F 243 
* ** ** **... 
.. 
*.... *. *.... 
....... 
**... * * 
Figure 8. Alignment between the amino acid sequences of the HRSV and PVM 
proteins. The P proteins of three strains of HRSV are shown. The comparison was 
performed using the CLUSTAL program (Higgins and Sharp, 1988). Amino acid 
identities are shown with the symbol (*) and similarities are shown with the symbol (. ). 
The cut off score for similarities is a Dayhoff(1978) value of 8. Numbers to the right 
of the sequences refer to the residues of each protein. 
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Figure 9. Matrix plot of identities between the PVM P protein (vertical axis) and the HRSV P 
protein (horizontal axis). The plot was obtained using Microgenie software (Beckman Instruments 
Inc. ). The plot indicates that the identity that exists between these these two proteins is not 
distributed evenly throughout their length, but is concentrated into two regions of good identity 
separated by a region of poor identity. The numbers along the axes refer to the amino acids of each 
protein. 
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proteins of PVM and TRTV in this region is 69%, rising to 82% upon consideration of 
similarities. The high level of homology that is seen between all four pneumoviruses in 
this region suggests that a functional domain may be contained here. The level of 
amino acid identity that is seen in this region is probably responsible for the 
observation that the PVM P: 19 protein is serologically related to the HRSV and BRSV 
P protein (Gimenez ei a/., 1984, Ling and Pringle, 1989a). In the poorly homologous 
amino-terminal region of the PVM Pz,, protein, which spans residues 18 to 180, there 
are only 38 identities with the HRSV P protein, and this corresponds to a percentage 
of just 23%. Interestingly, in this region there is a high degree of conservation 
between serine and threonine residues, the potential phosphorylation sites, with 13 of 
the 38 identities in this region being either serine or threonine conservations. The 
percentage homology between the PVM P4., protein and the BRSV P protein in this 
poorly homologous region is also extremely low, at 20.6%. The same distribution of 
homology that is found between the PVM and HRSV P proteins is also found between 
the two HRSV subgroups. Johnson and Collins (I 990) identified two relatively large 
conserved domains located between residues 1-58 and 86-24 I that between the two 
subgroups displayed an overall identity of 96%. However, the intervening region which 
separated these conserved domains was divergent showing an identity of only 52% 
between subgroup A and B isolates. Mallipedi and Samal (1992) demonstrated that the 
corresponding region of the BRSV P protein showed poor identity (37%) with the 
HRSV P protein of either subgroup over this region. This region lies within the portion 
of the HRSV and BRSV P proteins that displays poor homology with the 
corresponding region of the PVM P19 protein. It is possible that this poorly conserved 
region that is present on all these three pneumovirus P proteins does not contain a 
functional domain which requires strict conservation of amino acid residues, and is 
consequently tolerant to non-conservative amino acid changes. 
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Figure 10. Hydropathy plots of PVM P protein (upper plot) and (B) HRSV P protein (lower plot). The 
plots were generated using the procedure of Hopp and Woods (1981) using a window of 10 amino 
acids. The difference in the sizes of these P proteins mean they do not align over their entire lengths. 
However, by removing a 50 amino acid long segment from the PVM P protein hydropathy plot 
between residues 30 and 80, the two proteins show a good hydropathic similarity throughout their 
lengths. Arrows indicate some regions of hydropathic alignment. 
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In addition to performing a comparison between the amino acid sequence of the 
pneumovirus P proteins, their corresponding predicted hydropathy plots were also 
compared. A comparison between plots of the HRSV P and the AVM PY, proteins, 
shown in figure 10, is at first glance misleading because the difference in their sizes 
means that they do not align over their entire lengths. However by removing a 50 
amino acid segment from the PVM Pig, protein hydropathy plot between residues 30 
and 80, the HRSV and PVM Pzy protein hydropathy plots show a high degree of 
similarity. The resulting hydropathy alignment shows a matching of all hydrophilic 
peaks and all hydrophobic troughs. This degree of similarity shows that despite the 
low overall amino acid identities that these two proteins share, they show 
conservation of hydropathy, and presumably structural similarities, throughout their 
entire lengths. The portion of the PVM P,,,, protein removed to create the alignment 
represented a small hydrophobic region which is not present on the HRSV hydropathy 
plot. This portion of PVM sequence lies completely in the region of the PVM PI, ) 
protein that shows no significant homology with the other pneumovirus P proteins and 
this supports the proposal that the size diterence between the PVM and RSV P 
proteins is due to either loss or gain of sequence in this region. 
3.4.4: The PVM P gene second ORF. 
The position of the PVM P gene second ORF coincides with the region of the 
PVM P protein that is poorly homologous to the BRSV and HRSV P proteins, with 
the carboxyl-terminal end of the second ORF product lying almost exactly at the end of 
the region of poor homology. The termination codon for the PVM second ORF 
product is 8 nucleotides upstream of the codon that encodes the first residue of the 
large region of high conservation. The region of poor homology includes the entire 
length of the sequence corresponding to the second ORF. The apparent lack of need 
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for strict conservation of amino acid residues in this region has permitted changes at 
the nucleotide level to occur and alter the sequence of both the first and the second 
open reading frames. Included in these alterations has been the removal of all the stop 
codons in the second ORF for the length of the variable region, and the subsequent 
creation of a substantial coding region in the second ORF. There are 17 stop codons in 
the corresponding region of the third reading frame. The probable need for more strict 
amino acid conservation in the immediately adjacent homologous region of the PVM 
P39 protein has presumably prevented extension of the second ORF coding region past 
the boundary of the variable and homologous regions, thereby limiting the size of the 
second ORF. It would be interesting and informative to sequence the P genes of other 
PVM strains to see if the continuity of the second ORF is maintained. If P genes of 
other PVM strains were found to show differences in this region, but still possess the 
intact second ORF, then this would support the suggestion that the second ORF 
polypeptide performs a function that is advantageous to the replication of the virus. 
The P genes of BRSV, HRSV and TRTV do not contain an equivalent second 
extensive ORF. 
3.4.5: Comparison of the PVM P protein sequence with it protein sequence 
database. 
A more wide ranging search on a protein sequence database failed to identify 
any protein sequence which displayed amino acid sequence homology over a 
sufficiently large region to suggest definite relatedness. This search, however, did 
reveal a low level of amino acid homology between several short stretches of the PVM 
P39 protein and correspondingly short stretches of proteins that were related to one 
another by their function as protein kinases. This homology search using the SWEEP 
program searching the GENBANK database used small 15 amino acid sections of the 
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PVM P39 protein and compared them to small sections of database protein sequence, 
thus it could identify small regions of homology that would be often be lost if larger 
regions of sequence were being compared. The database protein sequence that each 
PVM P. jg protein section was homologous to was not always the same protein kinase. 
The short stretches of homology that were identified were spread virtually throughout 
the entire length of the P39 protein amino acid sequence, with only amino acid sections 
106-120,210-225 and 240-295 showing no homology to a protein kinase amino acid 
sequence. There has been no report as yet of the P protein of 1'aramyxoviridae family 
members having any auto-phosphorylation activity and so the relevance of this 
observed homology is unclear. It is possible that the similarities reflect motifs found in 
phosphorylated proteins. However due to the lack of amino acid homology between 
PVM P protein and the P proteins of other J'urcuny. wr, riduý family members, it is 
possible that the PVM P protein exhibits fundamental functional differences to these 
other P proteins. 
3.4.6: Coin parison of the PVM P2 protein with the P gene products of other 
Paramyxoriridae family members. 
A database search revealed no homology between the PVM P gene second 
ORF product, P2, and any protein product of another I'aruniyxoviriclae family 
member. The predicted P2 polypeptide does not possess a cysteine rich region that is a 
common feature of the V protein which is encoded by the P genes of most 
Paramyxoviric. Iae family members. 
A potential mRNA editing site that could be utilised by the PVM RNA 
dependent RNA polymerase to switch between the first and second ORFs during P 
gene transcription was not identified. Mallipedi and Samal (1992) identified a region 
on BRSV P gene rnRNA that resembled the consensus insertion sequence of 
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Yarani xo'iridue family members where the viral polymerase stutters and insertion 
occurs (Vidal et a/., 1990b. A number of 'P gene cDNA clones were sequenced and in 
one instance, an insertion of three nucleotides was observed at the position of the 
proposed insertion site. No such insertions have been identified in any of the PVM P 
gene cDNA clones that have been sequenced, and a site that resembles the insertion 
consensus sequence is not present on the PVM P gene cDNA. However the possibility 
that the PVM P gene exhibits some form of mRNA editing should not be ruled out as 
it is possible that the PVM P gene uses an editing mechanism that is different to the 
other Pcrrannyxnviric/ae family members. 
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CHAPTER 4 
CHARACTERISATION OF THE IN VITRO EXPRESSION PRODUCTS OF 
THE PVM P GENE. 
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4.1: CONSTRUCTION OF T7 TRANSCRIPTION PLASM ID PGEMP. 
A cDNA fragment representing the full-length PVM P gene was removed from 
plasmid pUC 13-P by restriction enzyme digestion, and inserted into the Sac I site of 
the T7 transcription plasmid, pGEM I (Promega Corporation). However, as a 
consequence of the procedure used to obtain a full-length cDNA clone of the PVM P 
gene (section 2.8), a long region of cytosine residues were located at the 5' end of the 
P gene cDNA sequence. Attempts to translate mRNA transcribed from this pGEM I 
derived plasmid were unsuccessful and this was believed to be due to the presence of 
this poly-C leader region. No convenient restriction enzyme sites were present to 
enable removal of this poly-C region by simple restriction enzyme digestion. In order 
to construct a full-length P gene cDNA clone without this leader sequence, PCR 
amplification on P gene cDNA was used to generate a fragment representing P gene 
nucleotides I to 139, thus removing the poly-C leader region. The oligonucleotide 
primers used for the amplification of the P gene cDNA fragment were designated 
PVMP2 (hybridises to P gene nucleotides 1-23, CGAGCTCGAGGATA 
AATATGGAGAAATTCGC) and PVMP I (hybridises to P gene nucleotides 115-139, 
GGTGACATGAGTAGTGGCAGTGTT('G(i) The following construction details of 
plasmid pGEMP are shown in figure I 1. The successfully PCR amplified fragment was 
blunted using Klenow fragment and then cleaved with restriction enzyme Acc 1. The 
cDNA segment was ligated into Acc I and Sac I cleaved pUC 13-P. The full-length P 
gene cDNA fragment was cleaved from this plasmid by digestion with restriction 
enzyme Sac I and then inserted into the Sac I site of pGEM 1. Correct orientation of 
the fragment was confirmed by restriction enzyme digestion of the ligated plasmid. 
This transcription plasmid was designated pGEMP. 
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Figure 11: Construction of transcription plasmid pGEMP. A cDNA fragment representing 
the full-length PVM P gene was removed from pUC13-P (plasmid construction details in 
section 4.1). (a). A cDNA segment representing nucleotides 1 to 139 of the PVM P gene was 
amplified by PCR using oligonucleotide primers PVMP1 and PVMP2 thus removing the 
5' poly(dC) tail from the full-length P gene cDNA clone. (b). The fragment was blunted using 
Klenow and digested using restriction enzyme Acc I at a site located within primer PVMP 1. 
(c). The cleaved fragment was ligated into Eco RI (Klenow blunted) and Acc I cleaved 
pUC 13-P thus reforming a full-length cDNA copy of the PVM P gene that did not possess a 5' 
poly(c) tail. (d). The full-length P gene cDNA was removed from pUC13-P using restriction 
enzyme Sac I, and this fragment was ligated into Sac I cut pGEMI thus deriving pGEMP. 
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4.2: IN VITRO EXPRESSION OF PVM P PROTEIN ANI) P PROTEIN RELATED SPECIES. 
4.2.1: In vitro expression of the PVM P ilrotein. 
RNA transcribed from pGEMP was translated in a rabbit reticulocyte lysate 
system and the 35S methionine labelled polypeptide products were analysed by SDS- 
PAGE. An autoradiograph of a gel on which these radiolabelled polypeptide products 
were electrophoresed is shown in figure 12. The primary polypeptide product of the 
PVM P gene cDNA is a 39 kDa species which represents the PVM P19 protein. In 
addition, at least 3 additional polypeptide species are synthesised, having molecular 
weights of approximately 37 kDa, 26 kDa and 23 kDa. A fourth polypeptide with a 
molecular weight of 16 kDa is also seen 1ollowiný, long exposure of the 
autoradiograph. These species, 'feferred to as P,,, Px P2.1 , and P166 respectively, are 
expressed at a far lower abundance than the 39 kDa species, and this can be seen in 
figure 12. The nature of these species is discussed in section 4.3. When subjected to 
SDS-PAGE, the 39 kDa species expressed in vitro from pGEMP transcribed mRNA 
comigrates exactly with the PVM-infected BSC I cell polypeptide species previously 
identified as the PVM P protein (Cash, 1979, Ling and Pringle, I989a). 
4.2.2: Construction of nGEMP derived transcription nfasmids. 
As described in section 4.2.1, the rnRNA transcribed from full-length P gene 
cDNA directs the synthesis of ihur smaller polypeptide species with molecular weights 
of 37 kDa, 26 kDa, 23 kDa and 16 kDa. In order to determine how these species arise, 
a series of T7 transcription plasmids containing 5' truncated PVM P gene cDNA 
inserts were constructed. 
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Figure 12. The full-length P gene cDNA directs the in vitro expression of the 
full-length P protein (P39) and three smaller polypeptides with molecular weights of 37 
kDa (P37), 26 kDa (P26) and 23 kDa (P26). mRNA transcribed from the full-length P gene 
cDNA insert within pGEMP was used to programme a reticulocyte lysate system and the 
radioactively labelled expression products were subjected to SDS-PAGE and 
auto-radiography. Lane A: No mRNA. Lane B: pGEMP transcribed mRNA. The 
positions of molecular weight markers are indicated on the left, and the polypeptides 
expressed from pGEMP transcribed mRNA are marked on the right. 
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The full-length P gene cDNA fragment excised from pGEMP was truncated by 
restriction enzyme digestion and inserted into pGEM I to generate the vectors 
pGEMP37, pGEMP26 and pGEMP23. The construction details of these plasmids are 
shown diagrammatically in figure 13. The first ATG codons downstream of the 17 
promoter on each of these four pGEM 1 derived transcription vectors (ATGiü, ATG14K, 
ATG3O1, and ATGz9) correspond to the first, second, third and fourth AUG codons 
respectively of the PVM P gene long ORF. 
4.2.3: In vitro expression of P protein related species. 
Radioactively labelled P protein related polypeptides were translated in vitro 
using rabbit reticulocyte lysate programmed with inRNA transcribed from plasmids 
pGEMP, pGEMP37, pGEMP26 and pGEMP23. The radiolabelled translation 
products were analysed by SDS-PAGE and an autoradio,, raph of the resulting gel is 
shown in figure 14. 
In pGEMP the first initiation codon that is in-frame with the P gene long open 
reading frame is ATG,,,. In the construction of pGEMP37, ATG,,, was removed and 
the first in-frame ATG on this plasmid became A'l'G, a,; which corresponds to the 
second AUG codon on the P gene mRNA that is in-frame with the P gene long ORF. 
The plasmid pGEMP37 directs the synthesis of the P. P,,,, P and P,,, polypeptides, 
which comigrate with the species expressed from pGEMP, but pGEMP37 does not 
express the full-length P protein (figure 14). This suggests that AUG,,, on the mRNA 
transcribed from pGEMP is responsible for initiation of the full-length P protein, 
since removal of the corresponding ATG in the case of pGEMP37, prevents synthesis 
of the full-length P protein. In the construction of plasmid pGEMP26, ATG14S was 
removed and mRNA transcribed from this plasmid directs the synthesis of the P,,,, P,, 
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Figure 13. Construction of T7 transcription plasmids pGEMP37, pGEMP26 and pGEMP23. 
(a). Construction of pGEMP37: pGEMP was cleaved with restriction enzymes Acc I and Eco RI 
to remove nucleotides 1-112 of the PVM P gene insert. The Eco RI site is present in the pGEMP 
multiple cloning site. The ends were blunted using Klenow and religated to create pGEMP37. 
(b). Construction of pGEMP26: pGEMP was cleaved with restriction enzymes Hinc II and Eco RI 
to remove nucleotides 1-289 of the PVM P gene insert. The ends were blunted using Klenow 
and religated to form pGEMP26. (c) Construction of pGEMP23: pGEMP was cleaved with Nsi I 
and Eco RI enzymes to remove nucleotides 1-303 of the P gene insert. The ends were blunted 
using Klenow and religated to give the plasmid pGEMP23. The first initiation codon of the P 
protein ORF is marked on each plasmid. 
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Figure 14. Identification of AUG codons used to initiate translation of five in vitro synthesised 
P protein related polypeptides. Radioactively labelled P protein related polypeptides were 
translated in vitro using rabbit reticulocyte lysate programmed with mRNA transcribed from 
plasmids pGEMP, pGEMP37, pGEMP26 and pGEMP23. Radioactively labelled translation 
products expressed from mRNAs transcribed from these plasmids were subjected to SDS-PAGE. 
The gel was loaded in the following order. Lane A: pGEMP directed products. Lane B: 
pGEMP37 directed products. Lane C: pGEMP26 directed products. Lane D: pGEMP23 directed 
products. Following electrophoresis the gel was fixed, dried and autoradiographed in order to 
visualise the labelled polypeptides. 
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and P,, polypeptides but not the P species. Thus the corresponding initiation codon, 
AUG148, on the P gene mRNA transcribed fi-om pGEMP37, and also pGEMP, is 
responsible for initiation of the P37 protein. 
Transcription plasmid pGEMP23 has lost ATGzi and directs the synthesis of 
the P23 and Per, species. Loss of ATG30 has prevented expression of the Per, species 
and so the corresponding colon AUG, o on the mRNA transcribed from pGEMP26 
appears to initiate translation of the P26 polypeptide. 
The first AUG on mRNA transcribed from pGEMP23 is AUG, The largest 
species translated from this message is the P23 polypeptide. There are no other AUG 
codons close enough on the mRNA to encode for a 23 kDa species and so AUG39i is 
almost certainly responsible for initiation of' the P23 species. The second AUG on 
pGEMP23 transcribed mRNA is AUG4 7 and this is probably responsible for initiation 
of the Pig, species, as there are no other AUG codons sufficiently close to allow 
production of a polypeptide of this size. 
4.3: DISCUSSION. 
4.3.1: In nitro expression of the PVM P protein. 
Messenger RNA transcribed from PVM P gene cDNA directs the translation of 
a polypeptide with a molecular weight of 39 kDa and this confirms earlier work which 
assigned the 39 kDa PVM-infected cell polypeptide as being the PVM phosphoprotein 
(Cash, 1979; Ling and Pringle, 1989a). The predicted molecular weight of the PVM P 
protein based on the nucleotide sequence data presented here is 32,916 Daltons and so 
clearly the PVM P protein runs with aberrant mobility when analysed by SDS-PAGE. 
Similar discrepancies have been found between the predicted and observed molecular 
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weights of the HRSV P proteins (Johnson and Collins, 1990) and also for many other 
negative sense single stranded RNA viruses such as VSV (Gallione el cr/., 198I ). It has 
been suggested that the anomalous electrophoretic mobility of the P protein may be 
due to its characteristically high proportion of negatively charged residues. These 
amino acid residues are thought to bind poorly to SDS due to electrostatic repulsion, 
and thus the polypeptide becomes less mobile during electrophoresis. The PVM P39 
protein has been shown to be phosphorylated (Cash, 1979, Ling and Pringle, 1989a) 
although phosphorylation of the P protein is not thought to significantly contribute to 
its anomalous migration (Hsu and Kingsbury, 1982). It is not known at which residues 
the PVM P39 protein is phosphorylated. The HRSV P protein is believed to be 
phosphorylated at serine residues at amino acid positions 1 16,117,119,143,156 and 
161 (Navarro el at, 1991). Interestingly, comparison between the PVM and HRSV P 
protein sequences reveals that the PVM P protein residues that are aligned to the 
HRSV amino acids 116,119, and 143 are also serines and in addition the amino acids 
that align with HRSV residues 156 and 101 are threonines, which is also a potential 
phosphorylation site. Thus PVM P39, like HRSV P may be phosphorylated at these 
sites. 
4.3.2: In vitro expression of other P protein species. 
Reticulocyte lysate translation of the mRNA transcribed from plasmid pGEMP 
gave rise not only to the 39 kDa P protein but also to minor species with observed 
molecular weights of 37,26,23 and 16 kDa. This observation supports hybrid arrested 
translation experiments which showed that PVM P gene cDNA was able to arrest the 
translation of not only P39, but also P and several smaller polypeptides which 
probably correspond to P26 P23 and Pig, (Chambers el a/., 1990a). By constructing 
transcription vectors containing truncated P gene cDNAs, the initiation codons that are 
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responsible for these P protein species have been napped to AUG codons located at 
nucleotide positions 148,301,391 and 457 respectively. These are the second, third, 
fourth and fifth AUG codons respectively on the PVM P gene. In mapping these 
initiation codons the assumption was made that only AUG codons were capable of 
initiating translation. This assumption is almost certainly valid as the occurrence of 
non-AUG initiation codons is very unusual, although the C' polypeptide encoded by 
the P gene of SEN has been shown to be synthesised by initiation from an ACG codon 
(Gupta and Patwardhan, 1988, Curran and Kolakofsky, 1988a) and the C' polypeptide 
of PIV-3 is translated from a GUG codon (Boeck ei al., 1992). These non-AUG 
codons presumably function because they lie in excellent nucleotide context which 
partially offsets the absence of the A at position + I, or the G at position +2. Initiation 
of these PVM P protein species from an ACG codon is unlikely since all the mapped 
AUG codons are located on the P gene cDNA in such a place as to be capable of 
initiating synthesis of polypeptides having the correct molecular weight for the species 
to which each AUG was mapped. There are no ACG or GUG codons on the P gene 
mRNA which are in good context and are also in the vicinity of these mapped AUGs. 
To definitely demonstrate that the AUG codons at positions 10,148,301,391 and 457 
are responsible for these species the codons would have to be altered to non-initiating 
codons by site directed mutagenesis. A candidate for the polypeptide product of the P 
gene second ORF was not identified in the expression products of rabbit reticulocyte 
lysate programmed with mRNA transcribed from either pGEMP or pGEMP37. This 
was probably due to presence of globin which, in my hands, caused smearing of 
polypeptides in the 16-20 kDa region of the gel (see section 82). 
4.3.3: Leaky scanning and the expression of the P protein species. 
The way in which the P17, P-,,,, P and P,,, polypeptide species arise is 
probably through the process of leaky scanning (reviewed in Kozak, 1986a, 1986b, 
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1986c, 1989). According to this hypothesis a proportion of scanning 40S ribosomal 
subunits fail to initiate at a 5' proximal initiation codon which is surrounded by 
nucleotide sequence that renders it in a sub-optimal context. Having failed to initiate, 
the 40S subunits commence scanning for the next initiation codon. The actual 
proportion of ribosomes that fail to initiate at the sub-optimally situated initiation 
codon depends on just how poor the context is. When these ribosomal subunits reach 
the next potential initiation codon, they may initiate translation or if the context 
surrounding the codon is not favourable, they may once more resume scanning. The 
first AUG colon of' the PVM P gene (AUG,,, ) is situated in a context that is 
considered to be highly favourable for initiation by virtue of similarities to the 
initiation consensus sequence which in the higher eukaryotes is CCACCAUGG 
(Kozak, 1986b). The G nucleotide at position +3 and the A nucleotide at position -4 
are particularly critical for optimal context (Kozak, 1986a), and AUG,,, has both of 
these. The context of AUG,,, and the next four downstream AUG codons in the large 
ORF is displayed in figure 17. Since AUG,,, is the first potential initiation codon from 
the mRNA 5' terminus, a high proportion of rihosomal subunits would be expected to 
initiate at this position and only a few, if any, would he expected to continue scanning 
(Kozak, 1987). The context which surrounds the second AUG colon in-frame with 
the P gene long ORF located at nucleotide position 148 is not as favourable as that for 
AUG,,, since, whilst there is an A at position -3, there is aC at position +4 which 
renders this codon sub-optimal. However, this context is considered to be sufficiently 
favourable for initiation to occur by virtue of the purine at position -3. Since the 
context around AUG14 is not optimally favourable for initiation, a proportion of 
those ribosomes that failed to initiate at AUG,,, may also fail to initiate at AUG,: ºr and 
117 
P protein ORF p gene sequence surrounding AUG codon nucleotide AUG codon 
number 
1 10 UAAAU 
2 148 AUAAC 
3 301 AGACU 
4 391 AGCCG 
5 457 AGACC 
AUG 
AUG 
AUG 
AUG 
AUG 
G 
C 
C 
G 
C 
P2 ORF 
initiation codon 
AUG 
131 CACUC AUG U 
Figure 15. The nucleotide context that surrounds the first 5 initiation codons of the PVM 
P gene mRNA. For each of the P gene AUGs listed, the nucleotide identities with the 
optimal context motif (determined to be CCA/GCCAUGG; Kozak, 1986a) are shown in 
bold face and are underlined. The context of the first initiation codon of the P gene P2 ORF 
is also shown. 
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would be able to pass along to the next potential initiation codon. The downstream 
AUG initiation codons at nucleotide positions 301,391 and 457 are also situated in 
context that is not optimal (either no G at position +4, or no A at position -3) but due 
to the presence either one of these critical nucleotides, may be sufficiently favourable 
for initiation to occur providing ribosomal subunits had progressed that far. The 
scenario described above would mean that due to the favourable nature of AUG, t, the 
major expression product of the P gene mRNA transcribed from pGEMP would be 
the full-length P protein and studies using rabbit reticulocyte lysate have shown that 
this is certainly the case. However when pGEMP transcribed P gene mRNA is 
translated in vitro, small amounts of the P17, P.,,,, P and P, 6 polypeptides are clearly 
expressed. If these polypeptide species are expressed as a result of leaky scanning from 
their corresponding initiation codons (mapped as AUGs 148,301,391 and 457 
respectively) then a number of ribosomal subunits must pass by the extremely 
favourable initiation codon AUG,,,. Precisely what proportion of ribosome subunits 
that pass an initiation codon that is, by conventional rules, considered to be favourably 
situated, is not presently known, and so whether a sufficient number of ribosomes do 
pass AUG, o in this case to support the expression of the P37, P26, P23 and P, 6 
polypeptides is also unknown. 
4.3.4: mRNA breakage and expression of the P protein species. 
There are two other less likely but theoretically possible reasons that can 
account for the presence of these P protein related polypeptide species when full- 
length P gene mRNA is translated, and these must be considered. The first possibility is 
that in vi(ro transcribed full-length P gene mRNA may be degraded to create a series 
of fragments. mRNA breakage is thought to be responsible for activation of internal 
AUG codons in many systems (Kozak, 1989 and references therein). mRNA cleavage 
119 
Bacterial Expression 
would mean that the likelihood of translation being initiated from one of the normally 
internally located initiation codons becomes virtually assured due to its new position at 
the 5' end of the broken mRNA. This also means that initiation of translation from 
AUGs located further downstream of these newly positioned 5' proximal initiation 
codons also becomes more likely due to leaky scanning. For example, because of the 
favourable nature of AUG11, for ribosomal initiation, a breakage anywhere in the 
mRNA between nucleotide 10 and the position of AUG148 would probably result in 
translation from AUG149 since it would now be the first AUG on the mRNA fragment, 
and because of the only moderate favourability of this initiation codon, initiation from 
the downstream AUG codons in accordance with the leaky scanning hypothesis 
described above could occur. The P. 17, P2c, P,. { and P16 polypeptides would be 
expressed in this way if only a small proportion of full-length P rnRNAs became 
broken in this way. It is possible that the cleavage may occur at a variety of positions 
such that each of the in-frame AUG codons of the PVM P gene appears at the 5' end 
of a sub-set of the broken mRNA fragments. In this case, initiation could occur at each 
of the in-frame AUG codons, either by virtue of it being the first AUG on an mRNA 
fragment, or as a result of leaky scanning on all unfüvourably situated upstream codon. 
The lack of a cap structure at the 5' end of each of the theoretically broken mRNAs 
would not prevent utilisation of these codons since reticulocyte lysate translation 
systems are known to be able to translate uncapped mRNAs. 
The suggestion that leaky scanning gives rise to the smaller molecular weight P 
protein species is supported by the comparison of the polypeptide products that arise 
from pGEMP37 and pGEMP transcribed mRNA. Messenger RNA transcribed from 
pGEMP has the strong initiating codon AUG,,, in the 5' proximal position and 
consequently the full-length P protein is expressed in quantities vastly greater than the 
smaller P related polypeptides since this codon prevents the vast majority of 40S 
subunits from passing to downstream regions of the message. Messenger RNA 
transcribed from pGEMP37 has lost the strongly initiating AUG,,, and the less 
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favourable AUG148 becomes the 5' proximal AUG codon. When this mRNA is 
translated the most abundant species is the P37 polypeptide, but considerable quantities 
of the P26, P23 and P16 species are also made. Due to their similarities the two messages 
are probably of similar stabilities and since they are transcribed under identical 
conditions are therefore expected to be equally intact. The increased abundance of the 
lesser molecular weight P protein species is therefore probably due to the context of 
codon AUG148 which permits leaky scanning and not due to mRNA breakage. 
Expression abundance from P gene mRNA of'each of the P; q, P. 17, P26, P23 and 
P, 6 polypeptides in a reticulocyte lysate decreases in that order. This observation 
would be expected if initiation of the Tower molecular weight P protein species was 
due to the process of leaky scanning, as the number of' 40S ribosomal subunits 
scanning towards the AUG codons located further towards the 3' end of the message 
would be expected to drop as each successive AUG codon was passed. If mRNA 
breakage was responsible for expression of these species then in order to produce this 
profile of polypeptide products, there would have to be progressively fewer breakages 
of the rnRNA at sites towards the 3' end of the mRNA. Such breakages would result in 
the creation of progressively fewer mRNA species that had the second, third, fourth, 
and fifth AUG codons respectively at the 5' end of the broken mRNAs which would 
thus allow these AUGs to be used for initiation. The chances of breakages occurring in 
just this specific way seems unlikely. 
Another line of evidence arguing against mRNA breakage as the cause of low 
molecular weight P protein species production is that each new batch of mRNA 
transcribed from any of the transcription vectors containing truncated P gene cDNAs 
have given rise to a constant profile of expression products each time the mRNA is 
translated. If the broken mRNAs were generated by cleavage as a result of random hits 
by RNase attack then the proportions of the truncated P protein species would be 
expected to vary between batches of mRNA. 
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4.3.5: Proteolytic cleavage and expression of P protein species. 
The other mechanism which could possibly give rise to the P Protein related 
species in the rabbit reticulocyte in vitro translation system is proteolytic cleavage. 
This mechanism is unlikely to be responsible for P protein species production for 
several reasons. The cleavage events would have to occur at sites on P39 that precisely 
coincided with the position of corresponding AUG initiation codons on P gene mRNA 
that are responsible for expression of the lower molecular weight P protein species 
(P37, P2( P23, P, (, ) and this is highly unlikely. No other P protein species other than P39, 
P37, P26 P23 and Pi,, are expressed by translation of full-length P gene mRNA and if 
cleavage were responsible for generation of the lower molecular weight P protein 
related species, then cleavage events would also have to occur only at the sites and no 
others, and again this is unlikely. Furthermore, the absence of any other P protein 
related polypeptides other than P19, P37, P26 P23 and P16 does not support the idea of 
proteolytic cleavage because cleavage of P39 to yield these smaller polypeptides would 
also presumably generate low molecular weight polypeptide fi-agments. 
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CHAPTER 5 
BACTERIAL EXPRESSION OF THE PVM P PROTEIN AND PVM P 
PROTEIN RELATED POLYPEPTIDES. 
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5.1: THEE. COL/ BL21 EXPRESSION SYSTEM. 
E. co/i strain BL21 contains an IPTG inducible chromosomal copy of the gene 
which expresses T7 RNA polymerase (Studier and Moffatt, 1986). This RNA 
polymerase is able to transcribe cDNA sequences placed under the control of the T7 
promoter present on pGEM I derived plastids pGEMP and pGEMP37. Construction 
of these plasmids is detailed in sections 4.1 and 4.2.2. The transcription plasmids 
pGEMP and pGEMP37 were transformed into E. co/i strain BL2I using the procedure 
detailed in section 2.5.2, and expressed as detailed in section 2.122. The expression 
products were subjected to SDS-PAGE and then analysed by Western blot analysis 
using monoclonal antibody 26/3/B5. 
5.2: E. CO/. / BL21 EXPRESSION OF THE P PROTEIN AND P PROTEIN RELATED 
SPECIES. 
In Western blot analysis using the expression products of E. co/i BL2I 
transformed with pGEMP, monoclonal antibody 26/1! B5 (section 6.3) recognised one 
major species which was present in high abundance and four species with a lower 
molecular weight which were present at a lower abundance (figure 16). The major 
expression product of E. coli BL2I transformed with pGEMP that was recognised by 
antibody 26/3/65, comigrated with the PVM Po, protein translated in reticulocyte 
lysate using pGEMP transcribed mRNA. The four minor species recognised by 
antibody 26/3/B5 and expressed by E. coo/i BL2I under the direction of pGEMP 
migrated with molecular weights of 37 kDa, 26 kDa, 23 kDa and 16 kDa. Thus it 
would seem that E. coli BL21 is capable of recognising the P gene translation 
initiation signals (AUGs 10,148,301,391 and 457) and termination signals 
responsible for the expression of the P protein and the four P protein related species. 
The expression 
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Figure 16. Expression of the 39 kDa PVM P protein and 37 kDa, 26 kDa, 23 kDa and 16 kDa 
P protein related polypeptides in E. coli BL21. E. coli BL21 was transformed with pGEMP 
(lane A) and pGEMP37 (lane B) and pGEM1 (lane C) and the expression products of IPTG 
-induced cultures were subjected to SDS-PAGE and then Western blotted using monoclonal 
antibody 26\3\B5. The positions of the P protein related polypeptides are indicated on the right 
and the positions of molecular weight markers are indicated on the left. 
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products of E. coli BL2I transformed with pGEMP37 were also analysed by SDS- 
PAGE and then Western blotted using monoclonal antibody 2613/B5. In this system, 
pGEMP37 directed the synthesis of the Piz, P,,,, P,,, and P1 6 species (figure 16). By 
estimation of the signal intensity generated by antibody 26/3/B5 in Western blots, the 
quantity of each of the P protein species expressed by 11. coli BL2 I programmed with 
pGEMP37 was approximately equal to the quantity of their corresponding P protein 
species expressed by F. co/i BL21 programmed with pGEMP. E. coli BL21 
transformed with pGEMP26 expressed P, (' P and P1-6 in abundances that were also 
estimated as being equal to that of the corresponding P protein species expressed by 
pGEMP37 transformed /-:, co/i BL21. Similarly, /,,. cry/i BL21 transformed with 
pGEMP23 expressed P23 and P1 6 at an abundance that was approximately equal to the 
level of these P protein species expressed in /":. co/i BL2I by either of pGEMP, 
pGEMP37 or pGEMP26. 
5.3: DlscussloN. 
5.3.1: The Pprotein species expressed by E. coli BL21. 
E. coli strain BL2I transformed with pGEMP was able to express the full- 
length PVM P protein and also the P-related polypeptides with molecular weights of 
37,26,23 and 16 kDa. These polypeptides all precisely comigrated with their 
reticulocyte lysate expressed counterparts in SDS-PAGE suggesting that these P 
protein related polypeptides were being faithfully expressed and possibly post- 
translationally modified in the bacterial system. Thus T7 RNA polymerase expressed 
by E. co/i BL2I correctly transcribed the 1' gene rnRNA and the L. co/i protein 
synthesis machinery was able to recognise the translational initiation and translational 
126 
Bacterial Expression 
termination signals present on the message Transcription of the P gene mRNA would 
be expected to occur efficiently due to the presence of the T7 promoter sequence 
upstream of the P gene cDNA insert on pGEMP. Whether termination of transcription 
occurs at the 3' end of the P gene cDNA insert is not known as the pGEMP plasmid 
does not contain a transcription terminator which Would prevent transcriptional read- 
through of sequences downstream. Expression of the correctly sized polypeptide from 
the T7 transcribed rnRNA may therefore rely on the fidelity of translation. Clearly the 
ribosomes of E. co/i BL2I are able to bind to the P gene mRNA and initiate 
translation. Inspection of the PVM P gene sequence reveals a short sequence that 
would be located at the very 5' terminal end of the subsequently transcribed message 
which partly resembles the Shine-Dalgarno consensus sequence (5'- AGGAGG -3') 
that makes up the prokaryotic ribosome binding site. This sequence, which is shown in 
figure 7, is 6 nucleotides away from the 5' proximal AUG codon of the P gene rnRNA, 
and this spacing between Shine-Dalgarno sequence and initiating AUG codon is 
optimal according to the consensus spacing observed at I-, '. co/i mRNA initiation sites. 
5.3.2: Leaky scanning and E. coli BL2 t expression. 
There is one way in which bacterial expression of' the P17, P26, P2.1 and P16 
polypeptides from full-length P gene cDNA supports the suggestion that these species, 
and their counterparts expressed in reticulocyte lysate, are translated by way of leaky 
scanning, and not because of mRNA breakage. With the exception of AUGnone of 
the potential initiation codons of the PVM P gene has a sequence that resembles the 
Shine-Dalgarno motif sufficiently closely to act as a ribosome binding site. Therefore if 
breakage of the P gene mRNA did occur after it was transcribed, it would probably not 
be translated because, with the exception of a fragment having AUGv at its 5' end, it 
would not possess a functional ribosome binding site. The potential ribosome binding 
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site located just upstream of AUG3<, u almost pertectly matches the Shine-Dalgarno 
consensus, however this site may not function efficiently due to the observation that 
P23 is poorly expressed from !. co/i BL21 transformed with pGEMP23 which has 
AUG39º as the 5' proximal AUG codon on the P gene cDNA. 
Western blot analysis using an anti-P protein monoclonal antibody, showed that 
the only P related polypeptide expression products of E. coli BL2 I transformed with 
either pGEMP or pGEMP37 were the P protein and P protein related species seen in 
the reticulocyte lysate expression experiments (figure 12) There was no evidence of 
any initiation events taking place on any non-AUG codons that are known to occur in 
prokaryotic systems. 
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IDENTIFICATION OF MONOCLONAL ANTIBODIES SPECIFIC FOR THE 
PVM P GENE. 
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6.1: INTRODUCTION. 
In order to effectively study the PVM P protein it was necessary to be able to 
unambiguously identify it amongst the multitude of polypeptide products expressed by 
PVM-infected BSC I cells or the polypeptides expressed in bacterial culture. Specific 
identification would prevent any confusion that may arise from the presence of 
comigrating polypeptides, and in the case of the P protein this specificity would 
prevent confusion with the N protein which has a similar molecular weight and which 
is present in high abundance in PVM-infected ESC I cells The most effective tool with 
which the P protein could be specifically identified was with anti-P protein monoclonal 
antibodies. 
Hybridoma cell lines secreting PVM-specific antibodies were produced and 
screened by Dr. R Ling as described in Ling and Pringle (I989a) By screening these 
monoclonal antibodies against PVM-intected BSCI cell proteins in Western blot 
analysis, the specificity of four monoclonal antibodies was established. One of these 
antibodies was found to be specific for a PVM 31) kDa polypeptide and another was 
found to be specific towards either this 39 kDa species or the PVM N protein which 
has an apparent molecular weight of42 kD, r and which was not well resolved using the 
gel system used by these authors. The monoclonal antibody specific for the 31) kDa 
PVM polypeptide, designated 26/4/C4, also cross-reacted with the HRSV P protein 
(Ling and Pringle, I989a). For this reason it was proposed that 26/4/C'4 was specific 
for the PVM P protein. The second antibody, 26/1/A2 did not cross-react with a 
HRSV polypeptide and the identity of the PVM polypeptide for which it is specific was 
ambiguous. 
In order to be able to more fully characterise the expression products of the 
PVM P gene, approximately two hundred unscreened hybridoma cell lines prepared by 
Dr. R. Ling were screened for ability to recognise PVM P protein in the hope of 
identifying further P protein specific monoclonal antibodies 
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6.2: MONOCLONAL ANTIBODY SCREENING PROCEDURE. 
The tissue culture fluids collected by Dr. R. Ling from antibody-expressing 
hybridoma cell lines were used in Western blot analysis against PVM-infected BSCI 
cell material which had been subjected to SDS-PAGE and transferred to PVDF 
membrane. The PVM-infected and mock-infected BSC I cell material immobilised onto 
the membrane was cut into thin strips 4 mm wide and one strip of each PVM-infected 
and mock-infected BSCI cell material was probed with each antibody (figure 17) A 
total of 20 monoclonal antibodies recognised a band in the region of the blot 
corresponding to the position of the putative PVM P protein. However, as was 
mentioned above, the PVM N protein migrates close to the position of the PVM P 
protein and so to unequivocally determine their specificity these 20 monoclonal 
antibodies were used in further Western blot analysis using the PVM P protein and 
amino-terminally truncated P protein species expressed in E. coli BL21 transformed 
with pGEMP39 and pGEMP37. As described in section 4.2, pPEMP39 directs the 
synthesis of not only the full-length P protein but also the P37. Pu6, P23 and Pig, species. 
The quantity in which this system expressed the P1(, species was not Sufficient for 
reliable identification of this polypeptide to be made in Western blot analysis. In a 
similar way, pGEMP37 directs the synthesis of the P47, P26 P23 and Pu., polypeptide 
species. The expression of the P protein related polypeptides is discussed in section 
4.3.2. 
6.3: EPITOPE MAPPING OF PVM P PROTEIN SPECIFIC MONOCLONAL ANTIBODIES. 
Because the P17, PZ,,, P2 , and 
P,,, polypeptides all possess the carboxyl- 
terminal region of the PVM P protein but various amounts of the P protein amino- 
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Figure 17. Screening of monoclonal antibodies by Western blot analysis with PVM-infected 
BSCI cells. The position of the PVM P39 protein is indicated. The monoclonal antibodies (o) 
that were thought to be specific for the P protein were used in further Western blot analysis 
using bacterially expressed P protein. 
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terminus, recognition of all or just some of these species by a monoclonal antibody 
reveals the approximate location of the P protein epitope that the monoclonal antibody 
is able to recognise. Each of the 20 monoclonal antibodies identified as being specific 
for the P protein were used in Western blot analysis against P protein expressed in 
PVM-infected BSC I cells and in bacterial cultures The set of P protein species that 
these antibodies recognised fell into one of three groups. Figure 18 displays the results 
of the Western blot analysis by listing which of the four P protein species originating 
from both PVM-infected BSC I cells and from bacterial expression that the anti-P 
protein monoclonal antibodies were capable of recognising. This figure also displays 
the region of the PVM P protein that the epitopes recognised by these antibodies can 
be mapped to. A Western blot representative of the reaction pattern of two of the three 
groups is shown in figure 19. The monoclonal antibody 26/4/C4 (Ling and Pringle, 
1989a) which constitutes the third group is also included in this table. 
The position of the epitopes for these antibodies do not appear to he evenly 
spread throughout the length of the P protein. One of the 2I antibodies listed in figure 
18 recognised an epitope in the extreme amino-terminal 47 amino acids of the P 
protein, thirteen antibodies recognised a site within amino acids 48 to 98, and the 
remaining seven recognised a site somewhere in the carboxyl-terminal 157 amino 
acids. The region spanning amino acids 48 to 98 is the location for the epitopes of 
thirteen antibodies and this figure is four times that which would be expected if all 
sites of the P protein were equally likely to be epitope sites. Whilst it is possible that 
the low number of antibodies used in this study means the uneven distribution of 
epitope sites may not be statistically significant, it may also reveal that amino acids 
48 to 98 of the native PVM P protein that was used to immunise the mice for the 
production of antibodies was exposed on the surface of the molecule and thus was in 
a position to elicit an immune response. Arguing against this suggestion, the 
hydropathy plot of the PVM P protein (section 3.4.3) reveals that this region of the 
133 
Monoclonal Antibodies 
PVM P protein is predominantly hydrophobic which suggests that this region will not 
be exposed. More detailed analysis of the epitopes recognised by these antibodies 
would be beneficial as it would enable more detailed investigation of the lower 
molecular weight PVM P protein species. This would be possible by bacterially 
expressing smaller regions of the PVM P protein and subjecting these P protein 
polypeptides to Western blot analysis using the above monoclonal antibodies. 
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(A) MONOCLONAL P-PROTEIN REGION 
ANTIBODY SPECIES MAPPED 
RECOGNISED ON P PROTEIN 
26/4/C4* 39 A 
26/2/F8 39,37 B 
26/1/E4 39,37 B 
24/4/A4 39,37 B 
26/3/F11 39,37 B 
26/1/A2 39,37 B 
26/2/E9 37,37 B 
26/4/E6 39,37 B 
26/1/D7 39,37 B 
26/4/D10 39,37 B 
26/3/G4 39,37 B 
25/1/C10 39,37 B 
24/4/C9 39,37 B 
24/3/A7 39,37 B 
26/1/D12 39,37 B 
24/1B7 39,37,26,23 C 
26/3/E2 39,37,26,23 C 
26/4/C10 39,37,26,23 C 
26/2/C6 39,37,26,23 C 
26/1/F6 39,37,26,23 C 
26/3/B5 39,37,26,23 C 
(B) 
IAI 
u 
u IC ý 
P protein 
species 
39K 
37K 
26K 
23K 
Figure 18. (A) A listing of the 21 anti-P protein monoclonal antibodies that were characterised. 
*Antibody 26/4/C4 was characterised by Dr R Ling (Ling and Pringle, 1989a). The ability of the 
monoclonal antibodies to recognise bacterially expressed P39, P37, P26 and P23 P-related proteins 
is shown. The ability to recognise some or all of these polypeptides identified the approximate 
position of the P protein epitope that the monoclonal antibody was able to recognise. (B). A 
diagrammatical representation of the PVM P protein showing the three regions to which the 
epitopes recognised by the 21 monoclonal antibodies could be mapped to. For example, 
antibody 26/3B5 recognised P39, P37, P26 and Psi, therefore it must recognise an epitope in region 
C since only this region is common to all four P protein species. The recognition of the 16 kDa P 
related polypeptide is not recorded here as it was expressed at low abundance and was not reliably 
identified. 
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Figure 19. Mapping the regions of the P protein to which anti-P protein monoclonal antibodies bind. 
Three monoclonal antibodies specific for the PVM P protein were used in Western blot analysis with 
PVM-infected cell material, mock-infected cell material and also the expression products of E. coli 
BL21 that had been transformed with transcription plasmids pGEMP, pGEMP37 and pGEM1. Plasmid 
pGEMP is able to direct the expression of the full-length P protein and also the 37 kDa, 26 kDa, 
23 kDa and 16 kDa P protein related polypeptides, whereas pGEMP37 directs the expression of the 
four lower molecular weight species. Plasmid pGEMI does not direct the expression of any P protein 
related polypeptides and was used as a control. The lanes are assigned as follows. Lane A: 
PVM-infected cell material. Lane B: Mock-infected cell material. Lane C: IPTG-induced E. coli BL21 
transformed with pGEMP. Lane D: IPTG-induced E. coli BL21 transformed with pGEMP37. Lane E: 
IPTG-induced E. coli BL21 transformed with pGEMI. Depending on the reactiveness with the P 
protein species expressed both in PVM-infected cells and expressed in bacteria, a region of the P 
protein that is recognised by the antibodies can be determined (see section 6.3 for explanation). The 
monoclonal antibodies used in the blots shown above are (1) 26/3/G4. (2) 26/1/D7. (3) 26/3/E2. The 
position of the 39 kDa P protein and the 37 kDa, 26 kDa and 23 kDa polypeptides are indicated on the 
right. The 16 kDa P protein species is expressed in low abundance and was not detected by any of 
these antibodies. The position of the 35 kDa P protein species expressed in PVM-infected cells is 
shown and the position of molecular weight markers (lane S) is indicated on the left. 
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CHAPTER 7 
THE PVM P PROTEIN SPECIES EXPRESSED IN PVM-INFECTED BSC1 
CELLS. 
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7.1: WESTERN BLOT ANALYSIS OF PVM-INFEC TEI) BSC1 CELL MATERIAL. 
In Western blot analysis using PVM-infected BSC I cells, the anti-P protein 
monoclonal antibody 26/3/B5 identified eleven polypeptide species with estimated 
molecular weights of between 39 kDa and 14 kDa (figure 20). None of these species 
were seen in mock-infected BSC I cells. These eleven species were routinely identified 
by antibody 26/3/B5 using several different batches of PVM-infected BSCI cell 
material. These polypeptide species were also routinely identified by several other anti- 
P protein monoclonal antibodies described in section 6.3. As can be seen from figure 
20 the P protein related polypeptides recognised by monoclonal antibody 26/3/B5 were 
not all of equal abundancies. The most abundant species were the Pig polypeptide and 
also a polypeptide with a molecular weight of 35 kDa, which is discussed in section 
7.3.2. 
7.2: COMPARISON OF P PROTEIN SPECIES EXPRESSED IN PVM-INFECTED BSCI 
CELLS WITH P PROTEIN SPECIES EXPRESSED IN E. COLI BL21. 
The expression products of E. c"oli BL2I transformed with pGEMP were 
electrophoresed alongside PVM-infected and mock-infected BSCI cell species and 
then Western blotted using monoclonal antibody 2(! 3lB5 (figure 21 ). This antibody 
recognised eleven P protein related species expressed in PVM-infected BSCI cells 
and also five P protein species expressed in E. t li BL2I which have molecular 
weights of 39 kDa, 37 kDa, 26 kDa, 23 kDa and 10 kDa. The Pv, protein expressed in 
PVM-infected BSC I cells comigrated exactly with the bacterially expressed 39 kDa P 
protein. In addition, the 26 kDa and 23 kDa P protein related polypeptides expressed 
from E. coli BL21, corigrated exactly with species expressed in PVM-infected BSCI 
cells. Previous work described in sections 4.2.3 and 5.2 showed that the 26 kDa and 
138 
S AB 
kDa 
P39 
1 "40- A 67 
-446 
''ýº 
35kDa 
430 
-421.5 
Figure 20. In addition to the P protein, several P protein related polypeptides are synthesised 
in PVM-infected BSCI cells. PVM-infected cell material (lane A) and mock-infected cell material 
(lane B) was subjected to SDS-PAGE and Western blotted using anti-P protein monoclonal 
antibody 26/3B5 (section 6.3). The positions of the P protein and the P protein specific 
polypeptides are indicated with horizontal bars on the left. The positions of molecular weight 
markers (lane S) are indicated on the right. 
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Figure 21. The PVM P gene long open reading frame encodes at least 3 products in vivo. 
Transcription plasmids pGEMP and pGEMP37 were transformed into E. coli BL21 which is 
capable of expressing the proteins encodes for by these plasmids. E. coli BL21 expression 
products were subjected to SDS-PAGE along with PVM-infected and mock-infected BSCI 
cell material and then Western blotted using monoclonal antibody 26\3\B5 (section 6.3). 
Lane 1: PVM-infected BSC1 cell material. Lane 2: Mock-infected BSCI cell material. 
Lane 3: Expression products of E. coli BL21 transformed with pGEMP. Lane 4: Expression 
products of E. coli BL21 transformed with pGEMP37. Lane 5: Expression products of 
E. coli BL21 transformed with pGEMI. The molecular weights of the marked polypeptides 
are indicated and are expressed in kilodaltons. 
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23 kDa E. coli 81.21 expressed P protein related polypeptides are expressed from 
initiation codons AUG3,, 1 and AUG,,,, of the P gene long ORF. Recognition by 
monoclonal antibody 26/3/B5 identities the PVM-infected BSCI cell 26 kDa and 23 
kDa proteins as being expressed from the PVM P gene. The expression of the A. coli 
BL21 26 kDa and 23 kDa species only in the cultures that contained pGEMP and not 
pGEMI identifies these polypeptides as being products of the P gene. The observation 
that the bacterially expressed 26 kDa and 23 kDa P protein species comigrate with the 
PVM-infected BSC I cell 26 kDa and 23 kDa P protein species suggests that the PVM- 
infected BSC I cell polypeptides represent P protein species possessing identical amino 
acid sequence to the bacterially expressed species Apart from these three P protein 
related polypeptides with molecular weights of 31- kDa, 26 kDa and 23 kDa, none of 
the other eight PVM-infected BSC I cell species coniigrated with an E. co/i BL2 I 
expressed P protein related species. 
7.3: DISCUSSION. 
7.3.1: The 26 kDa and 23 kDa P protein species expressed in PVM-infected BSCI 
cells. 
The /: '. cry/i BL21 expressed 39 kDa, 26 kDa and 23 kDa P protein related 
polypeptides each comigrated with aP protein related species expressed from PVM- 
infected BSC I cells. The 39 kDa /,;. co/i BL2 I expressed P protein related species 
corresponds to the full-length Pty, protein expressed in PVM-intected BSC I cells. The 
E. co/i BL21 expressed species with molecular weights of 26 kDa and 23 kDa 
comigrate with the 26 kDa species and 23 kDa species expressed in PVM-infected 
BSCI cells. These P.. co/i expressed 26 kDa and 23 kDa species are translated by 
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initiation on ACUG30 and AUG,,  of the PVM P -cne respectively (sections 4 2.31 and 
5.2) and it is likely that the 26 kDa and 23 kDa polypeptides seen in PVM-infected 
BSCI cells are also expressed from these respective AUG codons. The possibility that 
these two PVM-infected BSC1 cell species comigrate with the bacterially expressed 
species and yet represent different regions of the PVM P protein is unlikely. If the 23 
kDa and 26 kDa species expressed in PVM-infected BSC I cells could be shown to be 
amino-terminally truncated version of the full-length P protein, then this would support 
the proposition that these polypeptides represent the same amino acid sequence as the 
bacterially expressed 26 kDa and 23 kDa polypeptides. A clue as to which region of 
the P protein the PVM-infected BSC I cell expressed 26 kDa and 23 kDa species 
represent comes from observations noted whilst identifying the position on the P 
protein where the anti-P protein monoclonal antibody epitopes were situated (section 
6.3). When a particular monoclonal antibody recognised the I;. ca/i BL2I expressed P 
protein species, the PVM-infected BSCI cell protein species of identical molecular 
weight was also always recognised. This observation was true for all the P protein 
specific monoclonal antibodies analysed. If' the PVM-infected BSC 126 kDa and 23 
kDa species did not represent the same region ofthe full-length PVM P protein as their 
comigrating /':. call BL2I expressed counterparts then instances would arise where the 
monoclonal antibody epitope was missing from either the PVM-infected BSC I cell or 
the bacterially expressed species and so the comigrating pair would not both be 
recognised by the same monoclonal antibody. Neither the 26 kDa or the 23 kDa 
species can be derived from full-length P protein by removal solely of carboxyl- 
terminal sequence because they would be recognised by an antibody that recognised an 
amino-terminal epitope such as 26/4/C'4 (Ling and Pringle, 1989a), or any of the 
antibodies that only recognise the 39 kDa and 37 kDa P protein species (section 6.3). 
This suggests that the 26 kDa and 23 kDa species seen in PVM-infected BSC I cells do 
not possess the P protein amino-terminus, and it is probable that they arise respectively 
by way of internal initiation on AUG,,,, and AUG,,,, of the PVM P gene. 
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7.3.2: Other P protein related species expressed in PVM-infected BSCI cells. 
Out of the eleven P protein related polypeptides identified by monoclonal 
antibody 26/3/B5, the identity of eight is still unknown. One of these remaining eight 
uncharacterised polypeptides is a highly abundant species having a molecular weight of 
35 kDa (figure 20). The precise identity of this polypeptide has not been established, 
however, there are several possibilities as to how this species might arise. 
The 35 kDa species may be generated by cleavage from the full-length P 
protein. The cleavage may arise either as a consequence of the procedure used to 
harvest PVM-infected BSCI cell material, whereby (he full-length P protein could be 
chemically degraded by cleavage at either the amino or carboxyl-termini to remove a4 
kDa fragment, and so yield a 35 kDa polypeptide, or alternatively by way of 
proteolytic cleavage by a host BSC I cell protease. In argument against the suggestion 
that the 35 kDa polypeptide is an artefact of the cell harvesting procedure is the 
observation that the full-length P protein expressed from F,. coli BL21, which is 
harvested in an identical procedure to that of PVM-infected BSC I cell material, is not 
cleaved or degraded to form a 35 kDa polypeptide This observation that the 35 kDa 
species is not represented in the expression products of h;. cu/i BL2 I transformed with 
pGEMP also suggests that the agent responsible for cleaving full-length P protein may 
be present in BSC I cells but not in l;. coli BL2 1, and such an agent may be a BSC 1. 
protease. 
Alternatively, since a polypeptide with a molecular weight of 37 kDa which 
could correspond to the P protein species expressed in º'itro from P gene initiation 
codon AUG148 was not identified by monoclonal antibody 26/3/B5 in PVM-infected 
BSCI cell material, this abundant 35 kDa species may represent a post-translationally 
modified form of the in vitro expressed P species. According to this scheme, AUG149 
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would be utilised to generate the 37 kDa polypeptide and this would then be modified 
to generate the 35 kDa species. 
Whilst mapping the sites on the PVM P protein where anti-P protein 
monoclonal antibody epitopes were located using P protein polypeptides expressed 
from both PVM-infected BSCI cells and E. co/i BL2 I transformed with pGEMP, it 
was noticed that whilst some of the anti-P protein monoclonal antibodies were able to 
recognise the 39 kDa, 37 kDa and 35 kDa P protein species (such as antibody 
26/l /D7, figure 19 [11) some monoclonal antibodies only recognised the 39 kDa and 
37 kDa species (such as antibody 26/3/G4, figure l) 121) This observation suggests 
that the PVM-infected BSCI cell 35 kDa P protein related polypeptide is amino- 
terminally truncated to a greater extent than the 37 kDa protein which does not 
possess the amino-terminal 40 amino acids. Pulse-chase labelling of PVM-infected 
BSC I cells may be able to establish a relationship between the 35 kDa polypeptide and 
either of the full-length P protein or the 37 kDa P species 
The remaining seven P protein specific polypeptides identified in PVM- 
infected BSCI cells by monoclonal antibody 26/3/E35 are of unknown origin. They 
are unlikely to be the unmodified products of internal initiation events due to their 
molecular weights not corresponding to the P protein related species expressed in 
vitro from the internal initiation codons of the PVM P gene. They may represent P 
protein breakdown products, and since none of these seven polypeptides are seen in 
the expression products of E. ruli BL2I transformed with pGEMI', they may be 
cleaved as a consequence of the PVM-infected USI'I cell harvesting procedure or 
they may be cleaved by a BSCI host cell protease. Some of the polypeptides may 
represent P protein species that have been phosphorylated to various extents as 
suggested for P protein related polypeptides seen in Newcastle disease virus infected 
cells (McGinnes et u!., 1988). The P genes of Purcwivxovii"iclue family members are 
unusual in that many are able to direct the expression of several polypeptide products 
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and they are able to utilise more than one reading frame in order to do this. The P 
gene of SEN has been particularly well studied and this gene is now known to direct 
the synthesis of at least 8 polypeptides by using all three of its reading frames. A 
review of the data accumulated on this gene is given in the introduction, section 
1.4.3.1. The 26 kDa and 23 kDa P protein species seen in PVM-infected BSCI cells 
are analogous to the SEN X protein in that they are derived from the same ORF as 
their respective P proteins. The SEN X protein has not been fully characterised and the 
exact way in which it arises has yet to be established, however it appears to be initiated 
from either of two internal codons located at nucleotide positions 1505 or 1523 of the 
SEN P gene rRNA (Curran and Kolakotsky, 1988b). There are other examples 
whereby the large ORF of the P gene of a negative sense single stranded RNA virus 
gives rise to more than one species irr vino A polypeptide representing the carboxyl- 
terminal 93 amino acids of the HRSV P protein was detected in very small quantities in 
HRSV-infected cells (Caravokyri er a/., 1992). This polypeptide, which had an 
observed molecular weight of 16 kDa, was believed to be initiated by leaky scanning, 
on an AUG codon (codon 148) which is the second AUG initiation codon in frame 
with the P ORF. It was suggested that the 16 kDa polypeptide may interact with the 
basic RRSV N and 22K proteins since it consists mainly of the acidic domains of the P 
protein. Another example is in the expression of a7 kDa polypeptide from the 
vesicular stomatitis virus P protein ORF (Herman, 1986; 1987). This species is thought 
to be expressed from the 3' proximal AUG of the P protein mRNA and represents the 
carboxyl-terminus of the VSV P protein. No function has been assigned to this 
polypeptide. The P gene of NDV is believed to utilise the P protein ORF to expresss 
polypeptides with molecular weights of 38 kDa and 29 kDa (McGinnes el a/., 1988) 
although this interpretation has been questioned (Samson er at., 1991). 
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IDENTIFICATION OF THE PVM P GENE SECOND ORF PROTEIN 
PRODUCT (P2) IN PVM-INFECTED BSCI CELLS. 
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8.1: EXPRESSION OF P2 INA WHEAT GERM LYSATE SYSTEM. 
In order to visualise the second open reading frame polypeptide product, 
mRNA transcribed from pGEMP37 was translated in a wheat germ lysate in the 
presence of 35S rnethionine. Radiolabelled translation products were subjected to SDS- 
PAGE and an autoradiograph of the gel is shown in figure 22. A polypeptide with an 
observed molecular weight of approximately 20 kDa was identified in the radiolabelled 
translation products, and this was the most abundant polypeptide species expressed by 
the mRNA transcribed from pGEMP37. This 20 kDa polypeptide is not present in the 
translation products of mRNA transcribed from either pC; EMP26 or pGEMP2 3, and 
therefore it must be initiated from an AUG codon situated upstream of AUGz1i. There 
is only one AUG codon upstream of AUG,,,, capable of initiating translation of a 
polypeptide of approximately 20 kDa and that is AUG,.,, which is the first initiation 
codon of the second ORF. This AUG codon is the first initiation codon of the mRNA 
transcribed from pGEMP37. The 20 kDa polypeptide is the most abundant species 
expressed in wheat germ lysate from pGEMP37 transcribed mRNA and this supports 
the suggestion that this species is initiated from the first AUG codon on the mRNA. 
The putative second ORF polypeptide migrates with an apparent molecular weight of 
20 kDa which is larger than the predicted molecular weight of 15,962 Da calculated 
from the second ORF polypeptide amino acid sequence. 
8.2: TRANSLATIONAL INITIATION OF THE P2 POLY PEPTIDE IN VI'T'RO. 
The initiation codon that is responsible for expression of the second ORF 
polypeptide is the first AUG on the message transcribed from pGEMP37. This codon, 
which is located at nucleotides 131 to 133 of the P gene mRNA (figure 7), is situated 
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Figure 22. In vitro expression of the polypeptide product (P2) of the PVM P gene second open 
reading frame. A wheat germ lysate was programmed with mRNA transcribed in vitro from T7 
transcription plasmids which contained P gene cDNA inserts. The radioactively labelled translation 
products were subjected to SDS-PAGE and the gel was autoradiographed in order to visualise the 
polypeptides. The plasmids used to transcribe the mRNA are as follows. pGEMP23 (Lane A), 
pGEMP26 (lane B), pGEMP37 (lane C), pGEMP (lane D). The P2 polypeptide is visible only in the 
expression products of wheat germ lysate programmed with mRNA transcribed from pGEMP37. The 
first initiation codon of the P2 ORF is the 3' proximal AUG codon on pGEMP37 transcribed 
mRNA. The ATG corresponding to this initaition codon is removed in the construction of pGEMP26 
and pGEMP23. The position of molecular weight markers is indicated on the left. 
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in a context that is considered to be relatively unfavourable for initiating translation 
since it has neither aG at position +4 nor a purine at position -3 and it has only 2 of 
the cytosine residues that are ideally located at positions -5, -4, -2, and -1 (Figure 15, 
Kozak, 1986a; 1986b). Presumably the positioning of AUG,.,, at the 5' end of the 
mRNA is sufficient to ensure that initiation will occur at this codon (Kozak, 1987). 
The mRNA transcribed from pGEMP37 expresses several other polypeptides, namely 
P37, P26, P23 ; and P16. in addition to the second ORF polypeptide, P2, and this probably 
results from a poor frequency of initiation from AUG,.,, which allows scanning 
ribosomes access to downstream AUG codons. The expression of polypeptides that 
are initiated from these downstream AUG codons is interesting as they are not in the 
same ORF as the first initiation codon, AUG,,,. This observation suggests that the 
scanning ribosomal subunits are not uniquely phased, either when they enter the 
mRNA species or when they encounter the first AUG codon. It has been suggested 
that the 40S ribosomal subunits may be nudged into the correct phasing by the GCC or 
ACC nucleotide sequence that immediately precedes the majority of AUG codons 
(Kozak, 1989). Perhaps in the case of the pGEMP37 transcribed mRNA, a large 
proportion of 40S subunits pass by AUG1., 1 because of the poor nucleotide context, 
and eventually encounter AUG14x which, by virtue of the immediately preceding 
nucleotides, is able to nudge the incoming ribosomes into the correct phase for 
expression of the 37 kDa polypeptide. 
The second ORF polypeptide was not seen when reticulocyte lysate was 
programmed with rnRNA transcribed from pGEMP37 and this was probably due to the 
presence of large quantities of globin which causes a smearing of polypeptide species 
that run in the lower region of the gel where the second ORF protein product migrates. 
Radiolabelled second ORF polypeptide product was not identified by SDS-PAGE 
when wheat germ lysate was programmed with mRNA transcribed from pGEMP. The 
context of AUG,,, is extremely favourable tier initiation to occur at this point (section 
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4.3.3, figure 15) and so only a small proportion of 40S ribosomal subunits would be 
expected to pass by AUG, (, and to scan towards downstream initiation codons. The 
context of AUG131 is poor and so ribosomes still scanning at this point may not initiate 
here, but pass to scan towards the more favourably situated AUG, 48. The lack of 
detection of the second ORF polypeptide does not unequivocally mean that it is not 
expressed by the full-length P gene mRNA, it may be that the polypeptide is expressed 
in amounts that require long autoradiograph exposure for its detection. 
8.3: THE GENERATION OF ANTISERUM AGAINST THE P GENE SECOND ORF 
PROTEIN PRODUCT. 
8.3.1: The Qiagen Express system. 
Antiserum specific against the PVM P gene second ORF protein product was 
generated by immunising rats with a synthetic oligopeptide representing amino acids 45 
to 62 of the P2 amino acid sequence, as described in section 2.13.2. In order to test the 
anti-P2 protein antiserum for the ability to recognise second ORF polypeptide, the 
PVM P gene second ORF polypeptide was expressed in L. coli M 15 [pREP4] using 
plasmid pQE32 of the Qiagen Express system (Qiagen Inc). This system can provide 
high level expression of protein which can be quickly and easily purified to a high level 
of homogeneity, cDNA inserts were cloned into these vectors such that their coding 
sequences were in-frame with an ATG initiation codon that initiated expression of a 
plasmid encoded peptide consisting of six histidine residues (6x histidine tag). The 
expressed fusion proteins therefore contain the 6x histidine tag linked to the amino- 
terminus. The plasmid constructs were transformed into /:. soli K-12 strain M 15 
containing multiple copies of plasmid pREP4 which carries the lac I gene encoding the 
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lac repressor. The multiple copies of pREP4 present in the host cells ensure high levels 
of lac repressor and tight regulation of protein expression. Transcription in this system 
is controlled by a promoter/operator element consisting of the E. cols bacteriophage 
T5 promoter and two lac operator sequences. Expression is therefore inducible with 
IPTG. One-step purification, to greater than 95% homogeneity, is mediated by the 
extremely high affinity of the 6x histidine tag for Ni-NTA resin, a metal chelate 
absorbent. 
8.3.2: Construction of nlasmid LQE32. P2. 
The PVM P gene second ORF coding, region was amplified using PCR on 
PVM P gene cDNA. The oligonucleotide printers used Ihr the amplification are shown 
below (both are in 5' to 3' polarity). 
PVMP2A CCGGGATCCTCATGTCACCAAATATAACATGCCC 
PVMP2B ACTAGATAGAATAGAGGAGAAGCTTAGG 
Primers PVMP2A and PVMP2B hybridise to P gene nucleotides 128 to 153 and 552 
to 572 respectively. The amplified fragment representing the P gene second ORF was 
isolated by agarose gel electrophoresis and purified by the fragment preparation 
technique. The fragment was end-filled using Klenow fragment, cleaved with 
restriction enzyme Bum HI and inserted into the Bti mi it and Simi I sites present in the 
polylinker region of pQE32. These construction details are shown diagrammatically in 
figure 23. The resulting plasmid, pQE32. P2 was transformed into E. coil strain M15 
[pREP4] and the PVM P gene second ORF polypeptide 
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Figure 23 (A) and (B). Construction of pQE32. P2. (A) The multiple cloning site of pQE32 
showing positions of the ribosome binding site (RBS), initiation codon (underlined) and 
the 6x his coding region. The coding triplets that are in-frame with the initiation codon 
are shown divided by vertical lines. (B). Construction details for plasmid pQE32. P2. PVM 
P gene second ORF coding region was amplified by PCR using oligonucleotide primers 
PVMP2A and PVMP2B (section 8.3.2). The amplified fragment was end-filled and 
cleaved using restriction enzyme Bam HI which cuts in PVMPI. The cleaved fragment 
was inserted into Bam HI and Sma I sites of pQE32. The coding triplets of the Bam HI 
recognition siteare shown divided by vertical lines at the termini of the P2 fragment and 
the cleaved pQE32 vector. 
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product was expressed and purified as described in section 2.12.1 
8.4: IMMUNOLOGICAL ACTIVITY OF ANTI-P2 ANTISERUM. 
Antiserum taken from rats immunised with a synthetic peptide representing 
amino acids 45 to 62 of the PVM P gene second ORF protein product was tested for 
its ability to recognise second ORF protein product, expressed by E. co/i M 15 
[pREP4] transformed with pQE32. P2, in Western blot analysis. The antiserum 
recognised a polypeptide of approximately 29 kDa, present only in the pQE32. P2 
expression products. The pre-immune antiserum did not recognise this polypeptide 
(figure 24). In addition, the pre-immune antiserum did not recognise any other PVM 
specific polypeptides as determined by Western blot analysis against PVM-infected 
BSC I cell material (and bacterially expressed PVM N protein). The molecular weight 
of the species recognised is greater than the observed molecular weight of the second 
ORF protein product expressed in vilro by translation in wheat germ lysate (20 kDa). 
However, the presence of the histidine leader affinity tag at the amino-terminus of the 
second ORF protein, encoded by the expression plasmid pQE32, increases the 
observed molecular weight of expressed species by approximately 6000 Daltons as 
described in section 9.2.2. Taking this into account, of the 29 kDa molecular weight 
observed for the I,. coli M 15 expressed second ORF fusion protein product, 6 kDa is 
likely to be due to the histidine tag and thus 23 kDa is likely to be due to the second 
ORF amino acid sequence. This calculated molecular weight for the bacterially 
expressed P2 protein is close to the observed molecular weight of P2 expressed in a 
wheat germ lysate (section 8.1), 
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Figure 24. The PVM P gene second ORF encodes a polypeptide in vivo. Rabbits were immunised 
with a synthetic peptide representing amino acids 45-62 of the PVM P gene second ORF protein 
product. Success of the immunisation procedure was tested by the ability of post-immune serum to 
recognise purified second ORF protein product in Western blot analysis. Second ORF product was 
expressed using K coil M15 [pREP4] which was transformed with the IPTG-inducable expression 
plasmid pQE32. P2 which contained the P gene second ORF coding sequence (see section 8.3.2 for 
construction details). Plasmid pQE32 did not contain the second ORF coding sequence and was used 
as a control. Lane 1: Products of pQE32. P2 expression blotted with pre-immune sera. Lane 2: Product 
of pQE32 expression blotted with pre-immune sera. Lane 3: Expression products of pQE32. P2 blotted 
with post-immune sera. Lane 4: Expression products of pQE32 blotted with post-immune sera. The 
positions of molecular weight markers are indicated at the sides of the blot. In this gel system, the 
bacterially expressed second ORF protein product migrates with an apparent molecular weight of 
29 kDa due to the presence of an amino-terminal affinity tag encoded for by the pQE32. P2 plasmid 
which facilitates purification of the species. The pre- and post-immune sera were then used in Western 
blot analysis with PVM-infected and mock-infected BSC 1 cell material. Lane 5: Mock-infected cell 
material blotted with pre-immune sera. Lane 6: PVM-infected cell material blotted with pre-immune sera. 
Lane 7: Mock-infected BSC I cells blotted with post-immune sera. Lane 8: PVM-infected cells blotted 
with post-immune sera. The Western blot analysis identified a 23 kDa polypeptide that was only present in 
the PVM-infected cell material, and was identified only with post-immune serum (*) 
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8.5: IDENTIFICATION OF P2 IN PVM-INFECTED I3SC'I CELLS. 
Figure 24 shows a Western blot on which the expression products of PVM- 
infected and mock-infected BSCI cell extracts were blotted against sera taken from 
rats both before and after immunisation with the synthetic peptide. A polypeptide with 
a molecular weight of approximately 23 kDa Daltons was identified in the PVM- 
infected BSC 1 cell material by the post-immune serum but not the pre-immune serum. 
This 23 kDa species was not present in the mock-infected BSCI cell material. The 
molecular weight of this species is similar, but not identical, to the observed molecular 
weight of the P gene second ORF protein product translated iii vitro using wheat germ 
lysate which is approximately 20 kDa. However the molecular weight of this PVM- 
infected BSCI cell species is the same as the calculated molecular weight of P2 
expressed from pQE32. P2 which is approximately 23 kDa (section 8.4). 
8.6: DISCUSSION 
The discrepancy between the observed molecular weight of wheat germ 
expressed second ORF product (20 kDa) and the PVM-infected BSC I cell polypeptide 
that is thought to represent the second ORF product (23 kDa) is cause for this 
assignment to be made tentatively. The recognition by the antiserum of both bacterially 
expressed P2 and the PVM-infected BSC I cell expressed P2 polypeptide dictates that 
these species share polypeptide sequences. It is possible that the calculated difference 
in the apparent molecular weights of these species is due to a modification that occurs 
to the in vivo expressed second ORF polypeptide in the host BSC I cells. However, the 
possibility that the 23 kDa species is expressed by either PVM or by the host BSC I 
cells in response to the infection, and cross-reacts with the post-immune serum due to 
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the presence of a common peptide motif must not be overlooked, although this is 
unlikely. 
The presence of an accessible coding region of considerable size, as is 
represented by the PVM P gene second ORF, would suggest that this is indeed likely 
to be used for the expression of a polypeptide because production of an unnecessary 
polypeptide would presumably burden the virus and so the presence of the useless 
coding potential would be selected against. This argument would support the idea that 
in viva, the P gene second ORF expresses a polypeptide species, and that it is 
functional. However, the first initiation codon on the second ORF is in poor nucleotide 
context (section 8.2). It may be that the context is sufficiently poor to prevent 
significant expression of the second ORF product and ii' this species had no function, 
then the second ORF coding region could exist without burdening the replicative 
efficiency of the virus. 
The 23 kDa polypeptide identified by Western blotting of PVM-infected BSC 1 
cells using the anti-second ORF antiserum does not correspond to the 23 kDa 
polypeptide expressed from the P protein ORF of the P gene, which was identified by 
antibody 26/3435 in Western blot analysis. If both were the same then the anti-peptide 
antiserum would also recognise the more abundant full-length P protein since the 
amino acid coding sequence ofthe 23 kDa P protein related polypeptide is also present 
in the full-length P protein. 
As was mentioned in section 7.1, the monoclonal antibody 26/3/B5 identifies a 
total of eleven PVM-infected BSC I cell protein products and of these eleven, seven 
are still uncharacterised. Several possibilities regarding the identity of these species are 
presented in section 7.3.2. There is another possibility and this is that these 
uncharacterised P protein related polypeptides may be composed, in part, of amino 
acid sequence that is encoded for by both the P protein ORF and also the second ORF 
as a result of polymerase slippage during transcription. The only PVM-infected BSC 1 
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cell polypeptide recognised by the anti-peptide antiseruIII was the 23 kDa species, and 
this observation suggests that no other PVM-infected BSC I cell polypeptides have 
second ORF amino acid sequences (from the Western blot shown in figure 24 the 
second ORF antiserum may appear to recognise PVM infected cell polypeptides with 
molecular weights of approximately 19 kDa and 40 kDa, however this is due to poor 
reproduction of the original blot which has failed to show a comigrating band in the 
mock infected cell material lane [lane 7]). However, since the immunogen used to 
raise the second ORF serum was a short peptide, then PVM-infected BSC I cell 
polypeptides representing second ORF amino acid sequences outside this small ORF 
would not be identified with this serum. There are two ways in which a polypeptide 
encoded by parts of both ORFs can be expressed and be recognised by monoclonal 
antibody 26/3/B5 but not the anti-second ORF polypeptide antiserum. Firstly, the 
polypeptide would have to be initiated from AL. J(j ,, and the frame shifting occur at a 
site upstream of that used to encode the region of P2 represented by the synthetic 
peptide. Alternatively, the polypeptide would have to be initiated from an AUG 
downstream of the region which encodes the sequence of the synthetic peptide and the 
frame shifting occur at some point within the remainder of the P2 coding region. These 
theoretical modes of polypeptide expression would be unlike that seen in any other 
Paramyxoviriclae family member and are very unlikely to occur. As mentioned in 
section 3.4.6, the PVM P gene does not contain a sequence that is known to promote 
polymerase slippage and thus if polypeptides are expressed by PVM which contain 
amino acid sequence from the two ORFs then the mechanism by which the ORFs are 
switched is probably not the same as for the I'arc, nit'. vurirtckw tämily members. A more 
informative picture of the expression of' the PVM P gene may be obtained by 
generating second ORF antiserum by immunising animals with a bacterially expressed 
version of the complete second ORF coding region. This would mean that any PVM- 
infected BSCI cell polypeptide that possessed second ORF sequence could be 
identified. 
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THE POLYPEPTIDE EXPRESSION PRODUCTS OF THE PVM N GENE. 
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9.1: PVM N GENE EXPRESSION IN VITRO. 
9.1.1: Construction of transcription plasmids nGEMN and nGEMNTR. 
A cDNA fragment containing the entire coding sequence of the PVM N gene 
was excised from plasmid 6.19 (Barr el al., 1991) by digestion with restriction 
enzymes Fok I and Rani HI. This cDNA segment was isolated by agarose gel 
electrophoresis and purified using the fragment preparation technique. The fragment 
was blunt ended with Klenow fragment and inserted into the . S'ma I site of the T7 
transcription vector pGEM 1. The resulting plasmid was named pGEMN. A 
transcription vector, pGEMNTR, was also constructed which contained nucleotides 
592 to 1215 of the PVM N gene. This was achieved by excising and blunting the full- 
length N gene cDNA from clone 6.19 as described above, digesting the fragment with 
restriction enzyme l)ra I and then inserting it into the . ''ma I site of pGEM 1. The 
details involved in the construction of these plasmids is shown in figure 25. 
9.1.2: In vitro translation products of pCEMN and pGEMNTR. 
Messenger RNA transcribed from pGEMN was translated in a rabbit 
reticulocyte lysate system in the presence of I'S methionine and the radiolabelled 
expression products were analysed by SDS-PAGE and autoradiography (figure 26). 
The N gene coding region of pGEMN directed the in vilm expression of two major 
polypeptides, the 43 kDa full-length N protein and a 24 kDa polypeptide. In order to 
establish the origin of the 24 kDa polypeptide, the transcription vector pGEMNTR 
was constructed (section 9.1.1) which contains nucleotides 592 to 121-S 
1 51) 
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Figure 25. Construction of pGEMN and pGEMNTR. (a). A fragment representing full-length 
N gene cDNA was excised from cDNA clone 6.19 (Barr et al., 1991) by digestion with 
restriction enzymes Fok I and Bam HI. The fragment was blunt ended using Klenow and 
inserted into the Sma I site of transcription plasmid pGEMI to derive the plasmid pGEMN. 
(b). A fragment representing nucleotides 592-1215 of the PVM N gene cDNA was removed 
from clone 6.19 using restriction enzymes Dra I and Bam M. The fragment was blunted 
using Klenow and inserted into the Sma I site of trasncription plasmid pGEMI to derive 
pGEMNTR. 
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of the N gene cDNA coding region. mRNA transcribed from pGEMNTR was 
translated in a rabbit reticulocyte system and analysis by SDS-PAGE revealed that 
pGEMNTR directs the in i'ilro synthesis of the 24 kDa N protein species alone (figure 
26). 
The first AUG codon on the mRNA transcribed from this plasmid is located at 
a position corresponding to nucleotides 612 to 614 of the full-length N gene and this 
AUG codon is not capable of directing the synthesis of a polypeptide due to the 
presence of multiple downstream stop codons in this reading frame (Barr ei a/., 1991). 
The next AUG codon downstream is located at nucleotides 629 to 631 of the N gene 
and this AUG codon is in the same open reading frame as the large ORF that encodes 
the PVM N protein. Initiation of translation at AUG629 is predicted to result in the 
translation of a polypeptide with a molecular weight of 2 1,478 Da. There are no other 
AUG codons sufficiently near to AUG629 that could initiate expression of a polypeptide 
of 24 kDa. The next in-frame AUG codon downstream of AUG629 is at nucleotide 
positions 720 to 722 which is predicted to initiate synthesis of a 16,204 Da 
polypeptide. There are no other alternative initiation codons, such as the ACG codon 
used to initiate translation of the Sendai virus C' polypeptide (Gupta and Patwardhan, 
1988; Curran and Kolakofsky, 1988a), that could give rise to the 24 kDa polypeptide, 
and therefore AUG62) must be responsible for initiation of the 24 kDa species. Because 
of the abundance of the 24 kDa species in riu"a, and its potential as a possible 
regulatory protein, a study was undertaken to see if the 24 kDa species could be 
immunologically detected in PVM-infected BSC I cell material. 
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Figure 26. The full-length N gene cDNA directs the in vitro expression of the full-length 
N protein (43 kDa) and a amino-terminally truncated polypeptide with a molecular weight 
of 24 kDa. mRNA transcribed from pGEMN (full-length N gene cDNA insert) and 
pGEMNTR (cDNA insert with nucleotides 592-1215 of the N gene) was used to programme 
a reticulocyte lysate system and the radioactively labelled expression products were 
subjected to SDS-PAGE and autoradiography. Lane A: mRNA transcribed from pGEMN. 
Lane B: mRNA transcribed from pGEMNTR. The positions of molecular weight markers are 
indicated on the left. 
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9.2: GENERATION OF ANTISERUM AGAINST THE 24 KDA PVM N PROTEIN SPECIES. 
9.2.1: Construction of p0E32.24. 
A cDNA fragment possessing nucleotides 621-1215 of the PVM N gene was 
generated by cleaving the fill-length N gene cDNA fragment with the restriction 
enzymes Kpn I and Hinc 11. The DNA segment was isolated by agarose gel 
electrophoresis and then purified using the fragment preparation procedure. The 
fragment was inserted into the Kjni I and Snit I sites of expression vector pQE32 of 
the Qiagen Express system (Qiagen Inc, described in section 2.12. I) such that the N 
gene open reading frame was in-phase with the pQE32 ATG initiation codon 
specifically intended for the expression of inserted DNA sequences. The construction 
of this plasmid is shown in figure 27. The resulting vector was designated pQE32.24. 
The plasmid was transformed into F. culi strain M 15 [pREP4] (Qiagen Inc. ) by the 
transformation procedure described in section 2.5.2. 
9.2.2: Immunisation of rabbit with Purified 24 kDa N protein species. 
The expression product of pQE32.24 was purified according to the procedure 
described in section 2.12.1, and subjected to SDS-PAGE to confirm the success of the 
purification procedure (figure 28). The purified polypeptide was used to generate 
antiserum in rabbits as described in section 2.13.1. Figure 29 shows a Western blot on 
which the expression products of IPTG induced and un-induced cultures of E. culi 
M15 [pREP4] transformed with pQE32.24 were reacted with the sera taken from 
rabbits both before and after immunisation with the purified 24 kDa N protein 
species. The post-immune antiserum reacted strongly with a polypeptide with an 
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Figure 28. Expression and purification of the truncated N protein using the Qiagen Express 
system. The products of bacterial expression were subjected to SDS-PAGE analysis before and 
after purification using Ni-NTA resin. Lane C: Total expression products of un-induced E. coil 
M15 [pREP4] transformed with pQE32.24. Lane D: Total expression products of IPTG-induced 
E. coil M15 [pREP4] transformed with pQE32.24. Lane A: Expression products of un-induced 
E. coil M15 [pREP4] transformed with pQE32.24 after purification using Ni-NTA resin. 
Lane B: Expression products of IPTG-induced E. coli M15 [pREP4] transformed with 
pQE32.24 after purification using Ni-NTA resin. The position of molecular weight markers are 
shown on the right, and the arrow on the left indicates the position of the purified truncated N 
protein 
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Figure 27 (A) and (B). Construction of plasmid pQE32.24. (A) The multiple cloning site of pQE32 
showing positions of the ribosome binding site (RBS), the initiation codon (underlined), and 
the 6x his coding region. The coding triplets that are in-frame with the initiation codon are shown 
divided by vertical lines. (B). Construction details for pQE32.24. (i). A full-length N gene cDNA 
fragment was cleaved with restiction enzyme Kpn I (ii). The Kpn I -Bam HI (blunt) fragment 
which represented nucleotides 621-1215 of the PVM N gene, was inserted into the Kpn I and 
Bam HI (blunted) sites of pQE32. 
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Figure 29. Antiserum was raised against purified 24 kDa N protein species expressed in E. coli 
MI5 [pREP4] transformed with pQE32.24. Post-immune serum was used in Western blot 
analysis against the expression products of E. coli MI 5 [pREP4] transformed with pQE32.24. 
Lane A: IPTG-induced total bacterial culture. Lane B: Un-induced total culture. Lane C: IPTG- 
induced culture after purification with Ni-NTA resin. Pre-immune rabbit serum used in Western 
blot analysis with expression products of E. coli M15 [pREP4] transformed with pQE32.24. 
Lane D: IPTG-induced total bacterial culture. Lane E: IPTG-induced bacterial culture after 
purification with Ni-NTA resin. The position of the bacterially expressed 24 kDa truncated N 
protein is marked (*). The position of molecular weight markers (lane S) is indicated on the left. 
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observed molecular weight of 30 kDa in the induced pQE32.24 extract. The PVM N 
gene coding sequence contained within pQE32.24 is identical to that contained in 
pGEMNTR which directs the in vitro expression of the 24 kDa N protein species 
(section 9.1.2). The observed molecular weight difference between the 30 kDa 
expression product of pQE32.24 and the 24 kDa in vitro expression product of 
pGEMNTR is therefore due to the presence of the Ox histidine tag. The antiserum did 
not identify a corresponding polypeptide in the induced pQE32 extract. The pre- 
immune serum did not recognise the purified 24 kDa species, similarly, the antiserum 
did not react with a protein in the expression products of un-induced E. coil M 15 
[pREP4] containing pQE32.24. 
9.2.3: Identification of the 24 kDa species in PVn1-infected BSCI cell material. 
The anti-24 kDa N protein antiserum was used in Western blot analysis with 
PVM-infected and mock-infected BSCI material (figure 30). In the PVM-infected 
BSCI cell material, the antiserum identified a 43 kDa species representing the PVM N 
protein and also a polypeptide with an observed molecular weight of approximately 30 
kDa. Neither of these two species were identified in the mock-infected BSCI cell 
material. A polypeptide with a molecular weight of 24 kDa was not identified in the 
PVM-infected BSCI cell material. The identity of the 30 kDa species is unknown 
although due to its recognition by the antiserum, it must represent a region of the PVM 
N protein that includes a portion of its carboxyl-terminal half 
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Figure 30. The N protein and aN protein related 30 kDa polypeptide are present in PVM- 
infected BSC1 cells. The anti-24kDa polypeptide antiserum was used in western blot analysis 
with PVM-infected BSC1 cell material (lane A) and mock-infected BSCI cell material (lane 
B). The PVM N protein (43 kDa) and also a polypetide with a molecular weight of 30 kDa 
were identified only in the PVM-infected BSCI cells. For comparison, the 43 kDa full-length 
and 24 kDa truncated N proteins expressed in vitro using reticulocyte lysate programmed with 
pGEMN were also electrophoresed (lane C), and the positions of these polypeptides are 
indicated (*) The positions of molecular weight markers are indicated on the left. 
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9.3: DISCUSSION 
9.3.1: Expression products of the PVM N gene. 
Rabbit reticulocyte lysate programmed with mRNA transcribed from pGEMN 
synthesises the full-length N protein and also a 24 kDa species which, by expression of 
mRNA transcribed from the truncated N gene cDNA of plasmid pGEMNTR, was 
shown to be initiated from the AUG codon at nucleotide position 629 to 631. 
9.3.2: Expression of the 24 kDa N protein species. 
There are several explanations that can account for the expression of the 24 
kDa polypeptide. Firstly it may be made as a consequence of the proposed leaky 
scanning mechanism (Kozak, 1986a; 1986b, 1986c, 1989) by 40S ribosome subunits 
that fail to initiate at the preceding initiation codons. Secondly, although extremely 
unlikely, it may be expressed as a result of mRNA breakage that occurs in such a place 
as to make AUG(, 2 the 5' proximal AUG codon on the broken mRNA and thus 
virtually ensure its usage (Kozak, 1987). Finally, it may also be generated as a result of 
proteolytic cleavage of the full-length N protein. 
If leaky scanning is responsible fir initiation of translation on AUG,, »,, the 
40S ribosomal subunit present in the reticulocyte lysate must pass and fail to initiate 
on the preceding sixteen AUG codons of' the N gene cl)NA many of which are in a 
different reading frame and are incapable of directing the synthesis of large 
polypeptides. The mechanism of leaky scanning appears to be heavily dependent on 
the nucleotide sequence surrounding the codons that could potentially initiate 
translation. The nucleotide sequence surrounding the first initiation codon on the 
PVM N mRNA is such that the context is sub-optimal (Kozak, 1986x; 1986b; Figure 
31). Consequently, in accordance with the leaky scanning hypothesis, a proportion of 
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Figure 31. The nucleotide context that surrounds the first 18 initiation codons of the PVM 
N gene mRNA. For each of the N gene AUGs listed above, the nucleotide identities with 
the optimal context motif determined to be CCA/GCCAUGG (Kozak, 1986a) are shown in 
bold face and are underlined. The initiation codons that are in the N protein ORF (ORF 2) 
are identified with an asterisk (*). 
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40S ribosomal subunits will initiate at the first AUG of the N gene mRNA, but since 
it is sub-optimally situated, some will pass along the )nRNA to the next AUG. The 
context of the next sixteen AUG codons are also poor (figure 31 ), thus while some 
ribosomes may initiate at these codons, some will pass by and scan downstream 
towards the next. For initiation to occur on the eighteenth initiation codon, AUG,,,, 
the proportion of ribosomes that pass all the preceding AUG codons must be vastly 
greater than the proportion that would stop and initiate, otherwise no ribosomes 
would be left scanning on the rnRNA to initiate at AUG,, 2,. The highly favourable 
sequence surrounding AUG,,,,, is such that the 40S ribosomal subunits that have 
reached this far will probably proceed no further. This suggestion is supported by the 
observation that no low molecular weight polypeptides are expressed in vitro from 
mRNA transcribed from pGEMN. Secondary structure prediction analysis for the 
PVM N gene mRNA indicates that AUG,, r) is located on an exposed and isolated loop 
structure, whereas the previous three AUGs of the N protein ORF are positioned 
within stem formations (figure 32). However it is thought that presence of buried 5' 
AUG triplets cannot direct a 40S ribosome subunit to initiate at downstream AUGs 
(Kozak, 1986c). The proposed in vitro expression of the 24 kDa polypeptide from the 
eighteenth AUG codon is therefore probably due to the consequences of local 
sequences surrounding the internal AUG triplets alone. Whether the proposed 
phenomenon of reading frame commitment (Kozak, I989 and references therein) 
could play a part in the expression of the 24 kDa polypetide is not known. This 
phenomenon suggests that the ribosomes only scan in one of the three ORFs because 
they move along the mRNA in steps of three nucleotides. If the phenomenon of 
reading frame commitment did operate in the translation of this message, then the 
number of AUGs that the ribosome had to scan past would he reduced from sixteen to 
four, thus making initiation at AUG629 considerably more likely. The abundance of 
the 24 kDa species in the expression products of reticulocyte lysate programmed with 
pGEMN transcribed mRNA suggests that initiation of translation on AUG629 is a 
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Figure 32. SQUIGGLES plot of the PVM N gene mRNA using the FoldRNA programme 
(Zuker, 1989). The AUG codon responsible for the initiation of the 24 kDa polypeptide in vitro 
(AUG629 ) is positioned on an exposed loop structure (indicated with the arrow) whereas the 
previous four AUG codons of the N protein ORF (at nucleotide positions 32,149,179 and 242) 
are buried within stem formations. Whether the location of AUG629 influences the ability of 
scanning ribosomes to initiate at this position is unknown, although it has been suggested that 
the presence of buried 5' AUG triplets cannot direct a ribosome to initiate at downstream AUGs 
(Kozak, 1986c). 
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common event and so whatever method of scanning is used it appears that a larger 
number of ribosomes do initiate at AUG(, r,. Also interesting is the apparent lack of 
detection of any N protein related species that could he expressed from the previous 
three upstream in-frame AUG codons located at positions 149,179 and 242, either in 
western blot analysis using the polyclonal anti-24 kDa N protein antiserum with 
PVM-infected BSCI cell material, or with in viii-o translations using N gene mRNA. 
These three seemingly inactive codons are all situated in a nucleotide context that is 
considered to be poor for translational initiation since whilst they have either an A or 
aG at position -3, they do not have aG at the critical -f 4 position (Figure 3I). The 
context of these codons is similar to that of the first AUG codon of the major ORF, 
but this is presumably used due to its position at the 5' end of the mRNA fragment. It 
is possible that the high frequency of initiation at : BUG,,,,, is a consequence of these 
preceding codons being unable to support translational initiation at a high frequency. 
Another possible, but highly unlikely, reason for expression of the 24 kDa 
polypeptide is mRNA breakage. If mRNA breakage was responsible for causing the 
expression of the 24 kDa polypeptide then the breakages would have to position 
AUG629 at the 5' end of an rRNA fragment and thus the cleavage event would have to 
be at a position somewhere between nucleotides 400 and 628. This would mean that 
there would be, in addition to the rnRNA fragment that had AUG629 at its 5' end, 
another mRNA with AUG12 at its 5' end, which \vould be capable of directing the 
translation of polypeptides with approximate molecular weights of between 13 kDa 
and 20 kDa depending on the position of cleavage. No such polypeptides are ever seen 
in the SDS-PAGE analysed iii º'in-o expression products of pGEMN mRNA. If the 
cleavage event occurred such that either of the second, third or fourth N gene long 
ORF polypeptides were at the 5' end of a cleaved mRNA fragment then expression of 
AUG629 would be more favourable but at the same time would lead to the expression 
of a polypeptide from one of these upstream AUGs, and, as was mentioned earlier, 
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polypeptides expressed from these AUGs are never seen If a proteolytic cleavage 
event was responsible for generation of the 24 kDa polypeptide in vitro, then the 
cleavage would have to occur at the precise position on the PVM N protein that 
corresponded to AUG629 and this is extremely unlikely. Additionally, if cleavage 
occurred at this position, then a 17 kDa species representing the amino-terminus of N 
protein would also be generated, and a species of this size has not been identified in in 
vitro translations. 
9.3.3: The 30 kDa N protein species expressed in PVM-infected BSCI cells. 
Antiserum was raised against bacterially expressed PVM 24 kDa N protein 
related polypeptide (section 2.13.1). In PVM-infected BSC I cell material, two 
polypeptide species encoded by the N gene were detected by the anti-24 kDa 
antiserum in Western blot analysis, the full-length 43 kDa N protein, and a 30 kDa 
species. A polypeptide with a molecular weight of 24 kDa was not recognised by this 
antibody in either PVM-infected or mock-infected BSCI cells (figure 30). There are 
several possibilities regarding the identity of the 30 kDa species. Firstly, it may be a 
breakdown product of the PVM N protein generated by a specific cleavage event. The 
cleavage event would have to be highly specific and only occur at one position to 
account for the total absence of any other polypeptides of a molecular weight smaller 
than the full-length N protein species. A 30 kDa species is not seen following in vitro 
translation of the PVM N protein, and so the putative cleavage event would probably 
be mediated by cellular agents. 
Alternatively, the 30 kDa species may be the product of an initiation event on 
an internal N gene AUG codon. There is no initiation codon present on the PVM N 
gene capable of initiating the synthesis of a polypeptide having a predicted molecular 
weight of 30 kDa. The two AUG codons that are capable of encoding polypeptides 
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closest to the 30 kDa species are AUG(, 2), which in 01ro encodes the 24 kDa species, 
and the next AUG codon upstream of this, located at nucleotide positions 242 to 244, 
which could potentially encode a polypeptide with a predicted molecular weight of 
approximately 36 kDa. Clearly, if internal initiation from either of these AUGs is 
responsible for the generation of the in vivo 30 kDa species the translation product 
must be modified in some way that changes its observed molecular weight. The 30 kDa 
species is not seen following in vitro translation of the PVM N protein, and thus if 
modification is responsible for the presence of this polypeptide, then the modification 
would appear to be a process mediated by cellular factors. As was mentioned above, in 
vitro studies indicate that the 24 kDa polypeptide is made in high abundance which 
suggests that initiation on AUG629 is a common event. In contrast to this, a 36 kDa 
polypeptide product is never seen when mRNA transcribed from pGEMN is expressed 
in rile suggesting that initiation of translation on AUG242 seems to be a rare 
occurrence. On the basis of these in rüro observations, if initiation on an internal AUG 
codon was responsible for the generation of the 30 kDa species AUG629 is probably the 
most likely candidate. It is well known that in wino translation using the rabbit 
reticulocyte system can lead to the synthesis of arteiiºctual polypeptides due to aberrant 
initiation events (Kozak, 1999 and references therein). This is due in part to the 
willingness of reticulocyte lysate 40S ribosomal subunits to use uncapped mRNAs as 
their substrate. It is possible therefore that the in vitro results do not give an accurate 
reflection of the abilities of the PVM N gene AUG codons to support translational 
initiation in vivo. 
Western blot analysis demonstrated within the estimation limits permissible 
using this technique, that the 30 kDa species is present in PVM-infected BSC1 cells at 
an abundance similar to that of the full-length N protein. Considering this high 
abundance, and regardless of its origin, the 30 kDa species may have an important role 
in the life cycle of this virus. Since this 30 kDa species is composed of a large 
proportion of the PVM N protein coding sequence, it is feasible that this species may 
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share a domain of functional importance with the tüll-length N protein. If this species 
performs a function, it may be regulatory. Possible functional aspects of the 30 kDa N 
protein polypeptides are discussed in section 11.4. 
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INTERACTION BETWEEN THE N AND P PROTEINS OF PVM. 
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10.1: THE WEST WESTERN BINDING ASSAY 
The west western binding assay involves incubating in vitro expressed and 
radiolabelled proteins with proteins that are immobilised onto a membrane support. 
The degree to which these proteins associate can be determined by autoradiography of 
the washed membrane (Homann et al., 1991). In negative sense, single stranded RNA 
viruses, the various RNA synthetic functions are carried out by the nucleocapsid 
complex which is formed by an association of the N, P, and L proteins. The function of 
the nucleocapsid complex is dependant on the presence of all three components 
interacting with one another and it is presumably through these interactions that the 
nucleocapsid complex is able to alter its function between genorne replication and 
mRNA transcription. The mechanism responsible for this switch is still not understood, 
and this mainly derives from the lack of understanding of how the nucleocapsid 
components interact. The interactions that occur between the components of the 
paramyxovirus SEN have been well studied (Ryan and Portner, 1990, Ryan et al., 
1990; Ryan et cr/., 1991, Homann el at, 1991). However nucleocapsid component 
interactions have not been studied in detail for a pneumovirus of which the 
nucleocapsid components are clearly structurally ditlerent to those of SEN and for 
which the nucleocapsid interactions are also likely to be ditlerent. The west western 
assay was used to study the interactions that occur between the PVM N and P proteins 
and the results of these experiments are presented below. 
178 
N and P Protein Interactions 
10.2: THE FULL-LENGTH PVM N PROTEIN IS ABLE TO INTERACT WITH THE PVM 
Py PROTEIN IN VITRO. 
By using the west western protein binding assay, ; 'S methionine labelled 
rabbit reticulocyte expressed full-length PVM N protein was found to bind to a 
membrane immobilised PVM-infected BSCI cell protein which had a molecular 
weight of 39 kDa (figure 33). Confirmation that the radioactively labelled N protein 
was binding to the PVM Pzq protein was made by using immobilised PVM P19 protein 
expressed from I. coli BL2I transformed with pGEMP (figure 33). There was no 
binding of radiolabelled N protein to cultures of induced /I.. coli BL21 transformed 
with pGEM I. Radiolabelled components of the reticulocyte lysate were unable to 
associate with a PVM-infected cell polypeptide species. 
10.3: IDENTIFICATION OF DOMAINS ON THE PVM N PROTEIN RESPONSIBLE FOR 
BINDING TO RENATURED P PROTEIN. 
10.3.1: Introduction. 
In order to identify regions of the PVM N protein that were involved in binding 
PVM P protein, a set of T7 transcription plasmids was constructed which were able to 
transcribe mRNA expressing a range of' amino and carboxyl-terminally truncated and 
also internally deleted N-related proteins. These N-related proteins were used in the 
west western assay system to see if they were able to associate with immobilised P 
protein. 
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Figure 33. The full-length PVM N protein binds to full-length PVM P protein. (i). Lane 1: 
Radioactively labelled full-length N protein expressed from reticulocyte lysate programmed with 
pGEMN bound to a polypeptide with a molecular weight of 39 kDa expressed in PVM-infected cells 
in the west western assay. No binding occured to a polypeptide with a simialr molecular weight in 
mock-infected cells (lane B). (ii). Confirmation that the PVM-infected cell 39 kDa polypeptide was 
the PVM P protein was made by using the reticulocyte expressed labelled N protein with P protein 
expressed by E. coli BL21 transformed with pGEMP in the west western assay. Lane 1: The 
expression products of IPTG-induced E coli BL21 transformed with pGEMP. Lane 2: Expression 
products of un-induced E coli BL21 transformed with pGEMP. The radioactively labelled N protein 
binds to the bacterially expressed P protein. 
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Figure 34. Construction of transcription plasmids 40-393,82-393,119-393 and 158-393. 
Regions of the PVM N gene cDNA that were lacking 5' sequences were amplified using 
PCR and oligonucleotide primers JB1, JB2, JB3, JB4, and JB5. The positions at which 
these primers anneal to the N gene cDNA is shown in the figure. The amplified fragments 
were blunt ended with Klenow and then digested with Bam HI which cuts within primer 
JB5. The fragments were then ligated into pGEMI that had been digested with Sma I and 
Bam HI. The number designated to each construct represents the amino acids of the 
PVM N gene that the construct has the capacity to encode. 
., ý `ý - 
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10.3.2: TranscriptionJnlasmids constructed using N gene cDNA. 
As described in section 9.1.1, full-length and 5' terminally truncated N gene 
cDNA was inserted into the multiple cloning site of linearised pGEMI, using 
standard molecular techniques, to create the transcription plasmids pGEMN and 
pGEMNTR respectively. The construction of plasmids N40-393, N82-393, N 119-393 
and N 158-393 which all feature a deleted region at the 5' end of the N gene cDNA as 
detailed in figure 34. As there are no appropriate restriction sites in this region of the 
N gene cDNA to create the appropriate deletions, the deletions were created by PCR 
amplification of N gene cDNA between either one of four 5' oligonucleotide primers 
(JB I GGAATTCATGCAGAAAGCCCTTGCAAGG, hybridises to N gene 
nucleotides 149 to I69; JB2 GGAATT('A"I'GATATTAAGAGAAGCCGGC, 
hybridises to N gene nucleotides 274 to 292, . 
I133 GGAATTCATGGATGCAGCC 
AATTTAGCTG, hybridises to N gene nucleotides 386 to 407, JB4 GGAATTCA 
TGATAGTTCTCTGTATTGCAGC, hybridises to N gene nucleotides 503 to 520) 
which determined the precise 5' end of the construct, and a 3' oligonucleotide primer 
(JB5, CCCGGGATCCTAAATATCATCATCAG(GAGTG"I'(', hybridises to N gene 
nucleotides I IS() to 1215) which was common to all four constructs. The location that 
these primers anneal to the PVM N gene cDNA in shown in figure 34. The resulting 
PCR generated fragments were blunt ended and cleaved at sites within the 
oligonucleotide primers by digestion with the restriction enzyme Sam HI. The cleaved 
fragments were isolated by agarose gel electrophoresis and purified by the fragment 
preparation technique after which the fragments were ligated into the multiple cloning 
site of pGEM 1. The number designated to each of these four plasmids and all other T7 
transcription plasmids constructed for use in this assay corresponds to the amino acids 
of the PVM N protein each cDNA clone was capable of encoding. 
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Figure 35. The removal of the Hind III restriction enzyme recognition site from the pGEMN 
multiple cloning site. pGEMN, which contains a full-length cDNA copy of the PVM N gene, 
was digested with restriction enzymes Hine II and Nhe I to remove nucleotides 2623 to 24 
of pGEM1. The ends of the plasmid were blunted using Klenow and ligated to form the 
plasmid pGEMN*. This plasmid now contained a unique Hind III site within the N gene 
cDNA segment which could be used in order to manipulate the N gene cDNA sequence. 
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Constructs NI-196/310-393 and NI-251/310-393 contain N gene cDNA 
which has had an internal segment of coding sequence removed. In order to generate 
Plasmids NI-196/310-393 and NI-250/310-393, the plasmid pGEMN was first 
modified by the removal of the Hind III site present within its multiple cloning region 
which allowed the Hind III site present within the N gene cDNA sequence to be 
utilised for the removal of an internal fragment. The construction of this modified 
version of pGEMN (pGEMN*) is shown in figure 35. Plasmid pGEMN was cleaved 
with Hine II and Nhe 1, blunt ended with Klenow and then religated. The removal of 
the Hine II-N/u' I fragment was confirmed by restriction enzyme digestion. In order to 
derive construct N 1-250/310-393, pGEMN* was then cleaved with Nvi I and Hind III 
which removed an internal region of the N gene cDNA sequence. The ends of the 
plasmid were blunted and then religated and the reading frame was maintained. 
Klenow is able to blunt the Nvi I end by digesting the protruding nucleotides and the 
Hind III end is blunted by the ability of Klenow to fill-in 5' recessed ends. Plasmid N 1- 
196/310-393 was derived from the modified pGEMN by digestion with restriction 
enzymes K/iii I and Hind III. The ends of the plasmid were blunted using Klenow and 
the plasmid was religated. As above, Klenow is able to digest the protruding end of the 
KJnn I cleaved site and fill-in the 5' overhang on the Hind III cleaved site. The 
construction of these plasmids is shown in figure 36. 
Constructs NI-249, NI-3308 and NI-381 were all derived from pGEMN by 
digestion with restriction enzymes to remove fragments of 'N protein carboxyl-terminal 
coding region. The restriction enzymes used to remove the internal fragment in each 
construct are as follows. Construct NI-249 (N., i I and thin, HI), construct NI-308 
(Hint/ III), construct NI-381 (/ vi II and than HI). The altered plasmids were blunt 
ended using Klenow and then religated. Constructs N200-327 and N257-393) were 
derived by removal of a segment of N protein coding region from pGEMNTR, followd 
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by blunt-ending and re-ligation. The restriction enzymes used were Ps/ and Barn HI 
(construct N200-327), and F, co RI and Nsi I (construct N257-393). 
A transcription plasmid capable of directing the expression of the HRSV N 
protein was also constructed by inserting a full-length cDNA copy of the HRSV N 
gene (a gift from Dr. C. Caravokyri, University of Warwick, UK. ) into pGEM1. 
The N gene cDNA fragments present in all the above constructs are 
schematically represented in figure 37. 
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Figure 36. Construction of transcription plasmids 1-196/310-393 and 1-250/310-393 which 
contain N gene cDNA fragments which have internally deleted regions. (a). pGEMN* (construction 
details figure 36) was cleaved with restriction enzymes Kpn I and Hind III which removed 
nucleotides 621-954 of the N gene cDNA. The ends of the plasmid were blunted using Klenow 
and then relegated to create the plasmid 1-196/310-393. The reading frame was maintained. (b). 
pGEMN* was cleaved with restriction enzymes Nsi I and Hind IH which removed nucleotides 
777-954 of the N gene cDNA. The ends were blunted using Klenow and then religated to form 
plasmid 1-250/310-393. The reading frame was maintained. 
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Figure 37. Diagrammatical representation of the N gene cDNA fragments contained within the T7 
transcription plasmids used to express the truncated and internally deleted N protein species for use in the 
west western binding assay. The PVM N gene is represented diagrammatically at the top of the figure, 
and the positions of the restriction enzyme recognition sites that were used for the construction of these 
transcription plasmids are indicated. The number of the construct that contained each individual N gene 
cDNA fragment is given at the S' end of each fragment. The designated number details the amino acids of 
the N protein that each cDNA fragment encodes. The amino acids of the PVM N protein that are deleted in 
the subsequently expressed N protein species is shown on the 3' end of each fragment. The ability of the 
N-related proteins to bind to the PVM P protein in the west-western assay is also shown, and is expressed 
as a percentage of the ability of full-length N protein to bind P protein. 
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10.3.3: In vitro expression of N protein related polypeptides. 
From this set of T7 transcription plasmids, mRNAs were transcribed which 
were able to direct the synthesis of a series of internally deleted and amino- and 
carboxyl-terminally truncated radioactively labelled fbrms of the N protein in a rabbit 
reticulocyte lysate system. SDS-PAGE analysis of the altered radiolabelled N protein 
species revealed that all the species migrated to give an observed molecular weight 
which was consistent with their predicted molecular weights (figures 38 and 39). In 
addition to the presence of the intended altered N-related proteins, minor species of a 
lower molecular weight were commonly seen as expression products of the various 
mRNA species. These are expressed as a result of initiation events on internal AUG 
initiation codons located downstream of the first and therefore most frequently used 
initiation codon present on each of the mRNA species. The initiation codon located at 
nucleotide positions 629 to 631 on the N gene is particularly favourable as a site of 
internal initiation due to its favourable context (section 9.3.2), and initiation seems to 
have occurred from this site during the expression of many of the constructs. It is likely 
that the internally initiated N-related proteins will probably not be as effective at 
binding P protein than the intended full-length product of each altered mRNA because, 
by the nature of their expression, they will represent only a portion of the intended full- 
length species. The inclusion into the binding assay of a quantity of polypeptides that 
are less able to bind immobilised P protein than the intended species may lower the 
apparent P protein binding ability of this species. This is because each set of translation 
products was applied to the membrane in a quantity that was determined by the level of 
incorporated radioactivity and so if an amount of poorly binding species were included 
in this quantity then there would be a lower proportion of the intended species present. 
However since in the case of each altered N-related protein 
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Figure 38. Expression of truncated PVM N proteins for use in the west western binding assay 
mRNAs were transcribed from a set of T7 transcription plasmids which contained inserts capable 
of directing the synthesis of amino-terminally truncated versions of the PVM N protein The 
mRNAs were used to programme a reticulocyte lysate system and the radioactively labelled 
expression products were analysed by SDS-PAGE and the resulting gel was autoradiographed in 
order to visualise the polypeptides. Theplasmids used to transcribe the mRNAs were as follows. 
pGEMN (lane A), pGEMNTR (lane B), N40-393 (lane F), N82-393 (lane E), N119-393 (lane D), 
N158-393 (laneC). Construction of theseplasmids is detailed in section 10.3.2. The position of 
molecular weight markers are marked on the left. 
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Figure 39. Expression of modified PVM N proteins for use in the west western binding assay. 
mRNAs were transcribed from a set of T7 transcription plasmids which contained inserts capable 
of directing the synthesis of amino-terminally, carboxyl-terminally and internally deleted versions 
of the PVM N protein. The mRNAs were used to programme an in vitro translation system and the 
radioactively labelled expression products were analysed by SDS-PAGE. The resulting gel was 
autoradiographed in order to visualise the polypeptides. The plasmids used to transcribe the mRNAs 
were as follows. N257-393 (lanes A and C), N200-327 (lane B), pGEMNTR (lane D), N1-196 (lane 
E), NI -249 (lane F), N 1-308 (lane G), N1 -196/310-393 (lane H), NI -196/251-393 (lane 1), NI -381 
(lane J), pGEMRSN (contains full-length HRSV N gene cDNA, lane K), pGEMN (lane L). With the 
exception of lane C, for which a wheat germ lysate was used, all translations were performed in 
reticulocyte lysate. The construction of the above plasmids is detailed in section 10.3.2. The position 
of molecular weight markers is indicated on the right. 
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construct, the intended polypeptide is present as the overwhelmingly major species, the 
minor internally initiated species probably do not make a significant difference to the 
calculated P protein binding affinities. 
10.3.4: The ability of the altered N protein species to bind to PVM P protein. 
By using the binding assay, it was possible to test each of the `SS methionine 
labelled N protein species for their ability to bind to PVM P protein present in the 
PVM-infected BSCI cell material immobilised onto the PVDF membrane. 
Autoradiographs of the filters on which the binding assays were performed are shown 
in figures 40 and 4I I. The autoradiographs were subjected to densitometric analysis to 
quantify the extent of binding that had occurred. The optical density of the 
autoradiograph that corresponded to an area of the filter immediately adjacent to a 
region where binding had occurred was taken as background and was subtracted from 
the optical density reading of the autoradiograph region which corresponded to the 
bound protein. In order to compare the binding abilities of each of the N-related 
proteins, the optical density of the autoradiograph band representing hound N-related 
proteins had to be related to the number of molecules of the radioactively labelled 
species bound to the immobilised P protein at that position. The N-related proteins 
that were applied to the membrane contained different numbers of radiolabelled 
methionine residues and consequently to relate the hound N-related protein species 
signal intensity to an actual number of molecules of that species, an adjustment factor 
was introduced which, for example, would account for the increased signal that a full- 
length N protein molecule, which contained nine radioactively labelled methionines, 
would produce compared with a truncated N-related proteins containing only three 
labelled methionines. The number of molecules of each N protein species applied to 
the membranes were not accurately standardised although the 30,000 cpm of 
incorporated label initially incubated with the membrane would contain 
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Figure 40. Determination of the regions of the PVM N protein that are required in order to bind 
PVM P protein. A series of modified N proteins were expressed using reticulocyte lysate 
programmed with mRNAs transcribed from T7 transcription vectors containing PCR amplified 
N gene cDNA fragments. The construction of these plasmids is detailed in section 10.3.2, and 
the polypeptides expressed by these plasmids are shown on figure 38. The radioactively labelled 
altered N proteins were then used in the west western assay with PVM-infected and mock 
infected cell material that had been subjected to SDS-PAGE and immobilised onto a PVDF 
membrane. The membrane was cut into strips of which the left hand lane (+) contained PVM- 
infected cell material and the right hand lane (-) contained mock-infected cell material. The 
plasmids used to express the various N proteins are as follows. N40-393 (strip A), N82-393 
(strip B), N119-393 (strip C), NI 58-393 (strip D), pGEMNTR (strip E), pGEMN (strip F). The 
position of molecular weight markers is shown on the right. 
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Figure 41. Determination of the regions of the PVM N protein that are required in order to bind PVM 
P protein. A series of modified N proteins were expressed using reticulocyte lysate programmed with 
mRNA transcribed from T7 transcription vectors containing altered N gene cDNA fragments. The 
construction of these plasmids is detailed in section 10.3.2, and the polypeptides expressed by these 
plasmids are shown on figures 38 and 39. The radiolabelled altered N proteins were then used in the 
west western assay with PVM infected and mock-infected cell material that had been subjected to 
SDS-PAGE and then immobilised onto a PVDF membrane. The membrane was cut into strips of 
which the left hand lane (+) contained PVM infected cell material and the right hand lane (-) contained 
mock infected cell material. The plasmids used to express the various N proteins are as follows 
pGEMN (strip A), pGEMRSN (contains full-length HRSV N gene cDNA, strip B), N1-381 (strip C), 
N1-196/251-393 (strip D), N1-196/310-393 (strip E), N1-308 (strip F), NI-249 (strip G), N1-196 
(strip H), pGEMNTR (strip I), N200-327 (strip J), N257-393 (strip K). The position of molecular 
weight markers is indicated on the right. 
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approximately equal numbers of radioactively labelled N protein species. However as 
the P protein would be present in vast excess, sub-saturation kinetics would apply to 
the association reaction and consequently, the small variation in the initial quantity of 
applied N protein species would not affect the degree of interaction between the N and 
P proteins. The extent to which radiolabelled full-length N protein bound to membrane 
immobilised P protein was considered to be 100%, and the binding of all other 
radiolabelled N-related proteins was expressed relative to this. These binding affinity 
values are listed next to the corresponding construct in figure 37. The values represent 
the means of binding affinities calculated from two identical binding experiments. The 
autoradiograph obtained from only one of these experiments is shown in figures 40 and 
41. 
All the amino acid deletions introduced into the various expressed truncated N 
proteins reduced their relative P protein binding allinities. These deletions spanned 
most of the coding region of the N protein and thus it seems that large parts or several 
domains of the N protein are involved in the binding, process. The expression product 
of construct pGEMNTR which represents the carboxyl-terminal half of the full-length 
N protein was able to bind the P39 protein with a relative binding affinity of 18% 
whereas the expression product of construct NI-196 which comprises the amino- 
terminal half of the full-length N protein bound P protein with an affinity of only 4%. 
Although this figure of 4% is small, specific binding was still clearly taking place and 
may reflect an inherent ability of certain portions of the N protein to contribute to the 
overall binding of the full-length protein. Polypeptides encoded by constructs N 1-249, 
N 1-308 and Nl -381 were all carboxyl-terminally extended derivatives over the product 
of construct N ]- 196. Polypeptides encoded for by constructs N 1-249 and N 1-308 
display approximately equal but extremely low P protein binding affinities, whereas the 
polypeptide generated from construct N 1-381, which lacks only 12 carboxyl-terminal 
amino acids of the N protein, has a relative binding affinity of 68% over full-length N 
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protein. This observation suggests that the immediate carboxyl-terminal region of the 
N protein is involved in the P protein binding process, but that it is not essential for it. 
Constructs N257-393 and N200-327 are derived from construct pGEMNTR by 
removal of either the amino-terminal or carboxyl-terminal N protein coding region 
respectively. Polypeptide products expressed from both constructs displayed 
considerably reduced binding affinities (6% and 5% respectively), when compared to 
the product of the original construct pGEMNTR. Expression products of constructs 
N 1- 196/25 1-393 and N 1-196/310-393 have lost internal regions of N protein coding 
sequence, and both show a marked decrease in P protein binding affinity relative to 
full-length N protein (1 1% and 5% respectively). The N-related proteins expressed 
from the PCR generated constructs N40-393, N82-393, N 119-393 and N 158-393 are 
all related to one another by progressive truncations at their amino-terminal ends. The 
largest of these truncated N proteins, expressed from construct N40-393, has lost only 
39 residues from the amino-terminal end of the full-length N protein and has a relative 
binding affinity of 32%. It thus seems that the immediate amino-terminal region of the 
N protein is essential for efficient binding of P protein. The expression products of 
constructs N82-393, N 119-393, N 158-393, pGEMNTR and N257-393 display 
respective binding affinities of 50%, 59%, 39%, ')1% and 6%. This series of N protein 
species, having progressively truncated carboxyl-terminal regions, displays 
approximately progressive reduction in P protein binding affinity. 
The relative binding affinity of the HRSV N protein for the PVM P protein is a 
reflection on the degree of similarity that exists between the N proteins of PVM and 
HRSV. 
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10.4: IDENTIFICATION OF DOMAINS ON THE PVM P PROTEIN THAT ARE INVOLVED 
IN BINDING TO PVM N PROTEIN. 
10.4.1: Introduction. 
Binding of 35S methionine labelled P protein species to membrane immobilised 
N protein was not detected using the west western assay described above. In order to 
identify domains on the PVM P protein involved in binding N protein an alternative 
approach was adopted which involved immobilising bacterially expressed amino- 
terminally and carboxyl-terminally truncated versions of the PVM P protein to a 
membrane support and determining which of these altered species were able to retain 
radioactively labelled full-length N protein. The carboxyl-terminally truncated P 
proteins were expressed using the transcription plasmids described in section 10.4.2 
and the amino-terminally truncated P proteins were expressed using transcription 
plasmids pGEMP and pGEMPi7 which are described in sections 4.1 and 4.2.2 
respectively. 
10.4.2: Construction of plasmids to express carboxyl-terminated P protein 
s e1 cies. 
A range of plasmids were constructed which were capable of directing the 
expression of various carboxyl-terminally truncated versions of the PVM P protein in 
E. cry/i BL2I. Construction details of these plasmids is shown in figure 42. The full- 
length P gene cDNA insert within pGEM I was cleaved with a variety of restriction 
enzymes to remove regions of the P protein coding sequence. The restriction enzymes 
used in the constructions are shown in figure 42. The ends of the plasmid were blunt 
ended using Klenow and then re-ligated. In this way the transcription vectors 
pGEMP. Sýy, pGEMPHinc and pGEMP. S/» were constructed. Figure 42. Construction 
of pGEMPsty, pGEMPStu and pGEMPHinc. 
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Figure 42. Construction of transcription plasmids pGEMPSty, pGEMPStu and pGEMPHinc. (a) The 
full-length P gene cDNA fragment within pGEMP was cleaved by restriction enzymes Sty I and Hind III 
which removed a segment containing P gene nucleotides 731-903. The resulting ends of the cleaved 
pGEMP were blunted using Klenow and religated to form the plasmid pGEMPSty. (b). pGEMP was 
cleaved with Stu I and Hind III to remove P gene nucleotides 591-903. The ends were blunted and then 
religated to form the plasmid pGEMPStu. (c). pGEMP was digested using Hinc II and Hind III to 
remove P gene nucleotides 289-903. The ends were blunted and religated to create plasmid 
pGEMPHinc. 
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Figure 43. Diagrammatical representation of the PVM P gene cDNA fragments contained within the 
T7 transcription plasmids used to express the truncated and internally deleted P protein species for 
use in the west western binding assay. The PVM P gene is represented diagrammatically at the top 
of the figure, and the positions of the restriction enzyme recognition sites that were used for the 
construction of these transcription plasmids are indicated. The number designated to each constructs 
is given on the right of each fragment. The amino acids that are present in the P protein related 
polypeptides encoded for by the P gene cDNA fragments is shown at the left of each fragment. Only 
the full-length P protein (amino acids 1-295) was able to bind to N protein using the west western 
assay 
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The regions of the P gene that were used to express altered P protein species are 
diagrammatically represented in figure 43. These transcription plasmids were 
transformed into E. coli BL21 in a method identical to that used for the transformation 
of E. coli TG2 (section 2.5.2). 
10.4.3: The abilities of the altered P protein species to bind to PVM N protein. 
By expressing the amino-terminally and carboxyl-terminally truncated P protein 
species in E. coli BL21, quantification and accurate standardisation of the amount of 
the modified P proteins initially immobilised to the membrane was not possible. 
However if the immobilised P protein species were present in excess over the 
radiolabelled N protein, which was probably the case, the kinetics of the reaction 
would suggest that standardisation of the quantity of P protein species immobilised 
onto the membrane would have little effect on the outcome of the binding experiments. 
Despite this, an attempt was made to immobilise each of the P protein species to the 
filter in approximately equimolar amounts. This was achieved by estimating the 
abundance of each of' the P protein species in the /".. cull BL2 I expression products 
from a Westen blot (figure 44) and then proportionately scaling up the quantities of 
bacterial expression product that were applied to the west western filter. The filter was 
then incubated with 35S methionine labelled N protein synthesised in vitro using 
pGEMN This construct also directed the synthesis of the 24 kDa N protein related 
polypeptide discussed in section 9.1.2. An autoradiograph of the filter on which the 
binding assay was performed is shown in figure 45. 
None of the amino-terminally deleted P protein species expressed from 
pGEMP37 were able to bind to radiolabelled full-length N protein. Similarly, none of 
the polypeptides expressed from the plasmids pGEMP. i'ty, pGEMPS/u or pGEMPHinc 
were able to bind the in vitr"n expressed full-length N protein. It thus 
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Figure 44. Western blot of truncated P proteins used in the west western blot assay. The 
expression products of IPTG-induced E coli BL21 transformed with transcription plasmids 
pGEMP (lane A), pGEMP37 (lane B), pGEMPSty (lane C), pGEMPStu (lane D), 
pGEMPHinc (lane E) and pGEMI (lane F) were subjected SDS-PAGE analysis, and then 
Western blotted using monoclonal antibodies 26/3/B5 and 26/1/A2. The positions of the 
polypeptides encoded for by these transcription plasmids are marked on the left. The 
position of molecular weight markers are indicated on the right. 
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Figure 45. Determination of the regions of the PVM P protein that are required in order to bind 
PVM N protein. E coli BL21 was transformed with a set of T7 transcription plasmids 
containing various P gene cDNA inserts that were capable of directing the expression of amino 
and carboxyl terminally truncated P proteins. The IPTG-induced bacterial expression products 
were immobilised onto a PVDF membrane and used with radioactively labelled full-length N 
protein in the west western assay. For comparison, PVM-infected (lane A) and mock-infected 
(lane B) cells were also immobilised onto the membrane. The transcription plasmids used to 
transform the E. coli BL21 are as follows. pGEMP (lane C), pGEMP37 (lane D), pGEMPSty 
(lane E), pGEMPStu (lane F), pGEMPHinc (lane G) and pGEMI (lane H). The position of 
molecular weight markers are shown on the left. 
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seems that regions at both the amino-terminus and the carboxyl-terminus of the P 
protein are required to be present for the PVM P protein to bind to N protein. 
10.5: DI$CUSSIoN. 
10.5.1: PVM N protein binds to immobilised PVM P protein. 
Under the conditions of this assay, the PVM N protein is able to specifically 
interact with the PVM P protein. In order to identify regions of the N protein 
important in binding to P protein, a series of truncated and internally deleted forms of 
the N protein were expressed and used in the assay to see if they were capable of 
binding to the P protein present in immobilised PVM-infected BSCI cell material. To 
find regions of P protein involved in binding to N protein, several bacterially expressed 
and modified terms of the P protein were immobilised onto a membrane and were 
assayed for their ability to bind radiolabelled full-length N protein. 
10.5.2: The regions of the N protein that are involved in binding P protein. 
Analysis of the interaction that was observed between P protein and the deleted 
N proteins revealed that the regions involved in binding to P protein are spread 
throughout the length of the N protein. All of the deletions introduced into the N 
protein coding region caused some degree of reduction in the ability to hind P protein. 
This observation does not suggest that all the residues in the N protein coding region 
are directly involved in forming an association with the P protein. It is possible that the 
ability of N protein to bind P protein is dependent on maintenance of a three- 
dimensional structure which holds certain domains of the N protein in the correct 
conformation for binding to occur. Removal of amino acids from any part of the N 
protein probably has the effect of altering this three-dimensional structure and 
201 
N and P Protein Interactions 
consequently the binding domains will no longer be arranged in the correct 
conformation for optimal binding to occur. if the amino acids that are removed are 
from the binding domains themselves then binding activity will be significantly reduced. 
Another possibility is that the N protein contains several P protein binding domains, 
some of which are able to hind P protein independently, and these domains all 
contribute to the binding of P protein in a cooperative manner. Although deletions did 
cause a reduction in binding affinity, in no construct was binding totally abolished. This 
suggests that all residues that were deleted in the constructs do contribute to the 
overall P protein binding capability of the N protein. This observation is similar to the 
findings of Homann of at., (1991) which suggested that large regions of the SEN N 
protein were involved in binding to SEN P protein. The polypeptide products 
expressed from construct N 1-196 and construct pGEMNTR, which represent different 
halves of the N protein, are able to bind P protein with affinities of 4% and 3 1% 
respectively even though they do not possess any common sequence. This suggests 
that there are independent domains in both the amino and carboxyl-terminal halves of 
the N protein which are on their own capable of binding P protein, albeit with low 
affinity. The expression product of construct pGEMNTR was able to bind to P protein 
with an affinity over 7 times that of the expression product of construct N 1-196 which 
suggests that the carboxyl-terminal binding domain may contribute more to the binding 
of P protein than the amino-terminal domain. The N protein species encoded for by 
construct N1-382 has lost only the carboxyl-terminal II residues of the full-length N 
protein. This deletion has reduced the P protein binding affinity of this species to 68% 
of the full-length N protein which indicates that the extreme carboxyl-terminus of the 
N protein is involved to some extent but is not a major determinant in the process of 
binding P protein. 
The region of the PVM N protein spanning residues 220 to 315 displays 
extremely high homology with the corresponding region of the HRSV N protein (Barr 
el cil., 1991). The conservation of amino acid sequence that is seen here suggests that 
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the homologous region may contain a functionally important site. The polypeptides 
expressed from construct NI-196/251-39') has lost amino acids 197 to 250 which are 
partly from this region and this deletion resulted in aP protein binding affinity of only 
11%. Perhaps the homologous region represents an area of the PVM N protein where 
conformation is particularly sensitive to structural changes such that removal of any 
part of this region severely reduces P protein binding ability. The 54 amino acids 
deleted from the protein expressed from construct N 1-196/251-393 are unlikely to 
constitute an independent P protein binding domain since the expression product of 
construct N200-327 contains this region plus an additional 83 carboxyl-terminal 
residues, but displays aP protein binding affinity of only 5%. This further reinforces 
the suggestion that the conformation of the N protein is important in determining 
binding capacity. It is not known what structural feature(s) of the PVM N protein 
makes it able to bind P protein. The P protein is highly negatively charged, particularly 
at the carboxyl-terminus, and so maybe the interaction that occurs is mediated by a 
binding domain on the PVM N protein that is positively charged. 
10.5.3: Regions of the P protein that are involved in binding N protein. 
The regions of the P protein involved in binding to N protein were investigated 
using a limited range of deleted P protein constructs. None of the amino-terminally 
truncated P protein species immobilised on the membrane were capable of binding to 
the radiolabelled, full-length N protein. The observation that the E. coli expressed P26 
or P23 polypeptides were not able to bind 35S methionine labelled N protein was not 
surprising as labelled N protein did not bind to the 26 kDa and 23 kDa P-related 
polypeptides expressed from PVM-infected BSCI cells (section 10.2). The 37 kDa P 
protein species expressed from pGEMP37 has lost only 40 amino-terminal amino acids 
of the Hull-length P protein and so the inability of this species to bind N protein 
indicates that the extreme amino-terminus of the P protein is essential for maintenance 
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of N protein binding ability. Additionally, none of the carboxyl-terminally truncated P 
protein species were capable of binding to radiolabelled N protein. The P protein 
species expressed from pGEMPSty has lost only the carboxyl-terminal 57 amino acids 
and since the loss of these residues coincided with the loss of N protein binding ability, 
the extreme carboxyl-terminal region of P protein also appears to be essential for 
preservation of N protein binding activity. Neither region however comprises a 
complete N protein binding site since the amino-terminal 40 amino acids is contained in 
the expression product of pGEMPSty and conversely the carboxyl-terminal 57 amino 
acids are contained within the expression product of pGI: MP37, and neither species 
can bind N protein. These results suggest that regions at both the amino-terminus and 
also the carboxyl-terminus are needed for the formation of a functional N protein 
binding site. The finding that both of the extreme termini of the PVM P protein are 
indispensable for N protein binding to occur is in contrast to the results obtained for 
the SEN P protein in which removal of the amino-terminal 344 amino acids had no 
affect on its ability to bind N protein (Ryan et al., 1991). This observation indicates 
that the pneumovirus P protein may have a different arrangement of functional domains 
to the P proteins of other members of the family Pararnyxuviridae. 
The ability of bacterially expressed P protein to associate with PVM N protein 
in this assay suggests that phosphorylation may not be important in the binding 
process, since bacterial systems are not considered able to be capable of' the 
appropriate phosphorylation that is a feature of' mammalian tissue culture systems 
(Barik and Banerjee, 1991). 
By analogy with other closely related viruses, including HRSV, the PVM N 
protein would be expected to be able to bind to itself (Sarnal et a/., 1993). However, 
using this assay, binding of radiolabelled N protein to immobilised N protein was not 
observed. Radiolabelled N protein did not bind to any PVM-infected BSC I cell species 
other than PVM P protein. 
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Since radiolahelled N protein was able to hind immobilised P protein, the 15S 
methionine labelled P protein might have been expected to bind to N protein present in 
the immobilised PVM-infected BSCI cell material. However, at no time in this study 
was immobilised N protein observed to bind either reticulocyte expressed N protein or 
reticulocyte expressed P protein. It is possible that the renaturation conditions used for 
the immobilised PVM-infected BSCI cell material were sufficient to restore the 
binding capabilities of immobilised P protein such that it could bind to radiolabelled N 
protein, but conditions were not suitable to restore the binding ability of the 
immobilised N protein for both radiolabelled N and P protein species. It thus seems 
that the immobilised N and P protein species require different conditions to allow 
restoration of their respective binding capabilities. These observations also suggest that 
the insufficient renaturation that the immobilised N protein has experienced has 
affected not only the domain that hinds the P protein but also the domain responsible 
for interaction with other N protein molecules. 
By the use of the PCR, more highly resolved N and P protein expressing 
constructs may be generated which, in conjunction with the binding assay described 
here, would provide further information as to which residues are required for 
interaction with nucleocapsid components. The assay system used in this study was 
able to investigate the way in which two virally encoded proteins interacted with each 
other in isolation from other viral proteins However, the pneumovirus nucleocapsid 
complex is, by analogy with the paramyxovirus complex, thought to he composed of 4 
components, the N protein, the P protein, the L protein and the RNA template. It is 
possible that the interaction that occurs between just 2 components of the nucleocapsid 
complex, as has been investigated in this study, may differ if other nucleocapsid 
complex components were present. Another important point to bear in mind in the 
interpretation of these binding assay results is that iii vivo, the nucleocapsid protein is 
usually present assembled into nucleocapsid structures composed of many hundred 
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associated N protein units surrounding the vRNA genome. The way in which the N 
protein interacts with P protein when it is assembled into nucleocapsid structures may 
well be different to the way in which it interacts when it is unassociated. In addition to 
the design of more highly resolved constructs, introduction of other nucleocapsid 
complex species into such an assay may lead to greater understanding of the 
interactions that occur in this elaborate association. 
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11.1: INTRODUCTION. 
Sequence homology comparisons suggest that the PVM P gene and P protein 
are closely related to the P genes and P proteins of the other pneumoviruses HRSV 
and TRTV, but show no homology to their counterparts in morbilliviruses or 
paramyxoviruses. Nucleotide sequence analysis of the PVM N gene has also revealed 
that, whilst the N gene and N proteins were highly homologous to their pneumovirus 
counterparts, they do not possess any significant sequence homology to the NP genes 
and NP proteins of morbilliviruses or paramyxoviruses (Barr ei crl., 199I ). Whilst these 
sequence homology comparisons show that the pneumovirus N and P proteins are 
different to their morbillivirus or paramyxovirus equivalents the pneumovirus 
nucleocapsid complex is believed to be organised and to function in a similar way to 
those of the morbilliviruses or paramyxoviruses. Whether this concept of the structure 
and function of the pneurnovirus nucleocapsid by analogy with what is known of other 
negative strand viruses is warranted, is not yet clear as it is not supported by 
experimental data. This study investigated the expression characteristics of the N and P 
genes of PVM both in viü"o and in vivo and attempted to characterise the polypeptides 
that these two genes are able to express. In addition, the interactions between the N 
and P proteins were investigated to characterise the nature of the association between 
the two major protein components of the nucleocapsid complex as an initial step in the 
characterisation of this structure which is central to the replication, transcription and 
assembly of the virus. 
11.2 THE EXPRESSION CHARACTERISTIC'S OF THE PVM P GENE. 
Work presented in this thesis has shown that in vitro, the PVM P gene long 
ORF is able to express the 39 kDa PVM P protein and at least four other polypeptides 
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with molecular weights of 37 kDa, 26 kDa, 23 kDa and 16 kDa. These four P protein 
related species were shown to be expressed by independent ribosomal initiation on 
internal AUG codons of the P gene rnRNA. In addition to the 39 kDa P protein, the 26 
kDa and 23 kDa P protein species identified in vitro also appeared to be expressed in 
PVM-infected BSC I cells and this was supported by the results of anti-P protein 
monoclonal antibody epitope ºnapping studies. Formal confirmation that the in vivo 
expressed 26 kDa and 23 kDa polypeptides represented their in vitro expressed 
counterparts would require amino-terminal peptide sequence analysis. Seven other P 
protein related polypeptide species were also expressed in PVM-infected cells although 
the identity of these species is unknown. Because of their observed molecular weights 
it is unlikely that they represent primary expression products of internal initiation. 
Many of these species appear to be highly abundant and so peptide sequence analysis 
on these polypeptides to determine their identity may he possible. The 26 kDa and 23 
kDa polypeptides are analogous to the X protein of SEN which is expressed from an 
internal AUG codon of the P protein ORF (Curran and Kolakofsky, 1988b). A 
polypeptide thought to represent the product of the PVM P gene second ORF (P2) 
was also identified in PVM-infected BSC I cells. As above, formal confirmation that 
this polypeptide was expressed from the P gene second ORF would require peptide 
sequence analysis of this polypeptide species. The (P2) polypeptide is analogous to the 
C, C', YI and Y2 proteins of SEN. In common with the P genes of many other 
paramyxoviruses and morbilliviruses, it thus seems that the PVM P gene is able to 
direct the in vivo expression of multiple polypeptides from both the long and the short 
ORFs. The expression of all the polypeptides in addition to the PVM P protein appears 
to occur by way of independent ribosomal initiation on downstream AUG codons. In 
many paramyxoviruses and morbilliviruses the P gene coding region contained in the 
alternative V ORF is accessed by way of RNA editing which allows transcription of 
mRNAs possessing non-templated nucleotides. A sequence corresponding to the 
consensus paramyxovirus and morbillivirus P gene polymerase slippage site was not 
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identified on the PVM P gene suggesting that the second ORF is not accessed through 
the process of RNA editing. Similarly, analysis using anti-peptide antisera used to 
detect the second ORF protein suggested that frame-shifting between the two ORFs is 
unlikely to occur. However, given the dissimilarity between the pneumoviruses and the 
other members of the Parwvyxoviridae family, the possibility that the PVM P gene 
uses a unique RNA editing mechanism to give rise to additional polypeptides should 
not be ruled out. 
The presence of an extensive second ORF in the PVM P protein is a feature 
unique within the pneumovirus genus. It is not known what function the polypeptide 
product that is expressed from the P gene second ORF performs in the life cycle of 
PVM. The expression of a polypeptide from this ORF may he indicative of a 
fundamental difference that exists between processes that occur in the life cycle of 
PVM compared to the other pneumoviruses. The additional coding capacity of the 
PVM P gene over the P genes of other pneumoviruses may reflect a different 
requirement dictated by the PVM host cell environment. Alternatively, PVM may have 
evolved control mechanisms additional to those used by other pneumoviruses which 
are able to regulate processes such as virus assembly and RNA synthesis. If this is the 
case then the PVM P2 polypeptide would be functionally analogous to the SEN C and 
V polypeptides which have been shown to down regulate RNA synthesis. However it 
is possible that the P gene second ORF may supply PVM with a function that is 
expressed by the other pneumoviruses in a different viral component such as the L 
protein or the largely uncharacterised IC and IB polypeptides. 
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11.3: THE EXPRESSION CHARACTERISTICS OF'F1lE PVM N GENE. 
In vitro expression studies revealed that the PVM N gene was able to direct the 
synthesis of the PVM N protein and an additional and highly abundant 24 kDa 
polypeptide. This 24 kDa species was shown to be expressed by initiation on an 
internal N protein ORF AUG codon that is in an extremely favourable nucleotide 
context. In vivo, two products of the PVM N gene were also identified, the PVM N 
protein and a highly abundant 30 kDa polypeptide. The 24 kDa N-related polypeptide 
seen in vitro was not present in vivo. Because of its molecular weight, the 30 kDa 
polypeptide was thought not to represent a primary expression product of initiation on 
an internal AUG codon. More likely is that the 30 kDa species represents a modified 
expression product of internal initiation or alternatively a cleavage product, arising as a 
result of a specific protease cleavage event. Although unlikely, it is possible that it 
arises as a result of the PVM-infected BSC I cell harvesting procedure. As with the 
other unidentified PVM proteins expressed in vivo, peptide sequence analysis could be 
used to reveal which part of the N protein the 30 kDa polypeptide represented, and 
pulse-chase labelling could be used to determine if the 30 kDa polypeptide arises by 
way of cleavage of full-length N protein. 
11.4: POSSIBLE ROLES FOR THE ADDITIONAL N AND P GENE ENCODED PROTEINS. 
The role played by the N, P and L proteins of I'arcrmyxoviridoe family 
members in the process of transcription and replication have been particularly well 
studied in SEN, and several tünctions and associations have been deduced for each 
nucleocapsid component. Amongst other associations there is much evidence to 
suggest that in VSV, the P protein binds to N protein to prevent N from assuming a 
self-aggregated form not capable of supporting genome replication (Howard and 
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Wertz, 1989). It is not known if the aggregated form of the SEN N protein performs 
any function. Therefore, any component that prevents the N and P proteins from 
binding to each other would affect genome replication. Whether the PVM N and P 
proteins are required to form a similar association that is essential for delivering the N 
protein in a replicational competent state is not certain although as this association is 
fundamental, it is likely that they do. 
The additional amino-terminally truncated polypeptides expressed in vivo by 
the PVM P gene long ORF and also the 30 kDa N polypeptide may be able to affect 
PVM RNA synthesis by interfering with the association between full-length N and P 
proteins. With the use of a protein binding assay, it was determined that neither of the 
two in vivo expressed internally initiated P protein forms (26 kDa and 23 kDa) were 
capable of interacting with the PVM N protein. Therefore, these truncated P protein 
species are probably unable to influence the association of the N and P proteins and if 
they are effectors of RNA synthetic mechanisms they would have to act through 
association with a component other than the N protein, such as the L protein or the P 
protein itself. 
Both the amino and carboxyl-terminal halves of the PVM N protein (amino 
acids 1-196 and 200-393 respectively) were found to be independently capable of 
binding P protein although with reduced binding affinities (5% and 20% respectively) 
This finding suggests that regardless of whether the 30 kDa N protein species is 
internally initiated or whether it is generated as a result of amino-terminal or carboxyl- 
terminal cleavage from full-length N protein, it will possess at least some PVM P 
protein binding ability. If the transcription and replication processes of PVM and SEN 
share a fundamental outline, presence of the 30 kDa N protein species in PVM-infected 
cells would result in a proportion of the free P protein being sequestered by the 30 kDa 
species and consequently being unavailable for binding to N protein. The quantity of N 
protein associated with P, and consequently the quantity of N protein available for 
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genorne encapsidation would therefore decrease and the quantity of aggregated N 
protein would increase. According to current opinion, if this situation existed in the 
course of a SEN infection it would delay the switch between transcription and 
replication (Kolakofsky el al., 1991). Expression of the 30 kDa species may also lead 
to an increase in the quantity of aggregated N protein, the function of which is 
uncertain. Since the P protein binding ability of the 30 kDa protein will be less than 
that for full-length N protein the postulated effect of the 30 kDa polypeptide may not 
be significant. These postulated functions may not apply to PVM because of the 
existence of uncharacterised proteins, such as the 1C and 113 proteins, which may be 
involved in mechanisms that control the polymerase complex in a wholly different way 
to that of SEN. 
In conclusion, the work presented in this thesis has revealed that the PVM P 
gene possesses two extensive open reading frames and that both of these are able to 
express polypeptide products iii vivo. The expression characteristics of the PVM N 
gene were also investigated and was found to direct the in Om synthesis of the 43 kDa 
N protein and possibly a polypeptide with a molecular weight of 30 kDa. The ability of 
the PVM N and P proteins to associate with each other was studied and broad regions 
of these polypeptides that were involved in this interaction were identified. 
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